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 ABSTRACT  
 
Proper lipid metabolism is essential to the maintenance of milk production 
and fitness in the modern dairy cow.  Little is known about the regulation of lipid 
metabolism in adipose tissue in dairy cattle, including the roles of adipokines and 
lipid droplet associated proteins. Therefore, the objectives of this study were to 
characterized changes in transcript abundances of adipokines during three different 
energy altering models, and lipid droplet associated proteins throughout the 
transition period and with leptin induced lipolysis. Transcript abundances of leptin 
decreased during feed restriction, while angiopoietin like protein 4 (ANGPTL4) 
increased during early lactation, feed restriction, and following growth hormone 
administration.  Therefore, reduced lipid uptake by adipose tissue during declining 
energy balance may be due to ANGPTL4 inhibiting lipoprotein lipase. 
Phosphorylation of hormone sensitive lipase (HSL) and perilipin increased during 
early lactation, but protein abundance of adipose triglyceride lipase (ATGL), the rate 
limiting step in lipolysis, decreased. Unlike lipid catabolism during early lactation, 
leptin induced lipolysis was mild, and protein abundance of ATGL and 
phosphorylation of STAT3 increased.  These responses were attenuated with the 
addition of a STAT3 inhibitor. Therefore, leptin increased ATGL protein abundance 
through STAT3. This novel regulation of ATGL by STAT3 demonstrates a potential 
mechanism that allows for the differential regulation of HSL and ATGL.  In 
conclusion, this research identified two novel mechanisms of lipid metabolism in 
dairy cattle which may allow for the development of strategies to optimize lipid 
metabolism.      
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CHAPTER 1.  GENERAL INTRODUCTION 
 
1.1 THESIS ORGANIZATION 
This dissertation presents the author’s research in the alternative thesis 
format. The first chapter contains a general introduction of the dairy industry and 
emerging roles of adipose tissue, objectives, and a review of relevant literature. 
Since the research presented in this dissertation pertains to adipokines and lipid 
droplet associated proteins, the review of relevant literature is split into these two 
sections with these sections divided by adipokine or protein. Review of relevant 
literature for each adipokine or protein identifies additional nomenclature, describes 
the known function of the adipokine or protein, and discusses current knowledge in 
dairy cattle.  
Chapters 2 and 3 are manuscripts published in Domestic Animal 
Endocrinology and Journal of Dairy Science, respectively. Chapter 2 is a manuscript 
that characterizes changes in leptin, adiponectin, adiponectin receptor 2 and 
angiopoietin like protein 4 transcript abundances in three energy altering models. 
Chapter 3 is a manuscript that characterizes the changes in protein abundance of 
perilipin, phosphorylated perilipin, hormone sensitive lipase, phosphorylated 
hormone sensitive lipase, adipose triglyceride lipase and comparative gene identity-
58 during the transition period in dairy cattle. Chapter 4 is a manuscript in 
preparation for publication in American Physiology Journal’s Endocrinology and 
Metabolism. This chapter is a manuscript that characterizes leptin induced lipolysis 
in bovine adipocytes and identifies potential mechanisms utilized by leptin to induce 
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lipolysis. Two additional methods were utilized to better characterize this 
mechanism.  They are included as appendix A and B.  Appendix A characterizes the 
translocation of hormone sensitive lipase and adipose triglyceride lipid to the lipid 
droplet.  This appendix may be combined with chapter 4 in the final publication.  
Appendix B identifies a potential promoter region of adipose triglyceride lipase that is 
bound by STAT3 during leptin treatment.  This chapter contains preliminary data and 
additional replication is needed prior to publication. Following Chapter 4 is a chapter 
that summarizes the major finding from all work in this dissertation. Additionally, 
hypotheses and proposals of additional research are included for each major finding 
that pertain to the basic understanding of lipid metabolism and implications for the 
dairy industry. 
1.2 INTRODUCTION 
 
1.2.1 Dairy industry background 
 
Demands for improved efficiency of agricultural systems are a result of 
declining farmland and increasing world population.  For the dairy industry, efficient 
cows are classified as those that produce similar or greater quantities of milk while 
consuming less than expected quantities of feed.  Nutritional, genetic, and 
management approaches can be used to optimize efficiency within dairy herds. 
Differences between individual efficiency can be dependent on appetite, nutrient 
digestion and absorption, maintenance requirements, nutrient partitioning, and 
utilization energy for production (Korver, 1988).  The differences in metabolic 
efficiencies between tissues may play a critical role in the overall efficiency of cattle. 
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However, the mechanisms that contribute to the efficiency of individual tissues are 
not well understood. 
Energy requirements fluctuate over the course of a single lactation.  Following 
parturition, energy intake is often not sufficient to meet the elevated energy 
requirements for milk synthesis.  Body energy reserves, in particular adipose tissue, 
are mobilized to meet this energy deficit. This state is often referred to as negative 
energy balance.  As the lactation cycle progresses, milk synthesis stabilizes, and 
eventually declines. This period is accompanied by increasing feeding intake. 
Typically between 45 and 83 days in milk (DIM) energy intake exceeds energy 
requirements and allows for body energy reserves to be recuperated in preparation 
for the next lactation (Banos and Coffey, 2010; Buttchereit et al., 2011; Hüttmann et 
al., 2009; Spurlock et al., 2012).  
Although cows that utilized body energy reserves instead of consuming feed 
to meet energy requirements may appear to be more feed efficient, times of severe 
or prolonged negative energy balance can reduce overall fitness. Declining 
reproductive fitness has been a leading reason for culling decisions in the United 
States (Stevenson, 2009). Various measurements of reproduction, including days to 
first ovulation and days open, have been negatively associated with severe or 
prolonged negative energy balance during early lactation (Patton et al., 2007; 
Veerkamp et al., 2000).  Additionally, the incidences of metabolic diseases, 
displaced abomasum and reproductive disorders increase during early lactation. 
Since pre-partum health can influence these diseases, they are often referred to as 
transitional diseases, which are usually diagnosed during the transition period, or 
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three weeks prior to and after parturition (LeBlanc, 2010).  Metabolic diseases and 
displaced abomasum are often associated with negative energy balance due to the 
etiology of the disease.  For instance, ketosis is diagnosed by observing elevated 
circulating ketone bodies which are a by-product of incomplete gluconeogenesis due 
to high lipid mobilization. Reproductive disorders, such as retained placenta and 
metritis, can occur in cows regardless of energy status.  However, reproductive 
disorders are more likely to occur in cows in negative energy balance due to 
decreased peripheral blood neutrophil function (Galvão et al., 2010; Hammon et al., 
2006). Therefore, understanding mechanisms involved that enable cows to best 
manage negative energy balance and the transition period may prevent reduced 
fitness. 
1.2.2 Emerging roles of adipose tissue  
 
Traditionally, adipose tissue has been viewed as a reservoir of densely stored 
excess energy which can be mobilized for use during times of energy shortage, or 
provide heat during times of cold exposure.  Since the discovery of leptin in 1994 
(Zhang et al., 1994) research has redefined adipose tissue as a dynamic endocrine 
organ which is capable of regulating satiety, reproduction, immune functions, 
angiogenesis, lipid metabolism in adipose and skeletal muscle, and glucose  
metabolism. These novels roles, along with the increased prevalence of obesity, 
have spawned an increased interest in adipose tissue (Figure 1).  However, many of 
the important factors that contribute to these functions lack characterization or are 
poorly understood in dairy cattle.  
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1.3 OBJECTIVES 
The overall objective of this dissertation was to characterize novel proteins 
involved in lipid metabolism of adipose tissue in Holstein cows to expand our 
understanding of potential mechanisms that contribute to the regulation of energy 
balance in dairy cattle. To accomplish this overall objective, three studies were 
conducted to 1) determine changes in the transcript abundance of adipokines in 
adipose tissue of cows with altered energy balance 2) define the regulation of novel 
lipolytic proteins during the transition from late pregnancy through early lactation and 
3) determine mechanisms involved in leptin induced lipolysis.  Results from this 
dissertation contribute to the understanding of lipid metabolism in dairy cattle. 
 
1.4 REVIEW OF RELEVANT LITERATURE 
 
1.4.1 Adipokines 
Adipose tissue is a dynamic tissue capable of communicating with other 
tissues through the secretion of hormones.  The first adipose derived hormones to 
be investigated had the ability to bind cytokine-like receptors and were called 
adipocytokines.  As the number of secreted factors from adipose tissue increased 
and their known functions expanded, adipocytokine, or simply adipokine, is now 
used to identify any factor secreted by adipose tissue.  To date, over 260 adipokines 
have been identified (Lehr et al., 2012). They contribute not only to the regulation of 
energy homeostasis, but to a wide range of functions in the body. For the sake of 
brevity, this review will focus on three adipokines that have been identified as 
possibly regulating energy homeostasis in dairy cattle.   
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1.4.1.1 Leptin 
Leptin was discovered in a population of mice (ob/ob) that were obese due to 
a spontaneous mutation in the obese gene that prevented the synthesis of functional 
leptin (Zhang et al., 1994). These mice were not only morbidly obese, but infertile.  
Restoration of proper circulating leptin concentrations through the injection of 
recombinant leptin protein decreased adiposity (Pelleymounter et al., 1995). Leptin 
has since been observed to reduce obesity in humans with leptin deficiencies 
(Montague et al., 1997). Additionally, leptin can significantly reduce feed intake in 
mice (Halaas et al., 1995), pigs (Barb et al., 2006) and sheep (Henry et al., 1999) 
with normal leptin expression, indicating that leptin could be a potential tool to 
increase weight loss in obese humans.   However, obesity is a complex disease that 
is often accompanied by leptin resistance and increasing circulating leptin 
concentration does not induce weight loss (Coppari and Bjørbæk, 2012).    
Leptin regulates body weight by inhibiting food consumption. As observed 
with the ob/ob mice and mice deficient in the leptin receptor (db/db), the disruption of 
leptin signaling prevents satiety and allows for over consumption of food and 
subsequently obesity. Normally, adiposity increases circulating leptin concentrations 
to decrease food consumption.  However, leptin signaling can be blunted with 
excess circulating leptin due to obesity, creating a state of leptin resistance.  
Inversely, circulating leptin concentrations decline during times of energy deficiency.  
This is expected to increase appetite, driving food consumption.  Since circulating 
leptin concentrations are correlated to adipose tissue mass, decreased leptin 
concentrations could be confounded with adipose tissue loss.  However, decreases 
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in leptin occurs prior to changes in weight (Maffei et al., 1995).  Additionally, 
changes in physiological status, such as parturition, are associated with changes in 
leptin concentrations. For example, leptin concentrations decline following parturition 
in humans (Saucedo et al., 2011). However, this decline in circulating leptin 
concentrations coincided with weight loss, and is difficult to conclude if the changes 
in leptin concentrations are a result of physiological status or simply the loss of fetus 
weight. Regardless, leptin has been shown to be an important adipokine in 
regulating energy homeostasis.  
Leptin has been associated with reducing appetite through signaling in the 
hypothalamus.  Five isoforms of the leptin receptor (a-e) have been identified, but 
leptin signaling occurs primarily through the long form of the leptin receptor, often 
referred to as leptin receptor b. Isoforms a, c, d, and e are shortened forms of the 
leptin receptor and cannot completely activate the leptin signaling cascade.  Binding 
of the long form of the leptin receptor by leptin in the hypothalamus activates the 
Janus kinase (JAK) /Signal Transducer and activator of Transcription (STAT) 
pathway, inhibiting neuropeptide Y (NPY) and agouti-related protein (AgRP) while 
activating α-melanocyte-stimulating hormone (αMSH).  Increases in αMSH signals 
satiety, while decreases in NPY and AgRP reduce appetite signals.  
Leptin also induces signaling in other cell types including cardiomyocytes via 
ERK1/2, and p38 (Rajapurohitam et al., 2012), oocytes via JAK2/STAT3, ERK1/2, 
and p38 (Arias-Alvarez et al., 2010; Lin et al., 2009), and adipocytes via 
Jak2/STAT3.  Other than to acknowledge that leptin can signal through multiple cell 
types, and utilize different secondary messenger to initiate downstream signaling, 
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this review will not go into detail about leptin signal transduction in all cell types and 
will focus on adipocytes.  
Leptin induces lipolysis in rodent (Bendinelli et al., 2000; Frühbeck et al., 
2001; Rodríguez et al., 2003; Wang et al., 1999), human (Singh et al., 2012) and pig 
(Ajuwon et al., 2003; Li et al., 2010; Ramsay, 2001) adipocytes through activation of 
Jak2/STAT3. Observed increases in lipolysis in both adipocytes and adipose tissue 
explants are milder than when stimulated by isoproterenol, and also result in an 
increase in only glycerol concentrations (Ajuwon et al., 2003; Li et al., 2010; Wang et 
al., 1999).   However, exposure of ovine adipose tissue explants to ovine leptin did 
not increase lipolysis or activate STAT3 or STAT5 (Newby et al., 2001).  These data 
suggest leptin that may be able to regulate feed intake in all species, but only alter 
lipid metabolism in monogastric species. Additionally, the contribution of lipolytic 
activity by HSL and ATGL remain unknown at this time.  In porcine adipocytes 
stimulated with leptin, ATGL protein abundance was decreased and transcript 
abundances increased.  Although Li et al. went on to determine that ATGL transcript 
and protein abundances were affected by activation of JAK, mitogen-activated 
protein kinase (MAPK) and peroxisome proliferator-activated receptor (PPAR)γ, the 
contribution of these pathways to leptin induced lipolysis remains unknown (Li et al., 
2010).   
Leptin is one of the most studied adipose tissue related proteins in dairy cattle 
due to its potential effects in regulating energy intake and fertility. Similar to rodents 
and humans, circulating leptin concentrations are positively correlated with body 
condition scores (BCS), nutritional status, and stage of lactation (Block et al., 2001, 
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2003; León et al., 2004). Declining circulating leptin or transcript abundances during 
feed restriction or early lactation is expected to stimulate feed intake to improve 
energy status in cattle (reviewed by Ingvartsen and Boisclair, 2001). The presence 
of leptin is required for fertility in mice and may be required to allow ovulation 
(reviewed by Wathes, 2012).  Additionally, single nucleotide polymorphisms (SNP) 
are associated with milk production, energy intake, and fertility.  However, these 
SNPs are not consistently validated across multiple populations. For example, the 
promoter SNP, A1457G was associated with growth and fertility in a study using 509 
Holstein Friesian cows (Clempson et al., 2011), but were not associated in a 
different population with 43,117 lactation records on each of 848 sires (Giblin et al., 
2010).  Although much is understood about leptin in dairy cattle, questions still 
remain about the effects of leptin at the tissue level.   
1.4.1.2 Adiponectin 
Adiponectin was discovered by four groups, and has since been identified to 
regulated insulin sensitivity and atherosclerosis (Hu et al., 1996; Maeda et al., 1996; 
Nakano et al., 1996; Scherer et al., 1995). Since adiponectin was identified 
independently, it is also known as Acrp30, AdipoQ, and gelatin binding protein 
(GBP28). In this manuscript, it will simply be referred to as adiponectin. Adiponectin 
is an adipokine that improves insulin sensitivity regardless of adiposity. Expression 
of adiponectin is lower in obese compared lean individuals and is increased with 
weight loss (Basu et al., 2007; Bobbert et al., 2005; Bodles et al., 2006) which can 
improve insulin sensitivity (Yamauchi et al., 2001). Insulin sensitivity can be 
improved in obese ob/ob mice by overexpression of adiponectin (Kim et al., 2007). 
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Thus adiponectin may be an adipokine that is essential for insulin sensitivity, and 
has been considered an independent risk factor for the development of metabolic 
syndrome and type II diabetes.  
Adiponectin signals through two receptors to increase β-oxidation and 
subsequently improve insulin sensitivity.  Both receptors are expressed in muscle, 
adipose tissue, and liver. However, abundances and signaling affinity are tissue 
specific. Activation of the either receptor is expected to increase activation of AMPK 
and subsequently β- oxidation in liver, or glucose uptake and β- oxidation in skeletal 
muscle (Figure 4, reviewed by Kadowaki and Yamauchi, 2005). Additionally, 
adiponectin may utilize a similar pathway to induce lipolysis in adipocyte, but this 
pathway has yet to be confirmed.  In adipocytes, adiponectin receptor 2 is more 
responsive to exterior stimuli suggesting it maybe the primary signaling receptor in 
adipocytes (Fasshauer et al., 2004; Fu et al., 2007; Kudoh et al., 2011; Yamauchi et 
al., 2003).  
Adiponectin circulates at low, medium, and high molecular weights in 3, 6, or 
12-18 multimers complexes, respectively (Suzuki et al., 2007). Activities of these 
mulitmers may be tissue dependent.  For example, high molecular weight 
adiponectin has been reported to activate nuclear factor kappa light chain enhancer 
of activated B cells (NFκB) in myocytes, but activates AMPK in hepatocytes (Lago et 
al., 2007). High molecular weight adiponectin has been associated with insulin 
sensitivity during times of insulin resistance following weight loss or treatment with 
PPAR γ agonist (Basu et al., 2007; Bobbert et al., 2005; Bodles et al., 2006).  
Additionally, a truncated or globular form of adiponectin has been observed in 
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circulation, and may be cleaved by active monocytes and/ or neutrophils through the 
secretion of leukocyte elastase (Waki et al., 2005). The globular portion of 
adiponectin has been observed to increase lipid clearance, LPL activity, and insulin 
sensitivity (Combs et al., 2001) while reducing atherosclerotic lesions (Yamauchi et 
al., 2003).  
Due to this complexity, characterization of adiponectin has been limited in 
dairy cattle. Adiponectin transcript abundances in adipose tissue do not change 
during the last part of gestation through the first 2 months of lactation (Giesy et al., 
2012; Khan et al., 2013; Lemor et al., 2009). Adiponectin receptors 1 and 2 
decreased in adipose tissue from 7 day pre-partum to 22 days postpartum (Lemor et 
al., 2009).  In contrast, others have not observed a change in adiponectin receptor 1 
or 2 abundance between late gestation and early lactation in adipose tissue of dairy 
cows (Giesy et al., 2012; Sadri et al., 2011). Recently, total plasma adiponectin, and 
molecular weight isoforms of adiponectin were measured using a bovine specific 
antibody.  Separation of adiponectin by molecular weight demonstrated that the 
majority of adiponectin was high molecular weight.  Both circulating high molecular 
weight adiponectin and total adiponectin declined 1 week prior to parturition and 
remained low for the first 7 weeks of lactation for the 4 cows used in this study 
(Giesy et al., 2012).  
1.4.1.3 Angiopoietin-like protein 4 
The generation of the PPAR α null mouse to search for unknown mechanisms 
involved in the regulation of fatty acid oxidation in the liver during times of fasting led 
to the discovery of angiopoietin-like protein 4 (ANGPTL4) (Kersten et al., 2000). 
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Through subtraction hybridization of liver between wild type and PPAR α null mice, 
Kersten et al. identified a novel sequence that was highly expressed in adipose 
tissue and elevated during times of fasting (2000).  Subsequently, this factor was 
called fasting induced adipocyte factor (FIAF).  Due to its angiopoietin-like structure, 
FIAF is also known as ANGPTL4. For consistency, ANGPTL4 will be used 
throughout.  Additional angiopoietin like proteins have been identified, and have 
roles in angiogenesis (ANGPTL 1, 2, 3, 4 and 6), hematopoietic stem cell activity 
(ANGPTL 5 and 7; Zhang et al., 2006), or energy metabolism (ANGPTL 3, 4 and 6; 
as reviewed by Hato et al., 2008). This review will focus on ANGPTL4 due to its 
potent role in regulating lipid uptake and lipolysis. 
Dysregulation of ANGPTL4 resulted in altered circulating lipid profiles. Mild 
over expression of ANGPTL4 in mice resulted in a 50% reduction in adipose tissue 
mass and increased circulating triacylglycerides, free fatty acids, glycerol, 
cholesterol and high density lipoproteins (HDL). Functional assays confirmed 
decreased lipid uptake suggesting ANGPTL4 can inhibit lipid uptake by adipose 
tissue (Mandard et al., 2006). These results were when ANGPTL4 deficiency mice 
had a 48% decrease in circulating triacylglyceride levels compared to wild type mice 
under fasted conditions. This decrease was due to decreased abundance of very 
low density lipoproteins (VLDL), suggesting increased uptake of dietary lipids.  
Additionally, circulating triacylglycerides were decreased 77% compared to wild type 
mice when both groups of mice were fed a high fat diet prior to fasting (Mandard et 
al., 2006).  These data suggest ANGPTL4 has a critical role in regulating lipid uptake 
during times of fasting.   
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Lipids circulate as lipoproteins for transport to various tissues in the body.  
Chylomicrons are formed from dietary lipids in enterocytes and released into the 
lymphatic system, while other lipoproteins are synthesized in the liver. Lipoproteins 
have proteins embedded in the phospholipids that interact with lipoprotein receptors 
along the vasculature.  Lipid uptake by tissue is mediated through the binding of 
chylomicrons or lipoproteins to the lipoprotein receptors which allow active 
lipoprotein lipase (LPL) to hydrolyze lipid to free fatty acids and glycerol. The 
decrease in available VLDL in fasted ANGPTL4 null mice would suggest that dietary 
lipid are hydrolyzed by LPL and taken up by surrounding tissue.   
Mice lacking ANGPTL4 have increased LPL activity suggesting ANGPTL 4 
inhibits lipid uptake by interacting with LPL. Through the use of enzyme linked 
immune sorbent assays (ELISA). Lee et al. were able to demonstrate that ANGPTL4 
binds LPL.  Additionally, they were able to generate an antibody which recognizes 
amino acid residues 29-53.  This antibody prevented ANGPTL4 from binding LPL, 
and when given to mice decreased circulating triacylglyceride to level comparable to 
ANGPTL4 null mice. Additionally, the introduction of a point mutation that change 
amino acid residue 40 from glutamate to lysine resulted in similar phenotypes as the 
ANGPTL4 null mice (Lee et al., 2009). These data demonstrate that ANGPTL4 
inhibits LPL by directly binding LPL, preventing the dimerization, and activation of 
LPL (Kersten, 2009). However, fatty acids can reduce this interaction (Robal et al., 
2012). 
To determine the importance of individual tissue expression of ANGPTL4 the 
ability of ANGPTL4 to inhibit LPL peripherally or locally needs to be considered. 
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Expression of LPL is tissue specific and dependent upon physiological status. For 
example, under fasted conditions, adipose tissue is releasing, and not storing lipids. 
During these conditions, adipose tissue LPL decreases.  However, muscle which is 
in need of energy substrates increases muscle LPL activity. Therefore, it becomes 
important to determine if ANGPTL4 secreted by adipose tissue inhibits muscle LPL.  
Increased expression of intestinal ANGPTL4 but not adipose or liver has been linked 
to decreased adiposity in germ-free mice (Bäckhed et al., 2004, 2007). These mice 
were also resistant to obesity, however; germ free mice lacking ANGPTL4 were not 
(Bäckhed et al., 2004).  Therefore, ANGPTL4 can act peripherally to inhibit LPL and 
prevent obesity. Interestingly, germ free rats had similar adiposity as conventionally 
raise rats despite increased intestinal ANGPTL4 expression. However, ANGPTL4 
expression in adipose tissue was decreases suggesting a tissue specific regulation 
of LPL activity (Swartz et al., 2013). These conflicting results indicated conclusions 
about individual tissue expression of ANGPTL4 should be drawn very carefully.  
Angiopoietin-like protein 4 abundance increases with fasting and enhances 
lipolysis in adipocytes.  Gray et al. observed a reduction in glycerol released from 
adipose tissue explants from ad libitum fed and fasted ANGPTL4 null mice 
compared to adipose tissue explants from wild type mice (Gray et al., 2012). This 
reduction was accompanied by a decrease in phosphorylation of HSL at serine 660, 
phosphorylated perilipin at 492 and ATGL protein abundance suggesting reduced 
activation of the PKA pathway with the absence of ANGPTL4. These results were 
confirmed by experiments utilizing chemicals that stimulated lipolysis at various 
points along the pathway. Maximal lipolysis was not achieved with the administration 
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of isoproterenol, which activates β-adrenergic receptors, in ANGPTL4 null 
adipocytes. While lipolysis induced with forskolin, which activates adenylate cyclase, 
3-isobutyl-1-methylxanthine (IBMX), which prevents hydrolysis of cAMP, and 8-Br-
cAMP, which is cAMP that is resistant to hydrolysis, were not different in ANGPTL4 
null mice compared to wild type adipocytes (Gray et al., 2012). These data suggests 
that ANGPTL4 is required for maximal lipolysis and acts up stream of adenylate 
cyclase.   
Angiopoietin-like protein 4  has been the only angiopoietin like protein 
described in cattle, and was originally characterized from tissue of 2 mature Angus 
based steers (Mamedova et al., 2010). Protein and transcript expression of 
ANGPTL4 were most abundant in liver and adipose tissue compared to intestinal 
tissue and pancreas.  However, omasum protein also showed high expression 
(Mamedova et al., 2010).  Characterization of differentially expression genes in 
adipose tissue of first lactation cows pre- partum (30 days) and post-partum (14 
DIM), showed a 2 fold increase in ANGPTL4 post-partum (Sumner-Thomson et al., 
2011). Given the potency of ANGPTL4 in mice, additional characterization of 
ANGPTL4 is necessary. 
1.4.2 Lipolytic proteins 
Catabolism of triacylglycerides is primarily stimulated through the protein 
kinase A (PKA) pathway.  During times of energy deficiency, particular during early 
lactation, this pathway is critical in supplying energy substrates to peripheral tissues. 
Activation of the PKA pathway occurs through the binding of catecholamines (e.g. 
epinephrine, norepinephrine) to beta adrenergic receptors (β-AR).  Activation of 
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adenylate cyclase occurs when the G-coupled proteins are released from β-ARs 
(Figure 2).  Adenylate cyclase elevates intracellular concentration of cyclic 
adenosine monophosphate (cAMP) by converting adenosine triphosphate (ATP) to 
cAMP. Activation of PKA occurs when cAMP binds and activates two catalytic 
subunits of PKA. Cytosolic hormone sensitive lipase (HSL) is phosphorylated by 
PKA and subsequently translocates to the lipid droplet. Triacylglycerides at lipid 
droplet surface are catabolized by phosphorylated HSL and monoglyceride lipase 
resulting in 3 free fatty acids (FFA) and glycerol.  
Additional proteins associated with the lipid droplet have been identified as 
critical regulators of lipolysis in adipocytes.  Perilipin, a member of the PAT (Perilipin, 
Adipophilin, Tail Interacting Protein at kilodalton 47 (TIP47)) protein family, coats the 
lipid droplet, preventing HSL from hydrolyzing lipids at the lipid droplet surface.  
When phosphorylated by PKA, perilipin can facilitate the catabolism of 
triacylglycerides by allowing phosphorylated HSL to interact with the lipid droplet 
surface (Granneman et al., 2007).  Additionally, cytosolic adipose triglyceride lipase 
(ATGL) translocates to the lipid droplet surface when PKA phosphorylates perilipin 
and releases comparative gene identity-58 (CGI-58; also known as α/β hydrolase 
domain containing 5) from the lipid droplet to remove the inhibitory protein G0/G1 
switch protein (G0S2) from ATGL. The translocation of ATGL to the lipid droplet 
allows for the initial hydrolyzes triacylglycerides to diacylglycerides (Zimmermann et 
al., 2004).  
Lipolysis primarily occurs in adipocytes, but can occur in other cell types that 
store small amounts lipids.   The focus of this review will pertain to literature relevant 
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to the regulation of lipolysis in adipose tissue. However, differences between the 
regulation of lipolysis in adipose tissue and other tissues will occasionally point out.  
1.4.2.1 Hormone sensitive lipase  
Hormone sensitive lipase was identified in the early 1960s and until recently 
was thought to be the rate limiting step in hormone stimulated lipolysis (Vaughan et 
al., 1964). Activation of HSL can be through PKA, adenosine monophosphate 
activated kinase (AMPK) (Garton and Yeaman, 1990; Garton et al., 1989), 
extracellular signal-regulated kinase (ERK) (Greenberg et al., 2001), glycogen 
synthase kinase-4 (Garton and Yeaman, 1990; Olsson et al., 1986), and protein 
kinase C (Carmen and Víctor, 2006; Fricke et al., 2004), but is primarily regulated 
by the PKA and AMPK pathways.  Increases in intracellular concentration of cAMP 
activate PKA which phosphorylates HSL and allows for the hydrolysis of tri- and 
diacylglycerides (Figure 2). Increased intracellular concentration of adenosine 
monophosphate (AMP) leads to the activation of AMPK, and prevents PKA 
phosphorylation of HSL (Garton and Yeaman, 1990).  However, it is not well 
understood if activation of AMPK stimulates (Gaidhu et al., 2009), inhibits (Daval et 
al., 2005), or does not affect (Chakrabarti et al., 2011) lipolysis in adipocytes.  
Activation of HSL can be through phosphorylation at 5 different serine 
residues (Anthonsen et al., 1998; Garton and Yeaman, 1990). Three of the five 
serine residues (563, 659, 660) are phosphorylated by PKA. Serine residue 563 was 
the first residue to be described (Egan et al., 1992). Serine residues 659 and 660 
are also phosphorylated by PKA and regulate activity of HSL more than 563 
(Anthonsen et al., 1998). The two remaining phosphorylated residues undergo PKA 
18 
 
independent phosphorylation. Serine residue 565 has been showed to be 
phosphorylated by AMPK (Garton et al., 1988). Due to its proximity to serine residue 
563, phosphorylation of serine residue 565 may inhibit PKA phosphorylation of 
serine 563 (Carmen and Víctor, 2006; Daval et al., 2005).  Phosphorylation of HSL 
serine residue 600 was identified to be phosphorylated by ERK, and may increase 
lipolysis (Greenberg et al., 2001). Phosphorylation of HSL by PKA increases the 
hydrophobicity of HSL (Krintel et al., 2009)  that induces the translocation of HSL 
(Egan et al., 1992) to the lipid droplet within 5 minutes of stimulation (Brasaemle et 
al., 2000a).  Once at the lipid droplet surface, PKA phosphorylated HSL interacts 
with phosphorylated perilipin to hydrolyze triacylglycerides (Carmen and Víctor, 
2006; Fricke et al., 2004; Miyoshi et al., 2006; Moore et al., 2005).  
Phosphorylation sites were identified and labeled according to their position in 
the rat HSL amino acid sequence.  Although sites are not located in the exact same 
locations in other species, they continued to be referred to by their originally 
identified location in rat.  Additionally, these sites were identified prior to the release 
of the rat genome in 2004 (Gibbs et al., 2004).  It is therefore not surprising that 
these sites are not located at the same amino acid as originally identified (Figure 3). 
Comparison of the rat and the bovine amino acid sequence revealed identical amino 
acid residues that correspond to serine 563, 565, and 660 (Figure 3, Flicek et al., 
2012). This conservation between species suggests that these sites may have 
similar activities between rodents and cattle. 
In dairy cattle, the conserved serine residues of HSL are more critical in 
regulating lipolysis than transcript or protein abundances in adipose tissue.  
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Transcript abundances of HSL have been reported to increase with feed restriction 
in sheep and cattle (Bonnet et al., 1998), and in the first 90 of lactation compared to 
pre-partum samples (Sumner and McNamara, 2007). However, others have 
reported no change in HSL mRNA abundance throughout lactation (Elkins and 
Spurlock, 2009; Khan et al., 2013; Sadri et al., 2011; Sumner-Thomson et al., 2011).  
Total protein abundance has been reported to increase (Locher et al., 2011) or 
remain constant (Elkins and Spurlock, 2009) during early lactation compared to pre-
partum. However, both studies showed an increase in phosphorylation of HSL at 
serine 563 (Elkins and Spurlock, 2009; Locher et al., 2011). Additionally, Locher et 
al. observed an increase in phosphorylation of HSL at serine 660 (Locher et al., 
2011), which was not examined by Elkins and Spurlock (2009).     
1.4.2.2 PAT proteins 
The PAT family is named after the original three member of this family: 
Perilipin, Adipophilin, and TIP-47 (Londos et al., 1999). The remaining two members 
are S3-12 and OXPAT (Ducharme and Bickel, 2008).  Due to a conserved perilipin 
domain in these proteins, they are also known as: Perilipin 1 (perilipin), perilipin 2 
(adipophilin), perilipin 3 (TIP47), perilipin 4 (S3-12), and perilipin 5 (OXPAT). For 
continuity, this review will refer to this family by their PAT family names.   
As with perilipin, members of the PAT family coat the lipid droplet to allow for 
storage of lipid. During the maturation of white adipocytes, multiple lipid droplets 
form from the endoplasmic reticulum (ER) and eventually unite into a single large 
lipid droplet.  Newly formed lipid droplets are coated with S3-12 and TIP-47.  As lipid 
droplets enlarge through fusion with other lipid droplets and lipid uptake, adipophilin 
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begins to coat the lipid droplet.  Once the lipid droplet becomes large and centrally 
located, perilipin begins to replace S3-12, TIP47, and adipophilin (reviewed by 
Ducharme and Bickel, 2008).  
Although the functions of PAT proteins can be redundant, only perilipin is 
critical for lipolysis in white adipose tissue. Tail interacting protein-47 can 
compensate for decreased adipophilin, because mice lacking adipophilin had 
increased expression of TIP-47. However, the loss of both TIP-47 and adipophilin 
increased lipolytic activity as observed by the reduced amount of lipid in the lipid 
droplet and the number of lipid droplets (Sztalryd et al., 2006). Adipophilin can 
protect the lipid droplet from lipolysis, but it is less efficient than perilipin because 
basal, or maintenance lipolysis was elevated in perilipin null mice. Additionally, 
stimulated lipolysis was decreased  in perilipin null mice suggesting adipophilin does 
have the capabilities to facilitate stimulated lipolysis, but cannot completely rescue 
perilipin null adipocytes (Tansey et al., 2001). Although OXPAT may regulate 
lipolysis via regulation of ATGL, it has been observed to be active only in highly 
oxidative tissues such as skeletal and cardiac muscle, where perilipin expression is 
low (Blanchette-Mackie et al., 1995; Greenberg et al., 1993; Servetnick et al., 1995). 
Since the focus of this review is lipolysis in adipose tissue, the regulation of perilipin 
in lipolysis will only be reviewed. 
Phosphorylation of perilipin occurs at six different serine residues, and 
phosphorylation of some but not all are required for maximal lipolysis. 
Phosphorylation of perilipin occurs at serine residues 81, 222, 276, 433, 492, and 
517 (Miyoshi et al., 2006). Adipocytes from perilipin null mice transfected with 
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perilipin that contained serine to alanine mutations at all six phosphorylation 
residues (Tansey et al., 2003) or the 3 amino terminal (serine 433, 492, and 517) 
residues (Miyoshi et al., 2006) had attenuated lipolysis. Confirmation of these 
findings in adipocytes showed that the amino-terminal serine, 517, was responsible 
for the majority of lipolytic response (Miyoshi et al., 2007), while serine 492 
contributes to lipolytic activity and lipid droplet fragmentation (Marcinkiewicz et al., 
2006; Miyoshi et al., 2007). Additionally, lipolysis in Chinese Hamster Ovary (CHO) 
was attenuated when perilipin with serine to alanine mutations of the 3 carboxyl 
serine residues (serine 81, 222, 276), but did not observe a reduction in lipolysis 
when the three amino terminal serine residues were mutated (Miyoshi et al., 2006). 
Chinese hamster ovary cells do not naturally contain lipolytic proteins and the lack of 
these proteins may contribute to the contrasting results.  
Since perilipin acts as a barrier to the lipid droplet, it was originally 
hypothesized that phosphorylation of perilipin resulted in the translocation of perilipin 
away from the lipid droplet (Daval et al., 2005; Tansey et al., 2001). However, 
fluorescence resonance energy transfer (FRET) and the use of immunofluorescence 
revealed that perilipin remained at the lipid droplet surface during stimulated and 
basal lipolysis (Granneman et al., 2007; Moore et al., 2005). Perilipin regulates 
lipolysis through its interactions with HSL and CGI-58. Translocation of HSL was 
decreased in adipocytes lacking perilipin following hormone stimulation (Sztalryd et 
al., 2003).  In contrast, adipocytes containing full length perilipin with mutations of 
the phosphorylation sites had normal translocation of HSL to the lipid droplet 
surface, but attenuated lipolysis (Granneman et al., 2007; Miyoshi et al., 2006). 
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These results suggest that perilipin, but not phosphorylation of perilipin, is required 
for translocation of HSL to the lipid droplet.  Hormone sensitive lipase binds perilipin 
at two distinct regions, amino acids between residues 141-200 and 406-480 (Shen 
et al., 2009). However, it is unknown if these interacting are critical for HSL activity.  
Regardless, perilipin is required to translocate to the lipid droplet and 
phosphorylation of perilipin is required to allow HSL access to the lipid droplet.  
Perilipin sequesters CGI-58 at the lipid droplet, but is released once perilipin 
is phosphorylated by PKA. Phosphorylation of perilipin at serine residue 517 is 
required for the translocation of CGI-58 from the lipid droplet (Miyoshi et al., 2007). 
Additionally, phosphorylation of perilipin at serine residue 492 and serine residue 
517 was critical for CGI-58 translocation to the cytosol to activate ATGL in COS-1 
cells (Granneman et al., 2009). The ability of perilipin to regulate the two major 
lipases during stimulated lipolysis suggests that perilipin is a master regulator of 
lipolysis. 
Similar to in vitro cell culture models, phosphorylation of perilipin was 
associated with lipolytic activity in dairy cattle.  Transcript abundances of perilipin 
either increase (Sumner and McNamara, 2007) at 90 DIM or remain constant (Elkins 
and Spurlock, 2009; Sadri et al., 2011; Sumner-Thomson et al., 2011) throughout 
lactation when compared to pre-partum abundances.  Total protein abundances of 
perilipin and mRNA transcript abundances were similar between adipose tissue from 
early (5-14 DIM) and mid lactation (176-206 DIM) cows. However, phosphorylation 
of perilipin abundance increased in with cows in early lactation, when adipose tissue 
mobilization was increase as determined by indicators of lipolysis. Additionally, 
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glycerol and non-esterified fatty acids (NEFA) were positively correlated with 
phosphorylation of perilipin (Elkins and Spurlock, 2009). These data suggest that 
phosphorylation of perilipin may be a critical regulator of lipolysis in the dairy cow 
during times of negative energy balance.  
1.4.2.3 Adipose triglyceride lipase and its co-activators 
  Adipose triglyceride lipase was discovered in 2004 by 3 different groups, 
(Jenkins et al., 2004; Villena et al., 2004; Zimmermann et al., 2004).  As a result, 
ATGL is also known as desnutrin, calcium-independent phospholipase A2, and 
patatin-like phospholipase domain containing 2 (PNPLA2), and will be referred to as 
ATGL throughout this review. Adipose triglyceride lipase only has the ability to 
hydrolyze triacylglycerides to diacylglycerides (Zimmermann et al., 2004). The 
absence of ATGL reduces stimulated lipolysis sin adipocytes (Vaughan et al., 1964). 
Since HSL can hydrolysis both tri- and diacylglycerides, ATGL is considered the rate 
limiting step in lipolysis (Haemmerle et al., 2006).  In addition to the involvement of 
ATGL in PKA dependent lipolysis, ATGL can regulates lipid droplet size through 
basal or maintenance lipolysis (Miyoshi et al., 2008).  
  The absence of functional ATGL and its cofactor, CGI-58, cause Neutral Lipid 
Storage Disease (NLSD), which is a slight to severe accumulation of neutral lipids in 
non adipose tissue depots (Akiyama et al., 2007; Campagna et al., 2008). Mutations 
of the carboxyl-terminal regions of human ATGL are associated with NSLD 
(Akiyama et al., 2007; Campagna et al., 2008). Initially, these mutations were 
considered to prevent ATGL activity, but in vitro work demonstrated that ATGL 
lacking the full carboxyl-terminal end had increased triglyceride hydrolase activity 
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relative to wild-type ATGL. However, these mutated forms of ATGL were not able to 
translocate to the lipid droplet which prevented lipolysis (Schweiger et al., 2008). 
Therefore, mutation in the C-terminal region of ATGL associated with NSLD may 
decrease translocation of ATGL and not activity of ATGL.  
  Mutations of CGI-58 have been associated with a more severe form of NLSD.  
Humans with this form of the disease not only have accumulation of neutral lipids in 
non-adipose tissue, but have congenital ichthyosiform erythroderma. Congenital 
ischthyosiform erythroderma is also known as nonbullous congenital ichthyosiform 
erythroderma which is characterized by increased hyperkeratosis, eclabion, 
ectropion and alopecia. Mice deficient in CGI-58 have systemic lipid accumulation, 
hepatic steatosis, and severe skin permeability barrier defect. These mice typically 
die within hours of birth, suggesting CGI-58 is critical to lipid metabolism and 
suggesting roles outside of those regulating ATGL (Radner et al., 2010). Mutations 
in CGI-58 have been reported in NSLD with ichthyosiform erythroderma, but not all 
are associated directly with decreased activation of ATGL (reviewed by Yamaguchi 
and Osumi, 2009). Therefore, inhibition of ATGL activity must be confirmed when 
determining the role of particular mutations in CGI-58. 
  Regulation of ATGL may occur at three different points: protein-protein 
interaction, phosphorylation, and protein abundance.  Adipose triglyceride lipase 
interacts with CGI-58 and G0S2 to regulate its translocation to the lipid droplet 
(Figure 4). G0/G1switch protein 2 binds to cytosolic ATGL between the first 254 
amino acids residues (Cornaciu et al., 2011), and may specifically bind within the 
patatin domain (amino acid residues 10-178, Figure 4) to prevent the translocation of 
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ATGL to the lipid droplet (Lu et al., 2010b; Schweiger et al., 2012). Additionally, 
G0S2 binds to the truncated form of ATGL associated with NLSD (stop codons 
introduced at amino acid 289 and 319 of 486 amino acids). Instead of inhibiting 
translocation, the truncated ATGL/G0S2 complex translocates to the lipid droplet 
(Schweiger et al., 2012).  These data suggest that the N-terminal region of ATGL is 
critical for inhibition of activity via G0S2.  Comparative gene identity58 is required for 
the translocation of ATGL to the lipid droplet surface, by removing G0S2.  Mutations 
of CGI-58 associated with NLSD prevent CGI-58 from activating ATGL. Amino acid 
residue 130 and residue 260 of CGI-58 increase ATGL activity during stimulated 
lipolysis in COS-7 cells (Gruber et al., 2010; Lass et al., 2006). Additionally, the 
carboxyl-terminal region of ATGL is critical for CGI-58 binding, in particular 
truncations before amino acids 255 and 254 significantly reduced triglyceride 
hydrolase activity (Cornaciu et al., 2011).  Residues 130-260 of CGI-58 potentially 
interact with the carboxyl- terminal end of ATGL. However, the direct interaction 
between these residues has yet to be determined.  
  Phosphorylation sites have been identified for ATGL, but their functions 
remain unclear. A phosphorylation site was discovered within ATGL shortly after its 
identification. However, it was not shown to be phosphorylated by PKA, and 
subsequently assumed not to be involved in simulated lipolysis (Zimmermann et al., 
2004). Two phosphorylation sites were identified by liquid chromatograph-tandem 
mass spectrophotomertry from lipid droplets in HeLa cells. One of these sites (serine 
residue 404) was predicted to have an ERK consensus site (Bartz et al., 2007). 
Additionally, five putative murine PKA and AMPK phosphorylation residues were 
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identified in Cos-7 cells including included both serine residues identified by Bartz et 
al. (2007). Mutation of the murine serine residue 406 to alanine, which corresponds 
with human serine residue 404, was associated with decreased in vitro triglyceride 
hydrolase activity, and radiolabelled oleate release in Cos-1 cells (Pagnon et al., 
2012).  Additionally, phosphorylation of this site can occur via AMPK during times of 
increased lipolysis (Ahmadian et al., 2011). However, research is needed to fully 
understand the relationship of this phosphorylation site and its role in in vivo 
lipolysis.     
    Given the difficulty of measuring protein-protein interactions in vivo, 
researcher have been determining if ATGL transcript or protein abundance differ 
between various lipolytic inducing treatments. Human studies observed increased 
ATGL protein abundance during fasting, but not following an hour of exercise in 
men.  The increase in ATGL protein abundance coincided with a decrease in G0S2 
protein and mRNA. However, HSL and CGI-58 remained constant suggesting 
increased ATGL abundance maybe associated with lipolysis (Nielsen et al., 2011). It 
should be noted this study did not explore protein abundance of phosphorylated 
HSL.  In swine, ATGL transcript and protein abundance increased in restricted feed 
studies, but porcine ATGL decreased with β-agonist (Deiuliis et al., 2008).  In broiler 
chickens and quail, ATGL mRNA and protein abundance increase after 24 hours of 
fasting this coincided with elevated NEFA concentrations.  Protein and transcript 
abundances of ATGL returned to with 8 hours of refeeding (Serr et al., 2009).  
However, others have reported decreased ATGL abundance with lipolytic stimuli.  
For example, ATGL abundance decreased in 3T3-L1 cells when treated with 
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isoproterenol and tumor necrosis factor α (TNFα; (Kralisch et al., 2005).  Differential 
expression of ATGL mRNA and protein was observed with porcine adipocytes 
derived from stromal vascular cells (Li et al., 2010).  A summary of this information is 
in table 1. Although the majority of researchers have reported increased transcript 
and protein abundances with elevated lipolytic activity, a better understanding is 
needed to study in vivo activity of ATGL.    
  In dairy cattle, research is limited to a single publication, aside from material 
in this manuscript. The authors reported increased ATGL transcript abundances in 
cows from low genetic merit sires at 28 and 56 DIM compared to cows from high 
genetic merit sires. However, no differences were observed between samples taken 
21 days pre-partum and 7, 28 and 56 days post partum. It should be noted that this 
study used 6 cows per group, and set the significance at P < 0.1 (Khan et al., 2013).  
1.4.3 Conclusion 
Since the discovery of leptin in 1994, our understanding of adipose tissue is 
more complex due to recently identified mechanisms.  Many of these mechanisms 
can regulate energy homoeostasis, but have not been characterized in dairy cattle. 
Therefore the exploration of these recently identified mechanisms can expand our 
understanding of lipid metabolism in dairy cattle.  This is particularly important since 
lipid mobilization is critical to meeting energy requirements during early lactation, 
and severe or prolonged mobilization of adipose tissue is associated with metabolic 
diseases and may contribute to reduced fitness.  
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1.5 TABLES 
Table 1.  Summary of ATGL abundance during times of lipolysis. 
Condition Species Length CGI-
58 
G0S2 ATGL Authors Year 
Fastinga Humans 72 hr -- Protein,   
mRNA 
Protein Neilson 
et al. 
2011 
Exercise Humans 1 hr -- -- -- Neilson 
et al. 
2011 
33% Feed 
Restriction 
 
 Gilts 2 
weeks 
N/A N/A Protein, 
mRNA 
Deiuliis 
et al. 
2008 
β-agonist 
and insulin 
 
Porcine  
SVC 
12 hr N/A N/A mRNA Deiuliis 
et al. 
2008 
Fasting Poultryb 24 hr N/A N/A mRNA Serr et 
al. 
2009 
Refeeding Poultry 8 hr N/A N/A N/A Serr et 
al. 
2009 
β-agonist 
and TNFα 
3T3-L1 4 hr N/A N/A mRNA Kralisch 
et al. 
2005 
Leptin Porcine 
SVC 
3 hr N/A N/A mRNA, 
Protein 
Li et al. 2010 
Abbreviations: CGI-58, comparative gene identity- 58; G0S2, G0/G1 switch protein 
2; ATGL, adipose triglyceride lipase; mRNA, messenger RNA; hr, hour 
a Fasting refers to the complete withdraw of feed, while feed restriction refers to a 
reduction in available feed. 
b Poultry refers to broiler chickens and quail. 
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1.6 FIGURES 
Figure 1.  Number of manuscripts by year. The bars indicated the number of 
searchable manuscripts on Google scholar identified with the keywords adipose 
tissue and obesity. The year leptin was discovered is indicated with an arrow. 
 
Figure 2. Hormone stimulated lipolysis. 1) Activation of β-adrenergic receptors by 
isoproterenol increases intracellular concentrations of cAMP via activation of 
adenylate cyclase through the activation of G-proteins. 2) Protein kinase A (PKA) is 
activated by cAMP and subsequently phosphorylates perilipin at 6 serine residues 
and hormone sensitive lipase (HSL) at 3 serine residues. 3) Phosphorylation of 
perilipin allows for the activation of adipose triglyceride lipase (ATGL) through the 
release comparative gene identity-58 (CGI-58) from the lipid droplet and 4) 
phosphorylated HSL translocates to the lipid droplet and interacts with 
phosphorylated perilipin to access lipids. Hydrolysis of triacylglyceride by ATGL 
results in diacylglyceride and a free fatty acid. Active HSL hydrolyzes 
triacylglycerides and diacylglycerides producing 2 or 1 fatty acids, respectively. 
 
Figure 3. Comparison of HSL phosphorylation sites in rat and bovine hormone 
sensitive lipase. The alignment of the amino acid sequence of rat and bovine 
hormone sensitive lipase (HSL) was done using the CLUSTALW feature built into 
the ENSEMBL website (www.ensembl.org). Highlighted amino acid sequence 
represents published rat amino acid sequences used to characterize the 
phosphorylation sites.  The specific serine residues phosphorylated are larger in size 
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and bolded.  Serine residue 600 (rat amino acid 900 and bovine amino acid 569) is 
in larger red text.  “*” indicates residues within the column that are identical. “:” 
indicates residues within the column that are conserved substitutions. “.” indicates 
residues within the column that are semi-conserved substitutions. 
 
Figure 4. Protein structure of adipose triglyceride lipase. The alignment of the 
amino acid sequence of mouse and bovine adipose triglyceride lipase (ATGL) was 
done using the CLUSTAL W feature built into the ENSEMBL website 
(www.ensembl.org). Amino acid sequence that is highlighted in gray represents the 
published patatin domain in the murine amino acid sequence.  Within the patatin 
domain, it is expected that G0/S1 switch protein 2 (G0S2) binds to and inhibits ATGL 
activity. The hydrophobic domain is highlighted in blue. The specific serine residues 
that potentially interact with comparative gene identity-58 (CGI-58) are bolded within 
the sequence.  “*” indicates residues within the column that are identical. “:” 
indicates residues within the column that are conserved substitutions. “.” indicates 
residues within the column that are semi-conserved substitutions. 
 
Figure 5. Adenosine monophosphate kinase activated lipolysis. Activation of 
adenosine monophosphate kinase (AMPK) occurs through 1) Increases in 
intracellular adenosine monophosphate (AMP) concentrations allow for the 
phosphorylation of AMPK or 2) external stimuli. Phosphorylated AMPK can 3) 
phosphorylate hormone sensitive lipase (HSL), potentially increasing lipolysis.  
Additionally, adipose triglyceride lipase (ATGL) may be phosphorylated by AMPK 
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allowing for it to hydrolyze triacylglycerides. However, perilipin and comparative 
gene-identity 58 (CGI-58) are not activated. 4). Activation of AMPK increases β-
oxidation by phosphorylating and subsequently inhibiting Acetyl Co-A Carboxylase 
(ACC).  This relieves the inhibition on carnitine palmitoyltransferase I b (CPT-1b), 
allowing fatty acids to be transported and oxidized in the mitochondria.  
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Figure 3 
COW_HSL ------------------------------------------------------------ 
RAT_HSL MKPRRPISFTREITTMEPSSTSVSRPEWRPEAQQTLTDYPGSRELQEFGIPQKQSLPNEA 60 
 
COW_HSL ------------------------------------------------------------ 
RAT_HSL TAQQGAEFQQEQGVQQSTLLQKLLTPLAFPVPQQSFPSHKVHSDQQEATSQNGPGAGKVH 120 
                                                                                       
COW_HSL ------------------------------------------------------------ 
RAT_HSL TTQKELEHRDEHVGTAESGPAEPPPATEVEATSIAQAVSGPDKKLPTQTDLVSQERAEQS 180 
                                                                                      
COW_HSL ------------------------------------------------------------ 
RAT_HSL DPTAQQTPLVQGVKSDQGSLIESGILARLQKLAIQQPSQEWKTFLDCVTESDMEKYLNSS 240 
                                                                
COW_HSL ------------------------------------------------------------ 
RAT_HSL SKSNPPEPSGGTVIPGTLPSKQKPDCGKMSGYGGKLPHGKKGILQKHKHYWDTASAFSHS 300 
                                                                                       
COW_HSL MDLRTMTQSLVTLAEDNMAFFSSQGPGETARRLTGVFAGIREQALGLEPALGRLLSVAHL 60 
RAT_HSL MDLRTMTQSLVALAEDNMAFFSSQGPGETARRLSNVFAGVREQALGLEPTLGQLLGVAHH 360 
        ***********:*********************:.****:*********:**:**.***  
 
COW_HSL FDLDTETPANGYRSLVHTARCCLAHLLHKSRYVASNRRSIFFRTSHNLAELEAYLAALTQ 120 
RAT_HSL FDLDTETPANGYRSLVHTARCCLAHLLHKSRYVASNRRSIFFRASHNLAELEAYLAALTQ 420 
        *******************************************:**************** 
 
COW_HSL LRALAYYAQRLLTTNQPGRLFFEGDERVIADFLREYVTLHKGCFYGRCLGFQFTPAIRPF 180 
RAT_HSL LRALAYYAQRLLTINRPGVLFFEGDEGLSADFLQDYVTLHKGCFYGRCLGFQFTPAIRPF 480 
        ************* *:** ******* : ****::************************* 
 
COW_HSL LQTISIGLVSFGEHYKRNETGISVTASSLFTGGRFAIDPELRGAEFERIIQNLDVHFWKA 240 
RAT_HSL LQTLSIGLVSFGEHYKRNETGLSVTASSLFTGGRFAIDPELRGAEFERIIQNLDVHFWKA 540 
        ***:*****************:************************************** 
 
COW_HSL FWNITEIQVLSSLANMASTTVRVSRLLSLPPVAFEMPLTSDPELTVTISPPLAHTGPGPV 300 
RAT_HSL FWNITEIEVLSSLANMASTTVRVSRLLSLPPEAFEMPLTSDPKLTVTISPPLAHTGPGPV 600 
        *******:*********************** **********:***************** 
 
COW_HSL LVRLISYDLREGQDSKELSSFVRSEGPRSLELRLRPQQAPRSRALVVHIHGGGFVAQTSK 360 
RAT_HSL LARLISYDLREGQDSKMLNSLAKSEGPR-LELRPRPQQAPRSRALVVHIHGGGFVAQTSK 659 
        *.************** *.*:.:***** **** ************************** 
 
COW_HSL SHEPYLKSWAQELGAPILSIDYSLAPEAPFPRALEECFYAYCWAVKHCALLGSTGERICL 420 
RAT_HSL SHEPYLKNWAQELGVPIISIDYSLAPEAPFPRALEECFFAYCWAVKHCELLGSTGERICL 719 
        *******.******.**:********************:********* *********** 
 
COW_HSL AGDSAGGNLCFTVSLRAAAYGVRVPDGIMAAYPATMLQSTASPSRLLSLMDPLLPLSVLS 480 
RAT_HSL AGDSAGGNLCITVSLRAAAYGVRVPDGIMAAYPVTTLQSSASPSRLLSLMDPLLPLSVLS 779 
        **********:**********************.* ***:******************** 
 
COW_HSL KCVSAYAGAETEDHPDSDQKALGVMGLVQRDTALLLRDLRLGASSWLNSFLELGGQKSHL 520 
RAT_HSL KCVSAYSGTETEDHFDSDQKALGVMGLVQRDTSLFLRDLRLGASSWLNSFLELSGRKPHK 839 
        ******:*:***** *****************:*:******************.*:*.*  
 
COW_HSL KSVSK------------TEPMRRSVSEAALTRPEGPLGTDSLKSLKLHDLGLRNSSDTTD 568 
RAT_HSL TPLPATETLRPTDSGRLTESMRRSVSEAALAQPEGLLGTDSLKKLTIKDLSFKGNSEPSD 899 
        ..:.             **.**********::*** *******.*.::**.::..*:.:* 
 
COW_HSL TPELSLSAETLGPSAPSTINFLLGSEDGSEMSEAPEELNNKDRVRGVGAAFPEGFHPRRC 628 
RAT_HSL SPEMSQSMETLGPSTPSDVNFFLRSGNSQEEAETRDDISPMDGIPRVRAAFPDGFHPRRS 959 
        :**:* * ******:** :**:* * :..* :*: :::.  * :  * ****:******. 
 
COW_HSL SQGAMWMPLYSAPIVKNPFMSPLLAPNSMLQTLPPVHIVACALDPMLDDSVMFARRLRGL 708 
RAT_HSL SQGVLHMPLYSSPIVKNPFMSPLLAPDVMLKTLPPVHLVACALDPMLDDSVMFARRLKDL 1019 
        ***.: *****:**************: **:******:*******************:.* 
 
COW_HSL GQPVTLRVVEDLPHGFLSLAALCRETRQAAALCVERIRLILNLPG-PPV 756 
RAT_HSL GQPVTLKVVEDLPHGFLSLAALCRETRQAAELCVQRIRLILTPPAAPLT 1068 
                  ******:*********************** ***:******. *. * . 
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Figure 4 
 
BOVINE_ATGL MFPKETTWNISFAGCGFLGVYHIGVASCLREHAPFLVANATHIYGASAGALTATALVTGA 60 
MURINE_ATGL MFPRETKWNISFAGCGFLGVYHIGVASCLREHAPFLVANATHIYGASAGALTATALVTGA 60 
            ***:**.***************************************************** 
 
 
BOVINE_ATGL CLGEAGANIIEVSKEARKRFLGPLHPSFNMVKTIRGCLLKILPADCYECASGRLGISLTR 120 
MURINE_ATGL CLGEAGANIIEVSKEARKRFLGPLHPSFNLVKTIRGCLLKTLPADCHERANGRLGISLTR 120 
            *****************************:********** *****:* *.********* 
 
 
BOVINE_ATGL VSDGENVIITHFNSKEELIQANVCSTFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKN 180 
MURINE_ATGL VSDGENVIISHFSSKDELIQANVCSTFIPVYCGLIPPTLQGVRYVDGGISDNLPLYELKN 180 
            *********:**.**:*********************:********************** 
 
 
BOVINE_ATGL TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQ 240 
MURINE_ATGL TITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPMVLREMCKQ 240 
            ***************************************************:******** 
 
 
BOVINE_ATGL GYRDGLRFLRRNGLLNRPNPLLALPPSQPPAPEDADAEEGAVAMERTGGKDHLPPPREDH 300 
MURINE_ATGL GYRDGLRFLRRNGLLNQPNPLLALPPVV---PQEEDAEEAAVVEERAGEEDQLQPYRKDR 297 
            ****************:*********     *:: ****.**. **:* :*:* * *:*: 
 
 
BOVINE_ATGL ILEHLPSRLNEALLEACMEPTDLLTTLSNMLPVRLAMAMMVPYTLPLESAVSFTIRLLEW 360 
MURINE_ATGL ILEHLPARLNEALLEACVEPKDLMTTLSNMLPVRLATAMMVPYTLPLESAVSFTIRLLEW 357 
            ******:**********:**.**:************ *********************** 
 
 
BOVINE_ATGL LPDVPEDIRWMKEQTGSICQYLMIRAKRKLGNHLPSRLSGQVVLRRARSLPSVPLSCAAY 420 
MURINE_ATGL LPDVPEDIRWMKEQTGSICQYLVMRAKRKLGDHLPSRLSEQVELRRAQSLPSVPLSCATY 417 
            **********************::*******:******* ** ****:**********:* 
 
 
BOVINE_ATGL SEVLPSWMRNSLSLGDVLAKWEECQRQLLLGLFCTNVAFPPDALRMRVPAGPA---PEPP 477 
MURINE_ATGL SEALPNWVRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPDALRMRAPASPTAADPATP 477 
            **.**.*:**.*****.******************************.**.*:   * .* 
 
 
BOVINE_ATGL QHPPSSPPC 486 
MURINE_ATGL QDPPGLPPC 486 
           *.**.*** 
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2.1 ABSTRACT 
Negative energy balance at the onset of lactation is unfavorably associated 
with fitness traits in high producing dairy cows. Angiopoietin-like protein 4 
(ANGPTL4) is an adipokine that has been associated with the regulation of lipid 
metabolism through the inhibition of lipoprotein lipase activity and regulation of 
lipolysis. Expression of ANGPTL4 messenger RNA (mRNA) increases during early 
lactation, but its regulation with changing energy status is currently unknown. 
Accordingly, the objective of this study was to determine if ANGPTL4 mRNA 
abundance is responsive to declining energy balance induced by the transition from 
pregnancy to lactation, feed restriction, and GH administration in lactating dairy 
cows.  The mRNA abundance of leptin, adiponectin, and adiponectin receptor 2 
were also measured to compare adipokine mRNA profiles during changes in energy 
metabolism. Repeated adipose tissue biopsies were taken from different cows 
during transition from late pregnancy to lactation (n=26), feed restriction (n=19), and 
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GH administration (n=20).  As expected, milk yield increased with the onset of 
lactation and GH administration (P < 0.01), but declined during feed restriction. 
Energy balance declined in each experiment, resulting in negative energy balance at 
the onset of lactation and following feed restriction.  ANGPTL4 mRNA abundance 
increased two- to six-fold with declining energy balance in each experiment. Leptin 
mRNA declined with feed restriction, and adiponectin mRNA decreased with the 
onset of lactation. The consistency and magnitude of the increase in ANGPTL4 
mRNA across multiple models of altered energy balance identifies it as an adipokine 
that is uniquely responsive to changes in energy balance in the lactating dairy cow.  
 
Keywords: Leptin, Adiponectin, Growth Hormone, Transition, Feed Restriction 
2.2 INTRODUCTION 
The onset of lactation in high yielding dairy cows typically leads to a period of 
negative energy balance. Energy stored in body tissues, particularly adipose tissue, 
is then mobilized to compensate for the energy deficit. A greater understanding of 
metabolic changes that occur in response to altered energy status in dairy cows is 
needed, because severe or prolonged negative energy balance is unfavorably 
associated with reproduction, health and fitness traits [1]. Adipose tissue is 
recognized as an important endocrine tissue that participates in the regulation of 
energy homeostasis through the secretion of signaling proteins, or adipokines. Some 
adipokines, including leptin and adiponectin, are recognized as important modulators 
of energy metabolism [2], whereas the role of other adipokines is less defined. 
Angiopoietin-like protein 4 (ANGPTL4) was initially identified as a novel peroxisome 
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proliferator-activated receptor target gene that was rapidly up-regulated in response 
to fasting in rodents [3]. This secreted protein is associated with lipid metabolism via 
inhibition of lipoprotein lipase (LPL) and enhanced lipolysis [4–7], and has been 
studied in the context of immune response [8] and angiogenesis [9]. The messenger 
RNA (mRNA) abundance of adipose ANGPTL4 increases with pregnancy and 
lactation in rodents [10], and the transition from pregnancy to lactation in cattle [11]. 
Thus, the underlying hypothesis of the current research is that ANGPTL4 is an 
adipokine whose expression is altered in response to changes in energy status in 
lactating dairy cows, and that altered expression of ANGPTL4 facilitates the 
regulation of lipid metabolism. 
Three models of altered energy balance in lactating dairy cows are utilized in 
this research, including the transition from late pregnancy to lactation, feed 
restriction, and administration of bovine GH. During the transition from pregnancy to 
lactation, negative energy balance occurs as a result of the rapid increase in energy 
utilization for milk synthesis that is not offset by increased energy intake [12]. 
Negative energy balance can also be induced by feed restriction, which is a 
consequence of limited energy intake.  In this model, milk synthesis decreases, but 
this adaptation does not fully alleviate the energy imbalance. Finally, administration 
of GH results in a shift in energy partitioning to favor milk synthesis. Although energy 
intake eventually increases, the delay in response relative to the increase in milk 
production results in a transient period of reduced energy balance [13].  
Leptin mRNA expression and secretion have been investigated using similar 
models of altered energy balance in dairy cows. In general, leptin mRNA abundance 
54 
 
[14] and secretion [14–17] decrease with the transition from pregnancy to lactation 
and during feed restriction, but changes in leptin abundance in response to GH 
administration are not evident [16,18]. Leptin mRNA abundance was measured in 
the current experiment for comparison to ANGPTL4 across experimental models. In 
addition, adiponectin is a significant determinant of insulin sensitivity, intertissue 
communication, and immune function in nonruminant species [19–21]. Signaling by 
adiponectin occurs through adiponectin receptor 1 or adiponectin receptor 2, with 
adiponectin receptor 2 recognized as the predominant functional receptor in adipose 
tissue [22,23]. Currently, the regulation of adiponectin and adiponectin receptor 2 in 
response to changing energy status is not well characterized in cattle. Therefore, 
specific objectives of this research were to quantify changes in mRNA abundance of 
ANGPTL4, leptin, adiponectin and adiponectin receptor 2 in 3models of altered 
energy status in lactating dairy cows.  These objectives contribute to efforts to 
understand the role of adipokines during changes in energy metabolism in Holstein 
cows. 
2.3 MATERIALS AND METHODS 
All procedures involving the use of animals were approved by the Iowa State 
University Institutional Animal Care and Use Committee. 
2.3.1 Animals 
A total of 65 cows were allocated across 3 experiments and  fed ad libitum a 
consistent total mixed ration (TMR) formulated to meet or exceed all nutritional 
requirements (1.41 or 1.65 MCal of NEl per kg of dry matter for pre and postpartum 
diets, respectively) [24], unless noted. Daily individual feed intake was measured for 
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the duration of all experiments using the Calan Broadbent Feeding system 
(American Calan, Northwood NH, USA). Cows were trained and acclimated to the 
feeding system 4 to 6 d prior to initiation of each experiment. Daily feed intake was 
calculated as the difference between the quantity of TMR provided daily, and orts 
remaining daily, expressed on a dry matter basis. Dry matter and NEl content were 
determined from weekly TMR samples (Dairyland Laboratory, Arcadia, WI) that 
represented pooled samples from > 3 individual feedings. Samples of orts were also 
analyzed for dry matter and energy content, and these values were used in final 
calculation of dry matter and energy intake. Milk yield was recorded at each milking, 
and milk samples were collected weekly during a morning milking for determination 
of milk components (Dairy Lab Services, Dubuque, IA).  Body weights were 
measured weekly following a morning milking (lactating cows) or at a consistent time 
of day (non-lactating cows). Energy balance was calculated as previously described 
[25], according to equations published by the National Research Council [24]. 
Subcutaneous adipose tissue samples were biopsied from the tailhead region 
under local anesthesia (2% lidocaine) using a minimally invasive procedure, as 
previously described [25,26].  Four 1-g adipose tissue samples were extracted at 
each biopsy, immediately frozen in liquid nitrogen, and stored at -80° C until 
analysis. Biopsies were taken from alternating sides of cows.  
2.3.1.1 Transition experiment 
Twenty-six multiparous Holstein cows were moved to pens equipped with the 
Calan Broadbent Feeding system (American Calan, Northwood, NH, USA) 4 wk 
prior to expected parturition.  Adipose tissue samples were collected to target 21 d 
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antepartum (AP), and 5, 21, and 150 d postpartum (PP). Samples and data 
collected on these days were designated as 21 d AP, 5 d PP, 21 d PP, and 150 d 
PP, respectively.  Five cows were removed from the study after 21 d PP due to 
prolonged illness or injury between 21 and 150 d PP. Blood samples were collected 
weekly via jugular venipuncture starting ~ 3 wk AP and continuing through 4 wk PP, 
and again following the adipose tissue biopsy at 150 d PP. Serum was analyzed for 
NEFA concentration using a colorimetric NEFA assay (Randox Laboratories, Co. 
Antrium, United Kingdom) according to the manufacturer’s recommended protocol. 
2.3.1.2. Feed restriction experiment 
Nineteen multiparous Holstein cows were evaluated in 2 replicates (n=8, 
n=11) separated in time by 1 mo. Cows in the first and second replicate averaged 
183 ± 5 and 178 ± 4 d in lactation, respectively, when adipose tissue was first 
sampled.  Baseline feed intake was measured for 5 d prior to initiation of feed 
restriction. Feed was restricted to achieve a targeted energy balance of -10 Mcal/d, 
similar to energy balance during the transition period, with a maximum restriction of 
50% of baseline feed intake. The quantity of feed provided to each cow was 
adjusted on day 3 of the experiment to account for changes in milk production.  Feed 
was provided to cows 4 times daily during the feed restriction period. Adipose tissue 
was sampled on experimental day -6, 1, and 4 relative to initiation of feed restriction 
on day 0. Blood samples were collected immediately after each biopsy for analysis 
of NEFA, as previously described in section 2.3.1.1. One cow from replicate 1 lacked 
sufficient adipose tissue for two biopsies on the same side.  Blood and adipose 
tissue were not sampled on day 1 for this cow.  
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2.3.1.3. Growth hormone experiment 
Twenty multiparous Holstein cows were evaluated in 2 replicates separated in 
time by 1 d. Cows in the first and second replicate averaged 186 ± 6 and 180 ± 6 d 
in lactation, respectively, when adipose tissue was first sampled. Baseline feed 
intake was measured for 5 d prior to administration of GH.  Bovine GH was 
administered as a single dose of Posilac (500mg sometribove zinc; Elanco, 
Greenfield, IN), given via a subcutaneous injection in the neck.  Adipose tissue was 
sampled on experimental days -4, 3, and 7 relative to GH administration on day 0.  
Blood samples were collected immediately following each biopsy for analysis of 
NEFA, as previously described in section 2.3.1.1. For the feed restriction and GH 
experiments, samples collected on days -6 and -4, respectively, were used as a 
baseline control. Although we considered utilizing a portion of the cows as an 
untreated control group to identify potential environmental effects associated with 
day of biopsy, assignment of these cows to a second replicate for increased 
experimental power was deemed more appropriate. 
2.3.4. Quantitative real-time PCR 
 Approximately 1 g of subcutaneous adipose tissue was used for RNA 
extraction following a guanidine thiocyanate-chloroform-phenol protocol [27]. 
Genomic DNA contamination was removed using DNA-free according to the 
manufacturer’s protocol (AM1906; Ambion, Life Technologies, Grand Island, NY). 
Quality and quantity of RNA was assessed by absorbance measurement using a 
Nanodrop (Thermo Scientific, Waltham, MA).  Complementary DNA was generated 
from 2.5 µg of RNA using Moloney Murine Leukemia Virus Reverse Transcriptase 
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with all other conditions according to manufacturer’s protocol (Invitrogen, 28025-
013). The absence of genomic DNA was confirmed by PCR amplification of 
reference genes, β -actin or 60S ribosomal protein L32 (RPL32).  Primers targeting 
these genes (Table 1) spanned 131 and 588-bp introns, respectively. All primer 
sequences and amplicon sizes for PCR are provided in Table 1. Quantitative PCR 
was carried out under the following conditions for all primers: 95° C for 2 min 
followed by 40 repeated cycles of 95° C for 30 s, 50° C for 30 s, and 72° C for 45 s. 
The PCR products were then held at 95° C for 1 min, followed by 56° C for 1 min. 
Finally, a melt curve was run to confirm each PCR resulted in a single product. The 
melt curve increased from 56° C to 96° C, with an increase of 0.5° C every 10 s. 
Quantitative PCR was run in a 96-well format on a MyiQ thermocycler (Bio Rad, 
Hercules, CA) using SYBR Green chemistry (Bio-Rad, Hercules, CA) according to 
manufacturer’s protocol, except all reactions were run at half volume.  A serially 
diluted standard curve (~ 2.0 x 102 to 2.0 x 108 copies of a plasmid containing the 
PCR product of interest) was included with each assay as a positive control and for 
evaluation of PCR efficiency. Negative controls were included in each PCR plate. All 
samples and controls were run in duplicate, and the average of duplicate threshold 
cycle (Ct) values was used in statistical analyses. Leptin and ANGPTL4 in the 
transition period were normalized to β-actin.  Adiponectin and adiponectin receptor 2 
in the transition experiment and all genes in the feed restriction and GH experiments 
were normalized to RPL32.   
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2.3.5. Statistical analysis 
2.3.5.1. Production and metabolic traits 
Differences in production traits and NEFA among biopsy days were 
determined within experiment using a repeated measures model implemented by the 
PROC MIXED procedure of SAS [28]. The analysis model included biopsy day as a 
fixed factor, replicate as a random factor (feed restriction and GH experiments), and 
cow as a random repeated factor sampled across biopsy day. Covariance matrices, 
including compound symmetry (CS), autoregressive heterogeneity (ARH), and 
unstructured (US) were evaluated.  The CS or ARH matrix was used in analyses of 
production data, based on Akaike information content. Non-esterified fatty acid 
concentrations were analyzed following a natural log transformation to ensure a 
normal distribution of residuals. For the transition experiment, the weekly NEFA 
sample collected closest to the day of biopsy was used for analysis. When the 
overall effect of biopsy day was significant (P < 0.05), differences among biopsy 
days were determined through pairwise comparisons using the PDIFF procedure of 
SAS [28]. Means and SEMs for production traits and NEFA are presented in Table 
2. Because the 21 d AP biopsies were taken over a range of 26 d for the transition 
experiment, correlations between actual day AP, and energy balance and NEFA 
were investigated for these samples using the PROC CORR procedure of SAS [28]. 
2.3.5.2. Quantitative PCR data  
The ΔΔCt analysis method was used to evaluate results of quantitative PCR.  
The average Ct for each sample and gene was normalized by subtracting the 
average Ct of the reference gene [29]. Each PCR run was tested for PCR efficiency 
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using the diluted standard curve. The Ct values for leptin and adiponectin in the 
transition experiment were adjusted for PCR efficiency, as previously described [30], 
because they had PCR efficiencies outside an acceptable range of 90 to 110% (72% 
and 168%, respectively).  Differences in mRNA abundance were determined within 
experiment by analysis of the normalized Ct values, as previously described [30]. 
The mixed model analysis included the same fixed and random factors as described 
in section 3.3.5.1., except that PCR plate was also included as a random effect. 
When the overall effect of biopsy day was significant (P ≤ 0.05), differences among 
biopsy days were determined through pairwise comparisons using the PDIFF 
procedure of SAS [28]. Results are presented as relative fold change [29] and 
expressed relative to 21 d AP for the transition period, day -6 for the feed restriction 
experiment, or day -4 for the GH experiment.  Standard errors of the means of the 
fold change were calculated as previously described [30].  Correlations between 
normalized Ct values and actual days AP were calculated for the 21 d AP samples 
of the transition experiment, as described in section 2.3.5.1.  
2.4 RESULTS 
2.4.1 Transition period 
Milk synthesis increased during the transition period from 5 to 21 d PP, and 
remained elevated from 21 to 150 d PP (Table 2). The increase in energy 
requirements during the transition period resulted in negative energy balance during 
the first 21 d PP, as well as increased NEFA concentrations (Table 2).  Serum 
concentrations of NEFA were greater at 5 d PP compared to all other sampling times 
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(Table 2). Correlations of energy balance and NEFA with days AP were non-
significant. 
The mRNA abundance of β-actin and RPL32 mRNA did not change with 
sampling day or treatment (P = 0.209, and P = 0.257 to 0.385 for β-actin and RPL32, 
respectively). Additionally, no consistent trend in mRNA abundance across 
experimental treatments was observed, and variability across all treatments was 
similar for both genes (Figure 1). Thus, both β-actin and RPL32 are appropriate 
reference genes for these experiments.  
The transition period was accompanied by significant changes in ANGPTL4 
and adiponectin mRNA abundance (P < 0.001, P = 0.050, respectively). The mRNA 
abundance of ANGTPL4 was greater at 21 d AP, 5 d PP, and 21 d PP compared to 
150 d PP (P = 0.003, P < 0.0001, P < 0.0001, respectively), and was elevated at 5 d 
PP and 21 d PP compared to 21 d AP (P = 0.012 and P = 0.006, respectively; Figure 
2A). Adiponectin mRNA decreased at 5 and 21 d PP compared to 21 d AP (P = 
0.011 and P = 0.038, respectively; Figure 2B). Leptin and adiponectin receptor 2 
mRNA abundance did not change with biopsy day (P = 0.083 and P = 0.483, 
respectively). A correlation between AP sampling day and normalized Ct values for 
leptin was observed (r = -0.52, P = 0.01). Correlations for AP sampling day with 
ANGPTL4, adiponectin, and adiponectin receptor 2 were not significant (P > 0.10). 
Analyses of ANGPTL4, adiponectin receptor 2, leptin, and adiponectin utilized the 
CS, ARH, US, and CS covariance matrices, respectively.    
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2.4.2 Feed restriction 
Restricting feed intake to mimic transition energy balance during mid lactation 
resulted in a decrease in milk production within 1 d of feed restriction, and milk yield 
continued to decrease throughout the 4 d experiment (Table 2). Energy balance 
decreased after 1 d of feed restriction and remained negative through the 4 d 
restriction. As designed, feed restriction resulted in a similar degree of negative 
energy balance as observed during early lactation (Table 2).  Plasma NEFA 
concentrations increased on days 1 and 4 of feed restriction, relative to the day -6 
concentration (Table 2). Days in lactation were similar between cows in the two 
experimental replicates (P = 0.42), and the effect of replicate was non-significant in 
all analyses (P > 0.20). 
The quantity of RNA or quality of cDNA was unacceptable for >1 samples 
from 3 cows. Therefore, all mRNA data from these cows were excluded from PCR 
analyses. Changes in leptin and ANGTPL4 mRNA abundance were observed 
following feed restriction (P = 0.005, P = 0.002, respectively).  Leptin mRNA 
abundance decreased following 4 d of feed restriction (P < 0.001; Figure 2C), while 
ANGPTL4 mRNA abundance increased with 1 and 4 d of feed restriction (P = 0.002 
and P = 0.034, respectively; Figure 2A). The overall effect of biopsy day on 
adiponectin (P = 0.129; Figure 2B) and adiponectin receptor 2 (P = 0.399; Figures 
2D) mRNA abundance was not significant.  Analyses of all genes for the feed 
restriction experiment utilized the CS covariance matrix.    
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2.4.3 Growth hormone administration 
Milk production increased and energy balance decreased over the 7 d after 
GH administration (Table 2). Average energy balance of GH treated cows remained 
slightly positive throughout the experiment, but altered lipid metabolism was 
confirmed by an increase in NEFA concentration (Table 2). Days in lactation were 
similar between cows in the two experimental replicates (P = 0.50), and the effect of 
replicate was non-significant in all analyses (P > 0.20). 
Changes in ANGPTL4 mRNA abundance were observed following GH 
administration (P < 0.001), as it increased 3 and 7 d following GH treatment (P < 
0.001; Figure 2A). The overall effect of biopsy day was not significant for leptin (P = 
0.063; Figure 2C), adiponectin (P = 0.075; Figure 2B) or adiponectin receptor 2 (P = 
0.902; Figure 2D) mRNA abundance following GH administration. Analyses of 
ANGPTL4, adiponectin receptor 2 and leptin utilized the CS covariance matrix, and 
analysis of adiponectin utilized the ARH matrix.    
2.5 DISCUSSION 
This study utilized 3 different models of declining energy balance to 
characterize the mRNA profile of ANGPTL4 as part of an overall objective to 
understand the potential role of ANGPTL4 in energy homeostasis in lactating dairy 
cows.  Although different cows were utilized in each experiment, basal production 
and metabolic status were similar among cows in each experiment. Each experiment 
successfully reduced energy balance, with negative energy balance occurring in the 
transition and feed restriction experiments. However, altered energy status occurred 
via different mechanisms. In the transition experiment, negative energy balance at 5 
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and 21 d PP occurred because energy intake did not keep pace with increased 
energy requirements for milk synthesis at the onset of lactation. The feed restriction 
experiment also resulted in negative energy balance due to insufficient energy 
intake, but daily milk production decreased with declining energy balance in this 
experiment, in contrast to increasing milk production with the onset of lactation. 
Administration of GH resulted in a significant reduction in energy balance, although 
the average energy balance across cows remained slightly positive. This decline in 
energy balance was primarily driven by increasing milk production, although a small 
decline in feed intake was also observed. Importantly, each model led to increased 
circulating NEFA concentrations, indicating altered lipid metabolism.     
It should be noted that blood sampling for NEFA analysis occurred 
immediately after the biopsy procedure in the feed restriction and GH experiments, 
and for the 150 d PP samples of the transition experiment.  Stress may alter 
circulating concentrations of catecholamines, which may in turn impact circulating 
NEFA concentrations [31].  Thus, the stress of the biopsy procedure (~ 15 min in 
duration) may have impacted NEFA concentrations in the present study.  Basal 
NEFA concentrations observed in this study (0.14 to 0.18 mM) are slightly greater 
than those previously reported in similar studies (0.09 to 0.13 mM, [16,32]).  
However, the magnitude of change in response to GH administration and short term 
feed restriction are similar. Thus, the potential impact of the biopsy procedure on 
circulating NEFA concentrations in this study is likely minimal. 
The abundance of ANGPTL4 mRNA increased with declining energy balance 
in lactating dairy cows, regardless of whether the change in energy status occurred 
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via the onset of lactation, feed restriction, or GH administration. These results 
support and extend existing data describing increased ANGPTL4 expression with 
pregnancy and the onset of lactation in mice and cattle [10,11].  It is important to 
note that ANGPTL4 mRNA abundance changed dramatically at all time points 
investigated, even with relatively small changes in energy status. Thus, ANGPTL4 
may serve as an early autocrine/paracrine or endocrine signal for changing energy 
status in lactating cows.   
Angiopoietin-like protein 4 impacts lipid metabolism through the inhibition of 
LPL. Specifically, ANGPTL4 converts active LPL dimers to inactive monomers, 
thereby limiting the release of lipids from circulating chylomicrons [33]. Lipoprotein 
lipase is expressed and active at multiple tissues including adipose, cardiac and 
skeletal muscle, and the mammary gland. However, LPL activity is often regulated in 
a tissue specific manner [34], and this regulation may be due in part to ANGPTL4. 
For example, cardiac-specific over-expression of ANGPTL4 in mice resulted in a 
significant decrease in cardiac LPL activity and triglyceride content, but liver, skeletal 
muscle, and adipose LPL activity were not altered [35].  In cattle, the activity of 
adipose LPL decreases with the onset of lactation [36], contributing to the 
partitioning of energy toward the mammary gland to support milk synthesis. The 
regulation of LPL may be due in part to reduced mRNA expression, as reduced LPL 
mRNA has been described with the onset of lactation [11] and in response to GH 
administration [37].  However, changes in LPL activity in the absence of altered 
mRNA have also been described in non-lactating cows following feed restriction [38], 
suggesting a mechanism for post-transcriptional regulation of LPL in cattle.  Data 
66 
 
from the current study support the hypothesis that ANGPTL4 mRNA is regulated in 
response to changing energy status in lactating dairy cows as part of a mechanism 
to partition energy away from adipose tissue through inhibition of LPL activity.   
Lipolytic effects have also been associated with ANGPTL4. Transgenic mice 
that mildly overexpressed ANGPTL4 in adipose tissue had approximately 50% less 
white adipose tissue mass compared to their non-transgenic counterparts, while 
consuming similar quantities of feed [6]. These mice also had increased circulating 
triglycerides, likely due to the inhibitory effect of ANGPTL4 on LPL, and increased 
circulating NEFA and glycerol concentrations. Increased circulating triglycerides and 
NEFA were also observed 30 min after injection of recombinant ANGPTL4 in mice 
[4]. The increase in circulating NEFA and glycerol with increased ANGPTL4 suggest 
a direct lipolytic effect of ANGPTL4 [4,6]. Additionally, mice lacking ANGPTL4 had 
diminished lipolysis following stimulation by catecholamines and glucocorticoids. In 
the same study, lipolysis was rescued with the addition of ANGPTL4 to adipocytes 
isolated from the ANGPTL4 deficient mice  [7]. These results suggest ANGPTL4 
contributes to changes in lipid metabolism that favor mobilization and utilization of 
energy from lipid reserves, while inhibiting lipid storage.  
Angiopoietin-like protein 4 is expressed by multiple tissues in cattle, with 
greatest expression in liver and adipose tissue [39]. Increased liver ANGPTL4 
mRNA abundance with feed restriction has been described in cattle [40], and is 
consistent with the current results for adipose tissue. Circulating concentrations of 
ANGPTL4 were not measured in the current study, and the relative importance of 
circulating concentration versus local expression of ANGPTL4 in adipose depots is 
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currently unknown. However, further investigation of ANGPTL4 as an adipokine 
closely linked to physiological changes associated with altered energy status, 
particularly in the context of lactation, is warranted. 
Leptin mRNA abundance decreased with feed restriction, consistent with 
previous results [16]. Although a numerical decline in leptin mRNA was observed 
with the onset of lactation in the current experiment, this change did not achieve 
statistical significance. A non-significant decline in leptin mRNA from pregnancy to 
lactation has been described previously [15,17], while others have reported 
consistent and statistically significant declines in leptin mRNA and circulating plasma 
levels at the onset of lactation [14]. Differences in statistical significance among 
studies may be related to differences in the timing of sampling or the severity of 
negative energy balance occurring across experiments. For example, the correlation 
between AP sampling day and leptin mRNA abundance observed in the current 
study suggests leptin mRNA may increase in the pre-partum period as cows 
approach parturition.  This trend may influence the magnitude of change in leptin 
mRNA observed between AP and PP samples.  Regardless, a consistent decline in 
leptin expression with the onset of lactation has been described across multiple 
studies, and this regulation has been specifically associated with negative energy 
balance [14]. In the current study, there was a trend for a decline in leptin mRNA 7 d 
following GH administration. Previously, changes in plasma leptin concentrations 
following 3 d of GH administration were not evident [16,18].  It is unlikely that GH 
has a direct effect on leptin expression, but results from the current research 
suggest a potential transient decline in leptin mRNA with altered energy balance 
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following GH administration. Both autocrine and endocrine actions of leptin have 
been described, as it can directly stimulate lipolysis in adipose tissue and act 
through the central nervous system to regulate appetite [41]. It has been proposed 
that the primary consequence of declining leptin concentration in cattle is appetite 
regulation [14]. This hypothesis is consistent with the increase in feed intake that 
occurs in early lactation, and the need for increased energy intake with declining 
energy balance due to feed restriction or GH administration. 
Adiponectin mRNA abundance decreased with the onset of lactation in the 
current study, in contrast to previous results that described no change in adiponectin 
mRNA with the onset of lactation [15]. However, changes in adiponectin mRNA were 
not observed with feed restriction or GH administration in the current experiments. 
Thus, adiponectin mRNA is not consistently regulated in response to altered energy 
balance. Adiponectin is recognized as an important regulator of insulin sensitivity 
[21], and the decline in adiponectin mRNA with the onset of lactation coincides with 
an expected decrease in insulin sensitivity in lactating cows [42].  However, 
additional research is needed to fully explore the relationships between adiponectin 
mRNA and protein expression, its circulating multimeric complexes [43], and insulin 
signaling in dairy cattle. Adiponectin signals through two receptors, adiponectin 
receptor 1 and 2. Adiponectin receptor 2 is recognized as the primary functional 
adiponectin receptor in adipose of rodents, humans, and cattle [22,23,44], and was 
the receptor of primary interest in the current study. Preliminary analyses confirmed 
that adiponectin receptor 1 was lowly expressed in the bovine adipose tissue 
investigated (data not shown), but further optimization of experimental conditions 
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was not pursued. Significant changes in adiponectin receptor 2 mRNA were not 
observed in any of the experimental models investigated in this study. Previous 
investigations of adiponectin receptor 2 mRNA report inconsistent results, as 
adiponectin receptor 2 mRNA either decreased [15] or did not change following 
parturition [17]. In the current study, mRNA abundance for adiponectin receptor 2 
was highly variable across all experiments.    
In summary, this research identifies ANGPTL4 as an adipokine that is 
markedly responsive to changes in energy balance in the lactating dairy cow. 
Abundance of ANGPTL4 mRNA consistently increased with declining energy 
balance across 3 models of altered energy balance. The regulation of ANGPTL4 
differs from that of leptin and adiponectin, suggesting a fundamental role for this 
adipokine in the regulation of energy metabolism in the dairy cow.  Additionally, the 
mRNA abundance of ANGPTL4 increased dramatically at the earliest time point 
sampled in each model. These observations differ from previous work in rodents that 
concluded ANGPTL4 is not an indicator of overall nutritional status [45]. Future 
studies to determine whether ANGPTL4 participates directly in the regulation of 
lipolysis in the adipocyte will be of particular importance.    
 
2.6 ACKNOWLEDGMENTS 
This project was supported by National Research Initiative Competitive Grant no. 
2009-35206-05222 from the USDA Cooperative State Research, Education, and 
Extension Service. 
   
70 
 
2.7 TABLES 
 
Table 1. Sequences of primers used for quantitative PCR.  
Primer 
Name 
Primer Sequence Accession 
Number 
Exon Amplicon Size 
(nucleotides) 
ANGPTL4a 
Forward 
5’- AAG TGG ATT GTT CCA GAT CC -3’ NM_001046043.2 4 148  
ANGPTL4 
Reverse 
5’- GCC ATC TTT GTA GGC TTC CC -3’  5  
AdipQ R2 
Forward 
5’- CAT CTG GAC ACA TCT CTT GG -3’ NM_001040499.1 1 269  
AdipQ R2 
Reverse 
5’-TGG CGG GTT ACA GTA GAA GG -3’  2  
Adiponectin 
Forward 
5’- TCC TAC TTC CAC CCT GAC TGA -3’ NM_174742.2 1 829  
Adiponectin 
Reverse 
5’- TCT TTC ACT TTG TGC TGC TTG -3’  3  
Leptin 
Forward 
5’-TGT GGA CCC CTG TAT CGA TTC C -3’ NM_173928.2 2 134  
Leptin 
Reverse 
5’- TGT GAG ATG TCA TTG ATC CTG -3’  2  
RPL32b 
Forward 
5’- GGA CCA AGA AGT TCA TTA GGC - 3’ NM_001034783.1 2 138  
RPL32 b 
Reverse 
5’- TCC CAT AAC CGA TGT TGG GC- 3’  3  
β-Actin b 
Forward 
5’-GAC AGG ATG CAG AAG GAG ATT ACT-3’ NM_173979.3 6 145  
β-Actin b 
Reverse 
5’-TGA TCC AGA TCT GCT GGA AGG T-3’  7  
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aAbbreviations: ANGPTL4, angiopoietin-like protein 4; AdipQ R2, adiponectin 
receptor 2;  RPL32, 60S ribosomal protein L32 
bReference genes used for normalization of mRNA abundance.  
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Table 2.  Mean + SEM of daily milk yield, BW, dry matter intake, energy balance, and 
circulating concentrations of  NEFA in lactating Holstein cows during altered energy 
balance due to the onset of lactation (transition), feed restriction, or following 
administration of bovine GH. 
Experiment
w
 Experimental Time Point 
Transition 21 d AP 5 d PP 21 d PP 150 d PP 
  n=26 n=26 n=26 n=21 
 Days in Lactation 18.9+1.0 5.6+0.2 22.3+0.4 154.2+0.5 
 Range in Days of Lactation  6 to 32 5 to 9 21 to 31 151 to 161 
 Milk Yield (kg/d) - 36.2
a
 ± 1.1 46.8
b
 ± 1.1 43.6
b
 ± 1.2 
 BW (kg) 713
a
 ± 15 624
b
 ± 13 598
c
 ± 11 625
b
 ± 11 
 DMI (kg/d) 11.35
a
 ± 0.62 16.81
b
 ± 0.68 21.66
c
 ± 0.62 26.15
d
 ± 0.70 
 EB (MCal/d) 2.56
a
 ± 0.49 -7.38
b
 ± 1.29 -7.22
b
 ± 1.03 4.91
c
 ± 1.17 
 NEFA (mM)
 x
 0.18
a
 ± 0.02 0.75
c
 ± 0.09 0.38
b
 ± 0.04 0.17
a
 ± 0.02 
Feed Restriction Day -6 Day 1 Day 4 
  n=19 n=19 n=19 
 Days in Lactation 180 ± 5 188 ± 5 191 ± 5 
 Range in Days of Lactation 157 to 206 165 to 214 168 to 217 
 Milk Yield (kg/d) 38.7
a
 ± 1.0 31.0
b
 ± 1.1 28.4
c
 ± 1.0 
 BW (kg)
 y
 664 ± 12 664 ± 12 664 ± 12 
 DMI (kg/d) 23.91
a
 ± 0.53 14.63
b
 ± 0.39 12.53
c
 ± 0.33 
 EB (MCal/d) 5.00
a
 ± 1.23 -6.17
b
 ± 0.69 -8.17
c
 ± 0.68 
 NEFA (mM)
 x
 0.14
a
 ± 0.007 0.33
b
 ± 0.03 0.52
c
 ± 0.04 
Growth Hormone Day -4 Day 3 Day 7 
  n=20 n=20 n=20 
 Days in Lactation 183 ± 6 190 ± 6 194 ± 6 
 Range in Days of Lactation 154 to 216 161 to 223 165 to 227 
 Milk Yield (kg/d) 40.9
a
 ± 1.3 44.6
b
 ± 1.5 46.4
c
 ± 1.4 
 BW (kg)
 y
 713 ± 10.6 713 ± 10.6 713 ± 10.6 
 DMI (kg/d)
 
 27.41
a
 ± 0.57 26.50
a,b
 ± 0.57 26.12
b
 ± 0.58 
 EB (MCal/d) 6.47
a 
 ± 0.91 2.46
b 
 ± 0.82 0.16
c
 ± 0.94 
 NEFA (mM)
 x
 0.17
a 
 ± 0.01 0.35
b
 ± 0.04 0.39
b
 ± 0.04 
a,b,c Means within experiment with different superscripts differ, P < 0.05.  
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wFor all experiments and traits, the overall effect of experimental time point was 
significant (P < 0.01).  
xMeans and SEM were back-transformed following statistical analysis.  
yThe average of three BW was used to represent all three experimental time points, as 
maintenance energy requirements were not expected to change over the short duration 
of the experiment. 
Abbreviations: d AP, days antepartum; d PP, days postpartum; DMI, dry matter intake; 
EB, energy balance. 
  
74 
 
 
2.8  FIGURES 
 
Figure 1. Quantification of reference genes in three models of altered energy 
status.  (A) Quantitative PCR cycle thresholds (+ SEM) for β-actin and 60S ribosomal 
protein L32 (RPL32) from adipose tissue representing cows transitioning from late 
pregnancy to lactation.  Sampling days include approximately 21 d AP (-21; n=26), and 
5 (n=26), 21 (n=26) or 150 (n=21) d PP.   (B) Quantitative PCR cycle thresholds (+ 
SEM) for RPL32 following feed restriction or growth hormone administration.  Sample 1, 
2 and 3 represent days -6, 1, and 4 relative to initiation of feed restriction on day 0, or 
days -4, 3, and 7 relative to administration of growth hormone on day 0, respectively.   
 
Figure 2. Relative adipose tissue mRNA abundance of (A) angiopoietin like 
protein 4 (ANGPTL4), (B) adiponectin, (C) leptin, and (D) adiponectin receptor 2 in 
three models of altered energy status. Samples in the transition experiment 
represent approximately 21 d AP (-21; n=26), and 5 (n=26), 21 (n=26) or 150 (n=21) d 
PP.   Samples for the feed restriction (n=16) and GH (n=20) experiments are expressed 
as days relative to the initiation of feed restriction or GH administration on day 0.  Data 
are expressed as mRNA fold-change (+ SEM) relative to mRNA abundance in the 21 d 
AP, day -6, or day -4 sample for the transition, feed restriction, and GH experiments, 
respectively.  In the transition experiment, leptin and ANGPTL4 were normalized to β-
actin, and adiponectin and adiponectin receptor 2 were normalized to 60S ribosomal 
protein L32 (RPL32).  All genes were normalized to RPL32 in the feed restriction and 
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GH experiments. If the overall effect of sampling day was significant (P ≤ 0.05), means 
with different letters within experiment are different (P < 0.05). 
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3.1 ABSTRACT 
 
Dairy cows often experience negative energy balance with the onset of lactation, 
and severe or prolonged negative energy balance can contribute to declines in overall 
fitness. Energy stores, in adipose tissue triacylglycerides, are mobilized during times of 
energy deficit, and recent research has implicated several proteins associated with the 
lipid droplet as lipolytic regulators. The objective of this study was to determine if these 
novel proteins associated with lipolytic regulation are altered with the changing 
metabolic demands of lactation. Weekly blood samples were collected from 26 Holstein 
cows from 21 d prior to expected parturition through 28 d postpartum, and again at 150 
d postpartum. Serum non-esterified fatty acids, glycerol, and beta hydroxybutyrate were 
measured. Energy balance was calculated from daily feed intake and milk yield, weekly 
body weight, and monthly milk component measurements. Adipose tissue biopsies were 
taken 21 d prior to expected parturition (-21), and 5, 21, and 150 d postpartum. Semi-
quantitative western blotting was used to measure abundance of hormone sensitive 
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lipase (HSL), phosphorylated HSL, perilipin, phosphorylated perilipin (PPLIN), adipose 
triglyceride lipase (ATGL), and comparative gene identity-58 (CGI-58). Abundance of 
ATGL was less at 5 and 21 DIM compared to -21 and 150 DIM, even though cows were 
in negative energy balance and experiencing increased rates of lipolysis in early 
lactation. In contrast, phosphorylated HSL and PPLIN increased with increasing lipolysis 
immediately after parturition. Additionally, PPLIN was negatively correlated with milk 
yield at 5, 21, and 150 d postpartum, and negatively correlated with feed intake and 
energy balance at 21 d postpartum. This result is consistent with the hypothesis that 
phosphorylation of perilipin is responsive to signals for increased triacylglyceride 
mobilization. Finally, a consistent negative correlation between abundance of perilipin 
and CGI-58 proteins was observed throughout the transition period. These results 
confirm that novel lipolytic proteins in adipose tissue are regulated at the level of protein 
abundance and phosphorylation during the periparturient period and into mid lactation.  
Keywords: perilipin, adipose triglyceride lipase, transition period, energy balance 
 
3.2 INTRODUCTION 
 
Milk production per cow has doubled over the last 40 yr, resulting in increased 
energy requirements throughout lactation (AIPL, 2010). It is widely recognized that 
energy demands due to the initiation of milk synthesis in early lactation are often not 
met by energy intake, causing cows to experience negative energy balance. Although a 
period of negative energy balance is a natural part of the lactation cycle, severe and 
prolonged negative energy balance can contribute to declines in fitness traits, including 
fertility (Lopez et al., 2005; Veerkamp et al., 2000), udder health (Banos et al., 2006), 
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locomotive problems (Collard et al., 2000), and disease susceptibility (Hammon et al., 
2006; van Knegsel et al., 2007).  
During times of negative energy balance, mobilization of energy reserves from 
adipose tissue is a primary mechanism by which dairy cows compensate for their 
energy deficit.  It is well established that activation of hormone-sensitive lipase (HSL) 
via protein kinase A (PKA) is a critical pathway to the regulation of lipolysis. More 
recently, additional proteins have been associated with lipolytic regulation (Figure 1).  
Perilipin (PLIN) is a phosphoprotein that associates with lipid droplets. In the basal 
state, PLIN protects the lipid droplet from HSL mediated lipolysis (Brasaemle et al., 
2000b) and co-localizes with the protein comparative gene identity-58 (CGI-
58)(Subramanian et al., 2004; Yamaguchi et al., 2006).  The phosphorylation of PLIN by 
PKA stimulates a conformational change in PLIN that provides HSL access to the lipid 
droplet and facilitates the interaction between HSL and its lipid substrate (Miyoshi et al., 
2006).  Additionally, phosphorylation of PLIN results in the release of CGI-58 from the 
lipid droplet. When CGI-58 is not associated with PLIN, it acts as an activator of adipose 
triglyceride lipase (ATGL) in the cytosol.  The lipase ATGL can then translocate to the 
lipid droplet where it hydrolyzes triacylglycerides to diacylglycerides (Granneman et al., 
2007; Schweiger et al., 2008) (Figure 1). It has been suggested that the hydrolysis of 
triacylglycerides to diacylglycerides by ATGL is the rate limiting step in 
lipolysis(Haemmerle et al., 2006), and that phosphorylation of PLIN is a “master 
regulator” of lipolysis through its control of both HSL and ATGL, with the latter mediated 
by CGI-58 (Miyoshi et al., 2007; Moore et al., 2005).  
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 Appropriate regulation of lipolysis is critical for dairy cows to maintain health and 
productivity in times of negative energy balance. However, the coordinated regulation of 
HSL, PLIN, ATGL, and CGI-58 has not yet been studied in cattle. Thus, the current 
research was undertaken to determine if these proteins are altered at the level of 
protein abundance or phosphorylation with the changing metabolic demands of 
lactation. First, we quantified changes in protein abundance of HSL, PLIN, ATGL and 
CGI-58, as well as phosphorylation of HSL and PLIN, over the transition period.  
Second, we defined the relationship of these lipolytic proteins with traits influencing 
energy balance. Finally, we identified correlated changes among the lipolytic regulatory 
proteins. 
3.3 MATERIALS AND METHODS 
 
All procedures involving the use of animals were approved by the Iowa State 
University Institutional Animal Care and Use Committee.  
3.3.1 Animals 
 
Individual feed intake was measured daily on 26 multiparous (13, 7, and 6 cows 
in lactation 2, 3, and 4, respectively) Holstein cows using the Calan Broadbent Feeding 
system©. Feed intake was measured from approximately 30 d prior to parturition 
through 150 DIM.  Pre-calving and lactating cows were fed once or twice daily, 
respectively, and orts were removed and weighed daily. Cows were provided ad libitum 
access to a consistent total mixed ration (TMR) formulated to meet or exceed dry or 
lactating cow nutritional requirements (Clark, B.D., Erdman, R., Goff, J., Grummer, R., 
Linn, J., Pell, A., Schwab, C., Tomkins, T., Varga, G., Weiss, 2001). Lactating and non-
86 
 
 
lactating cows were weighed weekly following their morning milking and in early 
afternoon, respectively. Body condition scores (BCS) were determined weekly using a 1 
to 5 scale (Elanco, 1996).  
3.3.2 Milk Production and Milk Components  
 
Cows were milked twice daily with milk yield recorded at each milking. The 
software program Bestpred (Cole et al., 2009) was used to predict daily milk fat and 
protein percent based on monthly DHIA test day results. Additional milk samples were 
taken at the morning milking and analyzed for lactose content by a commercial 
laboratory (Dairy Lab Services, Dubuque, IA). 
3.3.3 Blood and Tissue Sample Collection 
 
 Blood was collected weekly via jugular venipuncture beginning at approximately 
21 d prior to parturition through 28 DIM, and again at the completion of the study, 
approximately 150 DIM. Serum was stored at -80°C until future analysis. Serum glycerol 
concentrations were measured using Free Glycerol Reagent (Sigma Aldrich, F6428, St. 
Louis, MO) according to manufacturer’s protocol. Non-esterified fatty acids (NEFA) and 
BHBA concentrations were analyzed from serum using commercially available kits 
according to the manufacturer’s protocol (NEFA and Ranbut assay kits, respectively, 
Randox Laboratories, Co. Antrium, United Kingdom).  
Subcutaneous adipose tissue was collected from the tailhead region using a 
minimally invasive procedure. Briefly, the tailhead region was shaved and cleaned prior 
to administration of local anesthetic (2% Lidocaine).  Following standard surgical 
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preparation, a straight line incision (approximately 3 cm) was made.  Tissue was 
excised using forceps and scalpel blade, and incisions were closed using surgical 
staples. With multiple sampling from each cow, samples were taken from alternating 
sides of the cow, and only from areas devoid of scar tissue. Four 1 g samples of 
adipose tissue were collected at each biopsy.  Biopsies were taken from each cow at 8 
to 31 d prepartum (-21 DIM; n=26), 5 to 9 DIM (5 DIM; n=26), 21 to 31 DIM (21 DIM; 
n=26), and 151 to 161 DIM (150 DIM; n=21).  Adipose tissue was immediately frozen in 
liquid nitrogen and stored at -80°C until protein analysis.   
3.3.4 Semi-Quantitative Western Blotting 
 
Semi-quantitative western blotting assays were optimized for each protein of 
interest to validate linearity of detection for the range of protein abundance for each 
protein of interest. Proteins were extracted from adipose tissue samples and prepared 
for Western blotting as previously described (Elkins and Spurlock, 2009). Protein 
concentrations were determined by BCA assay (Pierce Protein Research, 23227, 
Rockford, IL) and used to standardize the quantity of total protein loaded on each gel. 
Proteins (10 to 400 µg per lane, depending on protein of interest) were separated 
overnight through 10% [for detection of phosphorylated PLIN (PPLIN)] or 8 % (for 
detection of all other proteins) SDS-PAGE gels, and transferred to polyvinylidene 
fluoride membranes. Membranes were incubated with the following primary antibodies: 
PLIN (Chemicon, AB10200; 1:1000), phosphorylated PLIN (Chemicon, AB10200; 
1:5000), HSL (Cell Signaling, 4107;1:1000), Phospho HSL (PHSL) at Ser 563 (Cell 
Signaling, 4139;1:500), ATGL (Cell Signaling, 2138 ; 1:500), and CGI-58 (Everest 
Biotech, EB07657;1:200). Following incubation with secondary antibody [anti-goat IgG 
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horseradish peroxidase-linked whole antibody from Santa Cruz Biotechnology (Santa 
Cruz, CA) for CGI-58, or anti-rabbit IgG horseradish peroxidase -linked whole antibody 
from GE Healthcare (Pittsburgh, PA) for all other proteins], proteins were detected using 
the ECL Plus Western Detection Kit (Amersham Pittsburgh, PA) and imaged with Alpha 
Innotech Imager (FluorChem FC2, Cell Biosciences, Santa Clara, CA). Detected protein 
band areas were quantified using Total Lab software for 1D analysis (TL100, 
v2009;Totallab Limited, Newcastle upon Tyne, UK). All samples were run on duplicate 
gels. Protein abundance was normalized to abundance of the protein of interest 
quantified from a standard. The standard was an arbitrarily chosen sample that was 
loaded in lanes flanking samples from each cow on each gel. Normalization was 
achieved by subtracting the average standard protein abundance (measured in 2 lanes) 
from each sample. Normalized protein abundance was averaged across duplicate gels, 
and a constant was added to the normalized value of each sample for ease of statistical 
analysis and interpretation. For PPLIN, only the phosphorylated band (upper band) was 
used for data analysis. 
3.3.5 Energy Balance Calculations 
 
 Net energy balance was predicted using published equations (Clark, B.D., 
Erdman, R., Goff, J., Grummer, R., Linn, J., Pell, A., Schwab, C., Tomkins, T., Varga, 
G., Weiss, 2001). Samples of the TMR were collected from a minimum of three feedings 
per week, pooled, and analyzed by a commercial laboratory (Dairyland Laboratories, 
Arcadia, WI) using wet chemistry.  Net energy for lactation of the TMR was determined 
using Ohio Agricultural Research and Development Center (OARDC) equations for 
cows at 3 multiples of maintenance. Net energy of feed intake (NEI) was calculated as 
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the product of daily feed intake (kg), dry matter percentage of the TMR, and NEL of the 
TMR. Daily feed intake was the average intake over three consecutive days within three 
days of tissue collection of lactating cows, or within 7 days of tissue collection for non-
lactating cows. The NEL was calculated as [(0.0929 x fat% + 0.0563 x crude protein% + 
0.0395 x lactose%) x kg milk yield] using the average of three days of actual milk yield 
(tissue collection day, +/- 1d), fat and protein percent predicted from the Bestpred 
program (Cole et al., 2009) for the day of tissue collection, and the average of two 
lactose percent estimates from samples collected within 4 days before and after the day 
of tissue collection. Net energy for maintenance (NEM) was estimated as [0.08 * (BW 
0.75 
kg)].  Body weight was the average of two measurements, taken within one week before 
and after the day of tissue collection. For energy balance estimates at 5 DIM, BW 
represented the first weight measured after the tissue collection day if the previous 
week’s weight was taken prior to calving.  Net energy of pregnancy (NEP) was 
estimated as [(0.00318 x d of gestation – 0.0352) x (calf birth weight/45)]/0.218.  Energy 
balance for lactating cows was calculated as NEI – (NEM + NELAC), and for non-lactating 
cows as NEI – (NEM + NEP). 
3.3.6 Data Analysis 
 
     All data were tested for normality and homoscedasticity using the Shapiro-Wilk and 
Levene’s test, respectively (SAS/STAT User’s Guide, 1999). Serum metabolite data 
non-normally distributed and lacked homoscedasticity, and were transformed using the 
natural log transformation (loge) to achieve normality. Abundance of HSL and PHSL 
were also non-normally distributed. Multiple transformations were evaluated but none 
resulted in a normal distribution. The natural log transformation (loge) transformation 
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was used for analysis of these proteins, because the mixed model analysis failed to 
converge when non-transformed data were used. Results of the mixed model analysis 
were confirmed using the Kruskal-Wallis test ((SAS/STAT User’s Guide, 1999); results 
not shown).  Differences among biopsy days were determined using the mixed model 
methodology with repeated measures in SAS (SAS/STAT User’s Guide, 1999). Adipose 
tissue biopsy day, or week of blood sampling were classified as categorical fixed 
effects, and cow was included in the model as a random factor.  Day or week of 
sampling was the random factor. Alternate covariance structures were tested, and 
compound symmetry (CS), unstructured (UN), or heterogeneous first order 
autoregressive structure (ARH) resulted in models with the best fit. Correlations were 
determined using the PROC CORR procedure in SAS (SAS/STAT User’s Guide, 1999).  
Non-parametric Spearman correlations were calculated for all correlations involving 
transformed variables (NEFA, glycerol, HSL, PHSL). For correlations between protein 
and metabolite data, metabolite data were used if collected within 3 d of the adipose 
tissue biopsy.  
3.4 RESULTS 
 
Milk production based on 305 d mature equivalent for the completed lactation 
encompassing the experiment averaged 14,025 kg. As expected, cows utilized body 
energy reserves with the onset of lactation, as indicated by decreased BW (P < 0.0001; 
Figure 2A) and BCS (P < 0.0001; Figure 2B).  Energy balance differed significantly 
across biopsy days, with cows experiencing negative energy balance at 5 and 21 DIM 
(Figure 2C). 
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Serum concentrations of NEFA, glycerol, and BHBA were evaluated as indicators 
of lipolysis. Serum NEFA concentrations differed significantly during sampling (P < 
0.0001; Figure 3A). Increased NEFA concentrations were observed one week prior to 
calving through 3 weeks postpartum. Similarly, glycerol concentrations differed during 
the sampling period (P < 0.0001; Figure 3B.) Elevated glycerol concentrations were 
observed at calving and 1 wk postpartum. Serum BHBA concentrations were increased 
at calving relative to other weeks evaluated (Figure 3C).  
3.4.1 Lipid Droplet-Associated Proteins 
  
The protein abundance of ATGL differed significantly over the sampling period (P 
< 0.0001), with decreased abundance observed at 5 and 21 DIM relative to pre-calving 
and 150 DIM.  Abundance of HSL (P = 0.43), PLIN (P = 0.71), and CGI-58 (P = 0.13) 
did not differ among sampling times, although there was a numerical trend for 
increasing CGI-58 with stage of lactation. Phosphorylation of HSL (P = 0.02) and PLIN 
(P = 0.07) increased with the onset of lactation. Phosphorylation of HSL was similar pre-
calving and at 150 DIM, and elevated at 5 and 21 DIM.  Phosphorylated PLIN was 
significantly elevated at 5 DIM relative to 150 DIM (P = 0.01), with intermediate levels 
observed pre-calving and at 21 DIM (Figure 4).   
3.4.2 Correlations between Lipolytic Indicators and Regulatory Proteins  
 
 Correlations were calculated to evaluate the relationship between lipolytic 
indicators and proteins of interest. As expected, a significant (P < 0.05) correlation was 
found for NEFA with PPLIN, PHSL, and ATGL (r = 0.247, 0.372, and -0.376, 
respectively). Additionally, significant correlations were observed for milk yield on the 
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day of biopsy with PPLIN and PHSL (r = -0.310 and -0.262, respectively), for DMI with 
PPLIN (r = -0.292), and for energy balance with PHSL and ATGL (r = -0.293 and 0.359, 
respectively. Because these correlations may reflect changes across biopsies, 
correlations were also calculated within biopsy day.  Within biopsy day, correlations 
between NEFA and proteins of interest were not significant.  The correlation between 
milk yield on the day of biopsy with PPLIN was significant at both 5 and 21 DIM, but with 
PHSL was only significant at 150DIM.   Correlations of milk yield with HSL at 150 DIM, 
and with PPLIN at 150 DIM showed a statistical trend (P < 0.10). Dry matter intake was 
significantly correlated with PPLIN at 21 DIM and PHSL prior to calving.  The correlation 
with ATGL or PHSL with energy balance was non-significant when analyzed within 
biopsy day.  Energy balance was also correlated with total PLIN abundance at 150 DIM 
(Tables 1 and 2).  
3.4.3 Correlations among Lipolytic Proteins 
  
 Analysis of all data revealed a positive correlation between PLIN and HSL (r = 
0.259, P = 0.010).  Perilipin and HSL were negatively correlated with CGI-58 (r = -0.448, 
P <0.001 and r = -0.274, P = 0.006, respectively). Phosphorylation of PLIN and HSL are 
also correlated (r = 0.420, P < 0.001).  Analysis within biopsy revealed a consistent 
negative correlation between PLIN and CGI-58 at 5, 21, and 150 DIM.  Phosphorylated 
PLIN was positively correlated with phosphorylated HSL prepartum, and with ATGL at 5 
DIM. Finally, ATGL was significantly correlated with phosphorylated HSL prepartum 
(Tables 3 and 4).  
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3.5 DISCUSSION 
 
In this study, we describe changes in abundance of lipid droplet-associated 
proteins over the transition period, and the in vivo coordination of these proteins with 
energy balance and lipolytic indicators. Three important findings provide novel insight 
regarding the regulation of these proteins throughout the transition period. First, ATGL 
protein abundance decreased with the onset of lactation. Second, significant 
associations between PLIN and energy balance were observed, and third, changes in 
abundance of PLIN and CGI-58 proteins were coordinately regulated. 
Adipose triglyceride lipase was initially identified after HSL knock-out mice 
maintained normal lipolysis and body composition (Jenkins et al., 2004; Villena et al., 
2004; Zimmermann et al., 2004) Since then, ATGL has been described as a rate-
limiting step of lipolysis (Haemmerle et al., 2006). Abundance of ATGL increases in 
response to caloric restriction and glucocorticoids (Deiuliis et al., 2008; Villena et al., 
2004), suggesting that protein abundance increases in response to greater need for 
lipolytic mobilization of energy due to metabolic or pharmacologic stimuli. Thus in the 
current study, we expected increased abundance of ATGL at 5 and 21 DIM, when rates 
of lipolysis were greatest. Surprisingly, a clear and consistent decrease in ATGL was 
observed at these time points. One potential explanation for this unexpected result is 
the relative importance of ATGL during times of basal versus PKA mediated lipolysis. It 
is well documented that ATGL is necessary for both basal and stimulated lipolysis in 
3T3-L1 adipocytes and rodent models (Granneman et al., 2007; Haemmerle et al., 
2006; Miyoshi et al., 2008). However, results from experiments using human adipocytes 
indicate ATGL is less important than HSL in regulating PKA mediated lipolysis, whereas 
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both participate in basal lipolysis (Langin et al., 2005; Rydén et al., 2007). Additionally, 
ATGL but not HSL or PLIN regulates lipid droplet size under basal conditions in 
adipocytes derived from mouse embryonic fibroblasts (Miyoshi et al., 2008). Our 
observation that ATGL abundance is significantly less during negative versus positive 
energy balance potentially reflects a shift from ATGL-dependent basal lipolysis during 
positive energy balance, to HSL-dependent PKA stimulated lipolysis during negative 
energy balance. Furthermore, we hypothesize that this down-regulation of ATGL at the 
onset of lactation may protect the cow from a potentially detrimental depletion of lipid 
stores if both lipases were coordinately upregulated. This hypothesis is supported by 
cell culture experiments, in which ATGL mRNA is down-regulated by isoproterenol, 
forskolin, and cholera toxin (Kralisch et al., 2005). Potential mechanisms of ATGL 
regulation warrant further investigation in the transition dairy cow.  
Because PLIN is a known phosphorylation target of PKA, we expected its 
phosphorylation to increase at 5 and 21 DIM. This trend was observed, and is 
consistent with our previous report describing the abundance of PPLIN in cows in early 
(5-14 DIM) versus late (176-206 DIM) lactation (Elkins and Spurlock, 2009). However, 
significant correlations between PPLIN and circulating NEFA and glycerol 
concentrations within stage of lactation described previously (Elkins and Spurlock, 
2009) were not observed within biopsy day in the present study. Likewise, the 
significant correlations of PHSL with NEFA and glycerol were not observed in the 
present study. One possible explanation for this discrepancy is that the former study 
measured NEFA and glycerol from serum samples collected at the time of biopsy, 
whereas the current study utilized metabolite data from samples collected up to 3 d 
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before or after the biopsy. The lack of correlation in this study may reflect rapidly 
changing concentrations of NEFA and glycerol, or transient changes in phosphorylation 
of PLIN, during early lactation. This explanation is supported by the fact that the 
correlation between PPLIN and glycerol at 150 DIM, when biopsy and serum samples 
were collected on the same day, tended toward significance (r=.42; P = 0.08, data not 
shown) and was consistent with the correlation observed in late lactation cows in the 
previous study (r=0.65; P = 0.06). Alternatively, NEFA and phosphorylated proteins may 
not be correlated in the current data because of differences in lipolytic rates among 
adipose tissue depots.  In growing steers, increased lipolytic activity in subcutaneous 
adipose tissue compared to visceral adipose tissue depots (Pothoven et al., 1975; Rule 
et al., 1992).  However, a slightly higher lipolytic rate was observed in perireanal 
compared with subcutaneous adipose tissue of ewes (Etherton et al., 1977). 
Furthermore, lactation in sheep appears to alter the lipolytic responses of adipose tissue 
to β-adrenergic stimulation via depot-specific (Vernon et al., 1995). Thus in the current 
data, variation in circulating NEFA concentrations may reflect differences in visceral 
lipolysis, whereas the measurement of protein phosphorylation is from subcutaneous 
adipose tissue. 
Despite the lack of a significant relationship between PPLIN and NEFA within 
biopsy day, significant correlations between PPLIN and milk yield, DMI, and energy 
balance were observed in early lactation. Although cause and effect cannot be 
determined from correlative data, these results are consistent with the hypothesis that 
PPLIN plays an important role in energy utilization in vivo. The negative correlation 
between PPLIN and milk yield is particularly intriguing. A positive relationship would 
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have supported a hypothesis that increased energy mobilization through 
phosphorylation of PLIN supported higher milk production.  In contrast, it seems PLIN 
may be phosphorylated in response to a signal for increased energy mobilization when 
milk yield is limited by energy availability. Initially (5 DIM), only the relationship between 
milk yield and PPLIN is evident. However by 21 DIM, it appears that increased PPLIN is 
associated with cows experiencing more severe negative energy balance due to 
insufficient feed intake that is ultimately limiting the cow’s milk production. Thus, the 
combination of milk yield and feed intake, rather than either of these alone, may 
contribute to variation in PPLIN. However, further research is needed to test this 
hypothesis and define the mechanisms responsible for the observed correlations.    
In addition to the correlation with PPLIN in early lactation, total PLIN protein 
abundance was positively correlated with energy balance at 150 DIM. This correlation 
may reflect increasing adiposity and lipid droplet formation with increasing energy 
balance at 150 DIM. Perilipin was not correlated with BCS at this time point, but the 
subjective visual evaluation of BCS may have lacked the sensitivity to detect early 
changes in adiposity. Alternatively, variation in PLIN in the single adipose tissue depot 
sampled may not be reflective of overall body composition. Regardless, the biological 
relevance of the correlation between PLIN and energy balance in mid lactation warrants 
further investigation. 
Finally, PLIN protein abundance was negatively correlated with CGI-58 at all 
sampling times. To our knowledge, this is the first report of coordinated regulation of 
these proteins in any model. Although PLIN expression is known to be responsive to 
peroxisome proliferator-activated receptor-γ (Shimizu et al., 2006), estrogen receptor 
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related receptor (Akter et al., 2008), and RAR-related orphan receptor (ROR)-α (Ohoka 
et al., 2009), little is known about the regulation of CGI-58. However, expression of 
PLIN mRNA and protein is specific to adipocytes (Greenberg et al., 1991), whereas 
CGI-58 is expressed in both pre-adipocytes and adipocytes (Yamaguchi et al., 2007). 
Therefore, the negative relationship between PLIN and CGI-58 may in part reflect 
variation in abundance of pre- versus mature adipocytes in the adipose tissue sampled.   
3.6 CONCLUSIONS 
 
Proteins involved in the regulation of lipolysis are dynamically regulated 
throughout the transition period of multiparous Holstein cows. Although ATGL is often 
described as the rate-limiting step of lipolysis in other species, we show that it is 
dramatically down-regulated at the onset of lactation when the demand for lipolysis is 
greatest. In contrast, changes in phosphorylation of PLIN and HSL reflect changes in 
lipolysis across the time points sampled.  Additionally, PPLIN is negatively correlated 
with milk yield, DMI, and energy balance at 21 DIM, potentially reflecting a complex 
response to multiple signals of energy demands. Finally, the protein abundance of PLIN 
and CGI-58 appear to be closely coordinated throughout lactation. Together, these 
results demonstrate that the abundance of ATGL and phosphorylation of HSL and PLIN 
are altered throughout the transition period, and potentially contribute to the 
homeorhetic response to the onset of lactation. 
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3.8 TABLES 
 
Table 1.  Correlation coefficients (r) between milk production traits and lipid droplet-
associated protein abundance and phosphorylation.   
 Milk Yield Energy Corrected Milk 
 5 DIM
 a 21 DIM 150 DIM 5 DIM 21 DIM 150 DIM 
PLIN b -0.006 -0.255 -0.079 -0.142 -0.222 -0.297 
HSLc 0.186 -0.220 -0.428§ 0.017 -0.137 -0.335 
PPLIN -0.459* -0.419* -0.431§ -0.251 -0.097 -0.090 
PHSLc -0.312 -0.168 -0.556* -0.331§ 0.064 -0.427§ 
ATGL 0.125 0.162 -0.155 0.204 0.044 -0.052 
CGI-58 -0.202 -0.032 0.348 -0.108 0.040 0.100 
 
a 5 DIM indicates proteins from adipose tissue biopsy taken 4 to 9 DIM; 21DIM indicates 
adipose tissue biopsy taken 21 to 31 DIM; and 150 DIM indicates adipose tissue biopsy 
taken 151 to 161DIM. 
b Abbreviations: PLIN, perilipin; HSL, hormone sensitive lipase; PPLIN, phosphorylated 
perilipin; PHSL, phosphorylated hormone sensitive lipase; ATGL, adipose triglyceride 
lipase; CGI-58, comparative gene identity-58 
c Natural log transformed data were analyzed using Spearman correlation. 
§ P < 0.1 
* P < 0.05 
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Table 2.  Correlation coefficients (r) between energy balance and intake, and lipid 
droplet-associated protein abundance and phosphorylation. 
 Dry Matter Intake Energy Balance 
 -21 
DIMa 
5 DIM 21 DIM 150 DIM -21 
DIM 
5 DIM 21 DIM 150 
DIM 
PLIN -0.198 -0.163 -0.199 0.049 -0.234 0.017 0.007 0.489* 
HSLc -0.138 0.173 -0.033 -0.155 -0.141 0.104 0.166 0.327 
PPLIN -0.111 -0.260 -0.482* -0.182 0.042 0.053 -0.408* -0.064 
PHSLc -0.396* -0.203 -0.340§ -0.417§ -0.210 0.039 -0.368§ 0.151 
ATGL -0.097 -0.074 0.014 -0.158 0.146 -0.245 0.031 -0.041 
CGI-58 0.198 0.158 -0.027 -0.023 0.359§ 0.242 -0.118 -0.181 
 
a -21 DIM indicates proteins from adipose tissue biopsy taken 31 to 8 d prior to 
parturition; 5 DIM indicates adipose tissue biopsy taken 4 to 9 DIM; 21DIM indicates 
adipose tissue biopsy taken 21 to 31 DIM; and 150 DIM indicates adipose tissue biopsy 
taken 151 to 161DIM. 
b Abbreviations: NEFA, non-esterified fatty acid; PLIN, perilipin; HSL, hormone sensitive 
lipase; PPLIN, phosphorylated perilipin; PHSL, phosphorylated hormone sensitive 
lipase; ATGL, adipose triglyceride lipase; CGI-58, comparative gene identity-58 
c Natural log transformed data were analyzed using Spearman correlation. 
§ P < 0.1 
* P < 0.05 
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Table 3.  Correlation coefficients (r) among lipid droplet-associated protein abundance 
determined by semi-quantitative western blotting from adipose tissue biopsies collected 
4 to 9 DIM (above diagonal) and 21 to 31 DIM (below diagonal).  
 PLIN
 a HSL b PPLIN PHSL b ATGL CGI-58 
PLIN  0.279 -0.246 0.205 -0.086 -0.447* 
HSL b 0.131  0.228 0.145 0.400* -0.195 
PPLIN 0.081 -0.311  0.385§ 0.476* -0.178 
PHSL b 0.101 -0.004 0.350§  0.201 0.253 
ATGL 0.039 0.039 -0.137 0.186  -0.084 
CGI-58 -0.525* -0.063 -0.006 0.105 0.129  
 
a Abbreviations: PLIN, perilipin; HSL, hormone sensitive lipase; PPLIN, phosphorylated 
perilipin; PHSL, phosphorylated hormone sensitive lipase; ATGL, adipose triglyceride 
lipase; CGI-58, comparative gene identity-58 
b Natural log transformed data were analyzed using Spearman correlation. 
§ P < 0.1 
* P < 0.05 
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Table 4.  Correlation coefficients (r) among lipid droplet-associated protein abundance 
determined by semi-quantitative western blotting from adipose tissue biopsies collected 
31 to 8 d prior to parturition (above diagonal) and 151 to 161 DIM (below diagonal). 
 PLIN
 a HSL b PPLIN PHSL b ATGL CGI-58 
PLIN  0.252 0.050 0.182 0.3632§ -0.329 
HSL b 0.353  0.291    -0.041 0.097 -0.291 
PPLIN 0.117 -0.016  0.443* 0.223 0.016 
PHSL b 0.345 0.049 0.346  0.394* -0.230 
ATGL -0.168 0.122 -0.016 -0.025  -0.129 
CGI-58 -0.523* -0.316 -0.290 -0.123 0.252  
 
a Abbreviations: PLIN, perilipin; HSL, hormone sensitive lipase; PPLIN, phosphorylated 
perilipin; PHSL, phosphorylated hormone sensitive lipase; ATGL, adipose triglyceride 
lipase; CGI-58, comparative gene identity-58 
b Natural log transformed data were analyzed using Spearman correlation. 
§ P < 0.1 
*  P < 0.05 
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3.9 FIGURES 
 
Figure 1. Working model of lipolysis. Beta adrenergic receptors (β-AR) are activated 
by the binding of catecholamines. This stimulation results in activation of adenylyl 
cyclase which converts ATP to cAMP.  Increased intracellular concentration of cAMP 
activates Protein Kinase A (PKA) which phosphorylates hormone sensitive lipase (HSL) 
and perilipin. Phosphorylated HSL translocates to the lipid droplet to hydrolyze 
triacylglycerides to free fatty acids (FFA) and glycerol. Phosphorylation of perilipin 1) 
facilitates interactions between phosphorylated HSL and its lipid substrate, and 2) 
releases comparative gene identity-58 (CGI-58) from the lipid droplet.  CGI-58 
translocates to the cytosol where it interacts with adipose triglyceride lipase (ATGL). 
The translocation of ATGL to the lipid droplet allows for the hydrolysis of 
triacylglycerides to diacylglycerides.  Lines with + represent a positive action, a circled 
‘P’ represents a phosphorylation event, and dark gray filled shapes represents active 
proteins. 
 
Figure 2. Body weight, Body Condition Score and Energy Balance at the time of 
adipose tissue biopsy. A.) Body weight was measured weekly beginning 
approximately 30 days prior to calving through 150 DIM.  Body weight around the time 
of biopsy was a single weight + 3d of the adipose tissue biopsy.  B.) Body Condition 
Scores (BCS) was measured weekly beginning approximately 30 days prior to calving 
through 150 DIM.  BCS around the time of biopsy was a single weight + 3d of the 
adipose tissue biopsy. C.) Energy Balance was calculated from feed intake calculated 
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from daily amounts fed and refused, milk production, and milk components. Differences 
in letters indicate differences among means, P < 0.05.   
 
Figure 3.  Circulating concentrations of Non-esterified Fatty Acids (A), Glycerol 
(B) and Beta-hydroxybutyrate (C) at the time of adipose tissue biopsy. All 
circulating metabolites were measured weekly during the early afternoon. Weekly 
measurements of metabolites were from a single blood collection.  Following collection, 
serum was separated and stored at -80 °C until analysis.  Data were analyzed following 
natural log- transformation, but are presented on the linear scale for ease of 
interpretation. Differences in letters indicate differences among means, P < 0.05.   
 
Figure 4. Protein abundance of total and phosphorylated lipid droplet-associated 
proteins. Adipose tissue samples used for western blotting were taken approximately 
21d prior to parturition (31 to 8), and 5 (4 to 9), 21 (21 to 31), and 150 (151 to 161) DIM. 
Protein abundance of adipose triglyceride lipase (ATGL), hormone sensitive lipase 
(HSL), perilipin, comparative gene identity-58 (CGI-58), phosphorylated perilipin 
(PPLIN), and Ser-563 phosphorylated HSL (Phosphorylated HSL) was determined by 
semi-quantitative western blotting and expressed in relative units, normalized to a 
common standard. Each inset shows a representative western blot, and the arrow 
indicates the band used for quantification of PPLIN.   Biopsy days are represented as 
follows: -21, solid white; +5 DIM, diagonal stripe; +21 DIM, gray; +150 DIM, solid black. 
Lowercase and uppercase letters represent overall differences among means, P < 0.05 
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and P < 0.1, respectively. Differences in letters indicate differences among means, P < 
0.05.    
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CHAPTER 4. SIGNAL TRANSDUCER AND ACTIVATOR OF 
TRANSCRIPTION 3 INCREASES ADIPOSE TRIGLYCERIDE LIPASE 
PROTEIN ABUNDANCE DURING LEPTIN INDUCED LIPOLYSIS IN 
BOVINE ADIPOCYTES  
 
Proposed submission to American Physiology Journal’s Endocrinology and Metabolism 
 
  Dawn A. Koltes and Diane M. Spurlock 
 
4.1 ABSTRACT 
Regulation of lipid metabolism is critical for the maintenance of milk production 
and fitness in dairy cattle. Despite the knowledge that leptin can induced lipolysis in 
adipocytes of monogastrics, it remains unclear if bovine adipocytes undergo leptin 
induced lipolysis. Additionally, the mechanisms involved in leptin mediated lipolysis 
remain unclear. Therefore, the objectives of this study were to determine 1) if leptin 
signaling can induce lipolysis in bovine adipocytes and 2) the potential role of adipose 
triglyceride lipase (ATGL) and hormone sensitive lipase (HSL) in leptin stimulated 
lipolysis.  Lipolysis was increased after two hours of exposure to 100 ng/mL of bovine 
leptin.  As expected, phosphorylation of signal transducer and activator of transcription 
(STAT) 3 increased after leptin exposure. The addition of the STAT3 inhibitor, 
STATTIC, attenuated lipolysis and phosphorylation of STAT3. Phosphorylation of 
perilipin and HSL at serine 563, and serine 565 were not consistently increased with 
leptin exposure.  However, ATGL protein abundance was increased with leptin 
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exposure. The leptin-induced increase in ATGL protein abundance was attenuated with 
the addition of STATTIC.  These results identify for the first time that leptin induces 
lipolysis in bovine adipocytes. Additionally, increased ATGL protein abundance, but not 
phosphorylation of HSL or perilipin, indicates that leptin regulates lipolysis via a different 
mechanism than the traditional catecholamine stimulated pathway.   
Keywords: Hormone sensitive lipase, perilipin, STATTIC, glycerol, and non-esterified 
fatty acids 
4.2 INTRODUCTION 
 
Leptin is a hormone secreted by adipose tissue in proportion to adipose tissue 
mass and nutritional status (1, 20). One important role of leptin is to suppress feed 
intake (6, 15, 24, 26), but it can also act locally to increase lipolysis via the JAK/STAT  
pathway in rodents and pigs (19, 27, 28, 34). However, the mechanism by which leptin 
utilizes JAK/STAT to induce lipolysis remains unclear.  
Hormone sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) are 
major lipases associated with stimulated lipolysis in adipocytes.  Classically, the 
regulation of lipolysis has been attributed to catecholamines that stimulate lipolysis 
through the activation of protein kinase A (PKA),  which phosphorylates and allows for 
the translocation of HSL to the lipid droplet (11, 22). It is now recognized that additional 
proteins also participate in the PKA-dependent regulation of lipolysis. Perilipin, a lipid 
droplet barrier protein, is phosphorylated by PKA. Phosphorylated perilipin allows 1) 
access of PKA-phosphorylated HSL to the surface of the lipid droplet (23, 33) and 2) the 
release of the protein comparative gene identity-58 (CGI-58) from the lipid droplet which 
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facilitates the translocation of ATGL to the lipid droplet (14).  Additional evidence 
suggests ATGL may play a role in basal lipolysis in rodents and dairy cattle (17, 21, 29); 
however, the mechanisms by which ATGL are activated is currently under investigation 
(3, 22, 25).  
The dairy cow is a unique model for studying lipid metabolism due to the 
dramatic changes in lipid turnover that occur throughout a lactation cycle.  Following 
parturition, energy requirements greatly increase due to milk synthesis.  These energy 
requirements are typically not met by feed intake, requiring the mobilization of body 
energy reserves, in particular adipose tissue, to support lactation.  As the lactation cycle 
progresses, milk synthesis declines and feed intake increases to meet and eventually 
exceed energy requirements. Energy reserves are then replenished prior to the next 
lactation cycle (7). The depletion of lipid reserves during early lactation is associated 
with declining circulating leptin concentrations (1, 8, 9), which may contribute to 
increasing appetite during this time.  However, additional roles of leptin in energy 
homeostasis in dairy cattle remain unknown. Therefore, the objectives of this research 
were to: 1) determine if leptin can signal to induce lipolysis in bovine adipocytes and 2) 
determine the potential role of ATGL and HSL in leptin-stimulated lipolysis.  
 
4.3 MATERIALS AND METHODS 
 
All procedures involving the use of animals were approved by the Iowa State 
University Institutional Animal Care and Use Committee.  
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4.3.1 Adipocyte Collection 
Approximately 40 g of subcutaneous adipose tissue were collected under local 
anesthetic (2% lidocaine) from the tailhead region of 15 primiparous mid lactation 
(300.75 + 15.21 d in milk) Holstein cows. Adipocytes were isolated using a previously 
described method (4).  Briefly, adipose tissue was minced then digested in cocktail 
media [20 mM Sodium bicarbonate, 20 mM HEPES, 10 mM D-glucose, and 3% bovine 
serum albumin (w/v), pH 7.4, containing 1 mg/mL (w/v) of collagenase type I (C2674; 
Sigma; St. Louis, MO)]. Adipose tissue was digested for 40 minutes at 37C.  Following 
an additional collagenase digestion (1.8mg/mL of collagenase; w/v), adipocytes were 
collected by filtration, rinsed, and isolated adipocytes were suspended in media [10g/L 
low glucose DMEM, 3% bovine serum albumin (w/v), 6.6 mM Sodium bicarbonate, 6.25 
mM HEPES, pH 7.2]. Adipocytes were placed in plastic scintillation vials, and allowed to 
acclimate for 30 minutes prior to treatment at 37  C. 
4.3.2 Treatment of Adipocytes 
 Duplicate vials of adipocytes from eight cows were administered 0ng/mL 
(Control), 10ng/mL, 100ng/mL, or 200 ng/mL of bovine leptin (CYT-502; ProSpec; Ness-
Ziona, Isreal). To determine if the lipolytic effect of leptin was mediated by STAT3, 
duplicate vials of adipocytes from seven different cows were treated with 0, 1, 1.25, 1.5, 
1.75 or 2 μM of STATTIC (2798; Tocris; Bristol, UK) for one hour prior to administration 
of 100 ng/mL of bovine leptin. As a positive control, a subset of adipocytes from each 
cow was treated with 100 nM D-L isoproterenol for 2 hours (151358; MP Biomedicals; 
Solon, OH) or 0 or 2 μM of STATTIC for 1 hour prior to administration of 100 nM D-L 
isoproterenol (Figures 1, 3). Media was aspirated from under the adipocytes after two 
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hours after the final treatment. See supplemental figure 1 for a depiction of experimental 
design. Aspirated media was stored at -80⁰C until further analysis.  Adipocytes were 
homogenized in a protein homogenization buffer (12, 17), immediately frozen and 
stored at -80⁰C until further analysis. 
4.3.3 Glycerol and Non-esterified Fatty Acid Assays 
 Glycerol and non-esterified fatty acid (NEFA) from the aspirated media were 
measured in triplicate using colormetric assays in a 96-well plate format. Data were 
captured using a Tecan Spectrafluor Plus (Tecan Group Ltd).  Glycerol concentrations 
were determined using Free Glycerol Reagent (Sigma; F6428;St. Louis, MO), and 
NEFA concentrations using the NEFA-HR (2) assay (999-34691, 995-34791, 991-
34891, 993-35191, 276-76491; Wako; Richmond, VA), both according to manufacturer’s 
protocol. Glycerol and NEFA were normalized to protein abundance determined by 
bicinchoninic acid assay (BCA; 23227, Pierce Protein Biology Products, Rockford, IL) 
from the same vial. Protein samples were subsequently prepared for western blotting. 
4.3.4 Semi-quantitative Western Blotting 
Semi-quantitative western blotting assays were performed using previously 
described methods (12, 17).  Briefly, a constant quantity of protein was diluted in 
Laemmli sample buffer and loaded on either an 8% or a 10% SDS-PAGE gel. See table 
1 for antibody information. Gels were transferred to polyvinylidene fluoride membranes 
(Hybond-P, 45000931; GE Healthcare; Pittsburgh, PA), exposed to primary antibodies, 
rinsed, and exposed to ECL anti-rabbit horseradish peroxidase IgG antibody (NA9340-
1ml; GE Healthcare; Pittsburgh, PA). Membranes were rinsed and then exposed to ECL 
prime western blotting detection reagent (RPN 2232, GE Healthcare, Pittsburgh, PA), 
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according to manufacturer’s protocol. Membranes were imaged using an Alpha 
Innotech Imager (FluorChem FC2, Cell Biosciences, Santa Clara, CA) and protein 
bands were quantified using Totallab software for 1D analysis (TL100, v2009; Totallab 
Ltd, Newcastle upon Tyne, UK).  Phosphorylated perilipin was determined by 
quantifying the phosphorylated band (upper band; Supplemental Figure 1 and 2) on the 
perilipin membranes. All samples were run on duplicate gels. Protein abundance values 
were normalized to β-actin, and means are presented relative to control samples. For 5 
of the 60 gels, β-actin protein abundance was not detected either due to low abundance 
or accidentally excluded from the membrane.  The average β-actin protein abundances 
for all samples from a single trial were used for normalization of these samples. When 
β-actin protein abundance was not detected for a single sample within a membrane (23 
out of 1442 lanes), that sample was excluded from analysis because using the average 
β-actin protein abundance resulted in the loss of normality.   
4.3.5 Statistical Analysis 
A randomized complete block design was utilized for statistical analysis of 
glycerol, NEFA, and protein abundance for leptin and STATTIC treated adipocytes. For 
statistical analysis, the PROC MIXED procedure in SAS was utilized. Treatments were 
blocked within cow. Cow was fit as a random effect, and treatment was fit as a fixed 
effect. A 2x2 factorial design was used to compare the two factors control and 
isoproterenol treated adipocytes in the presence or absence of STATTIC. The PROC 
MIXED procedure in SAS was utilized for statistical analyses (30). In this 2x2 factorial 
design, cow was fit as a random effect and isoproterenol treatment, STATTIC treatment 
and the interaction were fit as fixed class effects.  Since phosphorylated perilipin was 
120 
 
 
not detectable in the majority of samples (64 out of 80 samples for the leptin experiment 
and, 156 out of 176 samples for the STATTIC experiment), a chi-squared test was 
performed in SAS to test if the presence of phosphorylation was higher than expected 
with a particular treatment (30).  All model residuals were tested for normality. Data that 
significantly deviated from normality included: total protein abundance for perilipin 
during leptin treatment; glycerol, NEFA, phosphorylation of HSL at serine 563 and 565, 
perilipin and STAT3 for the comparison of isoproterenol treatment of cows in the leptin 
experiment; and NEFA concentrations for the STATTIC treatment.  These data were log 
transformed to induce normality in the residuals. Pairwise comparisons were conducted 
between control and treatment groups using the contrast statement in PROC MIXED 
(30).  Significance was set at P < 0.05, and tendency set at P < 0.01. 
4.4 RESULTS 
4.4.1 Leptin treatment 
Primary bovine adipocytes exposed to 100nM isoproterenol had a 16 fold 
increase in glycerol and a 31 fold increase in NEFA concentrations in the media 
compared to control adipocytes (Figure 1 A and B). The increased lipolytic activity was 
accompanied by an increase in phosphorylation of HSL at Serine 563 and perilipin 
(Figure 1C).  Total protein abundance of HSL, perilipin, ATGL, STAT3, and 
phosphorylation of STAT3 at Tyrosine 705 and HSL at Serine 565 were similar between 
isoproterenol-treated and control adipocytes (Figure 1C). P-values are presented in 
Table 2. 
Glycerol concentrations were altered by leptin treatment after 2 hours (Figure 
2A), but NEFA concentrations remained constant (Figure 2B).  Glycerol concentrations 
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increased with 100 ng/mL of bovine leptin compared to control adipocytes (P = 0.016). 
Leptin stimulation altered the relative abundance of phosphorylated STAT3 at Tyrosine 
705, and ATGL protein abundance. Phosphorylation of STAT3 at Tyrosine 705 was 
elevated by treatment with 10 or 100 ng/mL of bovine leptin (P = 0.021 and P = 0.032, 
respectively), and ATGL was elevated with 10, 100 or 200 ng/mL of bovine leptin (P = 
0.025, P = 0.001, and P = 0.003, respectively). Phosphorylated HSL at Serine 563 
tended to be altered with leptin treatment, and was increased with 100 and 200 ng/mL 
of bovine leptin (P = 0.030 and P = 0.041, respectively). Phosphorylation of HSL at 
Serine 565, perilipin and total protein abundance of perilipin, HSL, and STAT3 remained 
constant with leptin treatment (Figure 2C and D).  Overall p-values are listed in table 2.  
4.4.2 STATTIC treatment 
To confirm signaling of leptin was mediated by STAT3 in bovine adipocytes, cells 
were treated with a STAT3 specific inhibitor, STATTIC.  The introduction of STATTIC at 
2μM did not alter lipolytic indicators or relative protein abundance in either control or 
isoproterenol stimulated adipocytes (Figure 3). Adipocytes treated with isoproterenol 
had elevated glycerol (Figure 3A) and NEFA concentrations (Figure 3B) in the media, 
and increased phosphorylation of HSL at Serine 563 and perilipin. Total protein 
abundance of ATGL was significantly altered by isoproterenol treatment, but pairwise 
comparisons between control and isoproterenol in the presence or absence of STATTIC 
were not significant. Total protein abundance of HSL, perilipin, STAT3, ATGL, 
phosphorylation of STAT3 at Tyrosine 705, and HSL at Serine 565 were not altered with 
isoproterenol treatment (Figure 3C). Overall p-values are listed in table 3.  
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Treatment of bovine adipocytes with STATTIC (0, 1, 1.25, 1.5, 1.75, 2 μM) plus 
100ng/mL of leptin altered overall glycerol concentrations (Figure 4A), while NEFA 
concentrations were similar across treatments (Figure 4B).  Glycerol concentrations 
were elevated in adipocytes treated with 0 or 1 μM of STATTIC plus 100 ng/mL of leptin 
compared to control adipocytes (P = 0.036 and P = 0.003, respectively). Overall, 
relative protein abundances were not significantly altered by leptin treatment (Figure 
4C). However, ATGL protein abundance tended to be altered with increased protein 
abundance in adipocytes treated with 0 or 1.75 μM of STATTIC plus 100 ng/mL of leptin 
(P = 0.026 and P = 0.026, respectively). Although treatment was not significant overall, 
phosphorylation of STAT3 at Tyrosine 705 increased with 100 ng/mL of leptin (P = 
0.032). Phosphorylation of HSL at serine 563 tended to be altered with STATTIC 
treatment, but only adipocytes treated with 1.75 μM of STATTIC plus 100 ng/mL of 
leptin had increased phosphorylation compared with control (P = 0.05). Phosphorylated 
HSL at serine 565, phosphorylation of perilipin, and total protein abundance of HSL, 
STAT3 and perilipin remained constant throughout the STATTIC treatment. Overall p-
values are listed in table 3.  
4.5 DISCUSSION 
Leptin is a potent adipokine that can regulate energy balance by altering feed 
intake (6, 15, 24, 26) and lipid metabolism (2, 5, 16, 19, 27, 28, 34).  In dairy cattle, 
circulating leptin concentrations decline following parturition to increase appetite (1, 8). 
However, the role of leptin later in lactation when energy intake exceeds energy 
requirements was unknown. By demonstrating that leptin induces lipolysis in bovine 
adipocytes, this study has elucidated a novel role for leptin in the dairy cow.  
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Additionally, the detailed mechanisms involved in leptin induced lipolysis had not been 
well characterized in previous studies.  This study indicates 1) that leptin activated the 
STAT3 signaling pathway to induced lipolysis, and 2) leptin treatment increased ATGL 
protein abundance via STAT3. 
Leptin induced a slight, but significant increase in lipolysis of bovine adipocytes.  
The approximately 30% increase in glycerol release was considerably lower than the 
1,600% increase in glycerol release during isoproterenol treatment. This mild lipolytic 
response was similar to responses observed in murine and porcine adipocytes (19, 34).  
In addition to the similar lipolytic response, murine and porcine adipocytes exposed to 
leptin had elevated glycerol concentrations but not NEFA concentrations (19, 34). 
Transcription of genes involved in β-oxidation increased in adipocytes treated with leptin 
(34) suggesting that NEFA undergo β-oxidation instead of being release into the media.  
Although we did not directly test for increased β-oxidation, we expected NEFA to 
undergo β-oxidation in bovine adipocytes due to the similarities of our result to other 
models.  The ability of bovine adipocytes to undergo leptin induced lipolysis and β-
oxidation suggest that increased circulating leptin concentrations may regulate adipose 
tissue accumulation and mobilization during later lactation in dairy cattle.  
Physiological circulating concentrations of leptin range between 1 and 20 ng/mL 
in cattle (1, 8–10, 32, 35). However, leptin consistently induced lipolysis at 100 ng/mL, 
and not 10 ng/mL of bovine leptin. Porcine and rat adipocytes can undergo leptin 
induced lipolysis at concentrations slightly elevated from physiological ranges (19, 27, 
34). However,  maximal lipolytic response occurs with  100 ng/mL of leptin (27, 31).  
The ability of leptin to induce lipolysis in primary adipocytes at approximately 10 times 
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circulating concentrations may indicate that either throughout the isolation process the 
adipocytes become less sensitive to leptin or that intratissue concentrations of leptin are 
higher than circulating concentrations as suggested by (2). 
Phosphorylation of STAT3 was increased at concentrations of leptin similar to 
circulating concentrations in cattle, as well as concentrations of leptin that induced 
lipolysis. The ability of leptin to increase phosphorylation of STAT3 at in vivo circulating 
concentrations indicated that circulating concentrations of leptin can induce signaling in 
bovine adipocytes.  Additionally, phosphorylation of STAT3 increased with leptin 
concentrations that induced lipolysis in bovine adipocytes. The attenuation of 
phosphorylation of STAT3 coincided with the attenuation of lipolysis in adipocytes 
treated with STATTIC. This attenuation confirms the importance of STAT3 to leptin 
induced lipolysis.     
The roles of ATGL and HSL are primarily associated with their participation in 
catecholamine stimulated lipolysis. Following activation of PKA, phosphorylation of 
perilipin releases CGI-58 from the lipid droplet surface where it allows ATGL to 
translocate to the lipid droplet surface.  This initial step results in the hydrolysis of 
triacylglycerides to diacylglycerides.  Activated PKA phosphorylates HSL at serine 563, 
serine 659, and serine 660.  The activation of HSL by PKA allows for the translocation 
of HSL to the lipid droplet (18). However, HSL can be phosphorylated at serine 565 by 
AMPK, and is expected to prevent phosphorylation at serine 563 and may prevent 
lipolysis (13).  
Leptin treatment increased protein abundance of ATGL, but not phosphorylation 
of HSL or perilipin. As previously mentioned, isoproterenol was included as a positive 
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control, and increased phosphorylation of HSL at serine 563 and perilipin. The lack of 
phosphorylation of HSL and perilipin with leptin treatment indicates these proteins may 
not be activated by leptin to induce lipolysis. However, leptin increased ATGL protein 
abundance. This increase in ATGL protein abundance was attenuated with the addition 
of STATTIC, and coincided with the decrease in lipolysis.  This indicated that ATGL may 
be active during leptin induced lipolysis.  Contradicting our results, porcine SVC-derived 
adipocytes had decreased ATGL protein abundance after 3 hours of leptin treatment at 
sufficient concentrations to induce lipolysis (19).  These differences may be due to 
differences in cell type, length of exposure or differences between species. However, 
protein abundance in SVC-derived porcine adipocytes were inversely affected by the 
JAK inhibitor, AG490 (19). This suggests that the JAK/STAT pathway regulates ATGL in 
both bovine and porcine adipocytes.  However, Li et al. did not determine the effect of 
the JAK inhibitor on lipolysis. Therefore, it is unclear how the altered ATGL protein 
abundance may influence leptin induced lipolysis in porcine adipocytes. Since, protein 
abundance of ATGL does not directly indicate activity of ATGL, these differences in 
ATGL protein abundance may not reflect differences in ATGL activity, and only 
differences in the regulation of ATGL protein abundance.  
In conclusion, these results indicate that leptin can regulate lipolysis in bovine 
adipocytes. This provides novel insight into lipid metabolism in the lactating dairy cow 
since leptin concentrations are known to be altered throughout a lactation cycle (1). 
Additionally, these results indicate that leptin regulates lipolysis via different 
mechanisms than isoproterenol.  In contrast to increased phosphorylation of HSL and 
perilipin by PKA, these results demonstrate that STAT3 increased ATGL protein 
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abundance which may lead to increased lipolysis.  This differential regulation of HSL 
and ATGL during leptin induced lipolysis may provide a mechanism for regulating basal 
lipolysis.   
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4.7 TABLES 
 
Table 1. Antibodies used for semi-quantitative western blotting. 
Antibody Company Catalog 
number 
Gel percentage Concentration 
PSTAT3 Try705a Cell 
Signaling 
9145 8 1:500 
STAT3  Cell 
Signaling 
8719 8 1:500 
ATGL Cell 
Signaling 
2138 8 1:500 
PHSL Ser563 Cell 
Signaling 
4139 8 1:500 
PHSL Ser565 Cell 
Signaling 
4137 8 1:500 
HSL Cell 
Signaling 
4107 8 1:500 
Perilipin Chemicon AB10200 10 1:1000 
P-Perilipinb Chemicon AB10200 10 1:1000 
β-actin Cell 
Signaling 
5125 -c 1:5000 
 
 aAbbreviations: STAT3,  signal transducer and activator of transcription 3; HSL, 
hormone sensitive lipase; PSTAT3 Try705, phosphorylated STAT 3 at tyrosine 705; 
ATGL, adipose triglyceride lipase; PHSL ser563, phosphorylated HSL at serine 563; 
PHSL ser565, phosphorylated HSL at serine 565; P-Perilipin, phosphorylated perilipin 
 b Phosphorylated perilipin was quantified based on the shift in the protein size between 
phosphorylated and unphosphorylated protein.  The upper band was quantified as 
phosphorylated perilipin and the lower band as unphosphorylated perilipin. 
c β-actin antibody was exposed to all membranes. 
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Table 2. List of P-values for main effects from the leptin experiment. 
Effect Isoproterenol 
treatment a 
Leptin 
Treatmentb 
Glycerol <0.001 0.017 
NEFA <0.001 0.985 
STAT3 0.703 0.636 
PSTAT3 0.894 0.039 
Perilipin 0.837 0.789 
PPLIN 0.002c 0.520c 
HSL 0.669 0.236 
PHSL 563 0.021 0.102 
PHSL 565 0.433 0.399 
ATGL 0.082 0.005 
Abbreviations: NEFA, non-esterified fatty acid; STAT3, signal transducer and activator 
of transcription 3; PSTAT3, phosphorylated STAT3 at tyrosine 705; PPLIN, 
phosphorylation of perilipin; HSL, hormone sensitive lipase; PHSL 563, phosphorylation 
of HSL at serine 563; PHSL 565, phosphorylation of HSL at serine 565; ATGL, adipose 
triglyceride lipase 
a P-values for the comparison of control and isoproterenol treated adipocytes. 
b P-values for the main effect of leptin treatment. 
c Phosphorylated perilipin was not detected many of samples from control and leptin 
treated adipocytes.  Therefore, a chi-squared test was used to determine differences in 
protein abundance.  
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Table 3. List of P-values for the main effects from the STATTIC experiment. 
Effect STATTIC 
treatmenta  
Isoproterenol 
treatment a 
Interactiona STATTIC 
+Leptinb 
Glycerol 0.892 <0.001 0.954 0.048 
NEFA 0.878 <0.001 0.978 0.839 
STAT3 0.109 0.833 0.234 0.748 
PSTAT3 0.818 0.380 0.324 0.143 
Perilipin 0.496 0.464 0.849 0.743 
PPLIN 0.554c 0.002c -c 0.342c 
HSL 0.923 0.746 0.868 0.743 
PHSL 563 0.074 <0.001 0.2524 0.104 
PHSL 565 0.416 0.666 0.776 0.203 
ATGL 0.681 0.038 0.766 0.107 
Abbreviations: NEFA, non-esterified fatty acid; STAT3, signal transducer and activator 
of transcription; PSTAT3, phosphorylated STAT3 at tyrosine 705; PPLIN, 
phosphorylation of perilipin; HSL, hormone sensitive lipase; PHSL 563, phosphorylation 
of HSL at serine 563; PHSL 565, phosphorylation of HSL at serine 565; ATGL, adipose 
triglyceride lipase 
a P-values for the main effect in analyses of the 2x2. 
b P-values  for the main effect of STATTIC treatment. 
c Phosphorylated perilipin was not detected in the control and STATTIC/leptin treated 
adipocytes.  Therefore, a chi-squared test was used to determine differences in protein 
abundance, and prevented calculating the effect of the interaction between STATTIC 
treatment and Isoproterenol treatment. 
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4.8 FIGURES 
 
Figure 1. Comparison of control and isoproterenol treated bovine adipocytes 
from cows in the leptin experiment. N = 8 cows per treatment. A) Glycerol 
concentration normalized to protein concentrations. B) NEFA concentration normalized 
to protein concentrations. C) Protein abundance normalized to β-actin and expressed 
relative to control. Representative western blots are shown under the graph for the 
corresponding antibody. The arrow indicates phosphorylated perilipin. Lane 1: Control 
Samples, Lane 2: Adipocytes treated with 100nM Isoproterenol.  Abbreviations: STAT3,  
signaling transducer and activator of transcription 3; HSL, hormone sensitive lipase; 
PSTAT3 Try705, phosphorylated STAT 3 at tyrosine 705; ATGL, adipose triglyceride 
lipase; PHSL ser563, phosphorylated HSL at serine 563; PHSL ser565, phosphorylated 
HSL at serine 565.  * represents P < 0.05 compared to control. 
 
Figure 2. Effects of leptin on lipolysis in bovine adipocytes. N = 8 cows per 
treatment. A) Glycerol concentration normalized to protein concentrations. B) NEFA 
concentration normalized to protein concentrations. C) and D) Protein abundance  
normalized to β-actin expressed relative to control abundance. Representative western 
blots are shown under the graph for the corresponding antibody. The arrow indicates 
phosphorylated perilipin band. Lane 1: 0 ng/mL of leptin (Control), Lane 2: 10 ng/mL of 
leptin, Lane 3: 100 ng/mL of leptin, Lane 4: 200 ng/mL of leptin.  Abbreviations: STAT3,  
signal transducer and activator of transcription 3; HSL, hormone sensitive lipase; 
PSTAT3 Try705, phosphorylated STAT 3 at tyrosine 705; ATGL, adipose triglyceride 
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lipase; PHSL ser563, phosphorylated HSL at serine 563; PHSL ser565, phosphorylated 
HSL at serine 565. * represents P < 0.05 compared to control where the overall effect of 
leptin was P < 0.05.  § represents P < 0.05 compared to control where the overall effect 
of leptin was P < 0.11. 
 
Figure 3. Comparison of control and isoproterenol treated bovine adipocytes in 
the absence or presence of 2 μM of STATTIC.  N = 7 cows per treatment. A) Glycerol 
concentration normalized to protein concentrations. B) NEFA concentration normalized 
to protein concentrations. C) Protein abundance normalized to β-actin and expressed 
relative to control adipocytes in the absence of 2 μM of STATTIC. Representative 
western blots are shown under the graph for the corresponding antibody. The arrow 
indicates phosphorylated perilipin band.  Abbreviations: STAT3,  signal transducer and 
activator of transcription 3; HSL, hormone sensitive lipase; PSTAT3 Try705, 
phosphorylated STAT 3 at tyrosine 705; ATGL, adipose triglyceride lipase; PHSL 
ser563, phosphorylated HSL at serine 563; PHSL ser565, phosphorylated HSL at serine 
565. Differences in subscript represent P < 0.05 for differences in isoproterenol 
treatment. 
 
Figure 4. Effects of STATTIC on lipolysis in control and leptin treated bovine 
adipocytes. N = 7 cows per treatment.  A) Glycerol concentration normalized to protein 
concentrations. B) NEFA concentration normalized to protein concentrations. C) Protein 
abundance normalized to β-actin and expressed relative to control abundance. 
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Representative western blots are shown under the graph for the corresponding 
antibody. The arrow indicates phosphorylated perilipin band. Lane 1: Control Samples 
(0 µM of STATTIC and 0 ng/mL of leptin), Lane 2: 0 µM of STATTIC plus 100 ng/mL of 
leptin, Lane 3: 1 µM of STATTIC plus 100 ng/mL of leptin, Lane 4: 1.25 µM of STATTIC 
plus 100 ng/mL of leptin, Lane 5: 1.5 µM of STATTIC plus 100 ng/mL of leptin, Lane 6: 
1.75 µM of STATTIC plus 100 ng/mL of leptin, Lane 7: 2 µM of STATTIC plus 100 
ng/mL of leptin.  Abbreviations: STAT3,  signal transducer and activator of transcription 
3; HSL, hormone sensitive lipase; PSTAT3 Try705, phosphorylated STAT 3 at tyrosine 
705; ATGL, adipose triglyceride lipase; PHSL ser563, phosphorylated HSL at serine 
563; PHSL ser565, phosphorylated HSL at serine 565. § represents a pairwise 
comparison of P < 0.05 when compared to control when the overall effect of STATTIC 
treatment was P< 0.11. 
 
Supplemental Figure 1. Experimental design.  Timelines for treatment during the 
leptin and STATTIC experiments.  Adipose tissue was collected from 8 and 7 cows for 
the leptin and STATTIC experiment, respectively. Following digestion fo adipose tissue, 
adipocytes were allowed a 30 minute acclimation period prior to treatment.  For the 
leptin experiment, duplicate vials were treated 0, 0, 10, 100, or 200 ng/ml of leptin at 
time 0.  For the STATTIC experiment, duplicate vials of adipocytes were treated with 0, 
1, 1.25, 2.5, 1.75, or 2 μM of STATTIC one hour (-1hr) prior to treatment with 100 ng/mL 
of leptin (0hr).  For both experiments, additional vials were treated with 100nM of 
isoproterenol at time 0.  Media and cells were collected after 2 hours of treatment with 
leptin.  
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CHAPTER 5. DISCUSSION 
 
5.1 BACKGROUND 
 
 Initiation of milk synthesis during early lactation increases energy requirements, 
which are often not met by feed intake. Body energy reserves, in particular adipose 
tissue, are mobilized during this time to meet the energy deficit. Severe or prolonged 
negative energy balance can reduce overall fitness, in particular reproductive fitness 
(Banos et al., 2006; Collard et al., 2000; Hammon et al., 2006; van Knegsel et al., 2007; 
Veerkamp et al., 2000). Since reduced reproductive fitness is a leading reason for 
culling in the dairy industry (Stevenson, 2009), understanding the regulation of lipid 
metabolism may be critical for preventing the decline in overall fitness.   
 Research presented in this dissertation characterized previously unknown or 
poorly understood mechanisms of lipid metabolism in the dairy cow.  These 
mechanisms were investigated in the dairy cow because they regulate lipid uptake and 
lipolysis in model systems.  Two major findings were identified in studies presented in 
this dissertation.  First, transcription of angiopoietin like protein 4 (ANGPLT4) was 
dramatically altered with declining energy balance. Second, adipose triglyceride lipase 
(ATGL) and hormone sensitive lipase (HSL) were differentially regulated in bovine 
subcutaneous adipose tissue.  These findings are important because they contribute to 
our understanding of lipid metabolism in dairy cattle and may allow for strategies to be 
developed to optimize lipid metabolism and reduce the risk of declining fitness. 
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5.2 MAJOR FINDINGS 
5.2.1 Transcript abundance of angiopoietin like protein 4 (ANGPTL4) increased 
with declining energy balance  
 Angiopoietin like protein 4 is a potent adipokine that regulates lipid uptake by 
preventing the activation of lipoprotein lipase (LPL). Increased transcript abundance of 
ANGPTL4 during declining energy balance indicates ANGPTL4 may regulate lipid 
uptake during altered energy balance in dairy cattle. This study was the first to 
characterize ANGPTL4 transcript abundances during times of altered energy balance.  
However, the effects of ANGPTL4 on lipid uptake in adipose tissue of dairy cattle 
remain unclear.  
   The specificity of ANGPTL4 to inhibit specific LPL isoforms is unknown.  In germ 
free mice, adipose tissue mass is smaller compared to conventionally raised mice. Also, 
expression of ANGPTL4 in intestinal tissues was greater in germ free compared to 
conventionally raised mice. It is expected that the increase in intestinal ANGPTL4 
transcription prevents LPL activity in adipose tissue, because adipose tissue ANGPTL4 
transcript abundances were similar between germ free and conventionally raised mice 
(Swartz et al., 2013). These results suggest that ANGPTL4 produced by one tissue can 
inhibit activity of LPL in other tissues.  Contrary to this finding, germ free rats had similar 
adipose tissue mass compared to conventionally raised rats despite increases in 
intestinal and hepatic ANGPTL4 transcript abundances (Swartz et al., 2013). Reduced 
adipose tissue ANGPTL4 transcript abundances were suggested to be the cause of 
adipose tissue mass accumulation. Together these findings suggest that ANGPTL4 may 
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inhibit LPL in the tissue it is produced or other tissues, and these differences may be 
species specific. 
Angiopoietin like protein 4 is secreted by multiple tissues in cattle (Mamedova et 
al., 2010).  During negative energy balance, LPL activity decreases in adipose tissue 
and muscle (Bonnet et al., 2004; Van den Top et al., 2005), but increases in the 
mammary gland (Shirley et al., 1973). These differences in activity of LPL may be due 
to differences in tissue specific production of LPL isoforms or the ability of ANGPTL4 to 
inhibit LPL in a tissue specific manner.  In cattle, LPL transcript abundances were not 
altered by negative energy balance in adipose tissue, but LPL activity decreased 
(Bonnet et al., 2004). This suggests post-transcriptional modifications of LPL instead of 
differences in LPL production are regulating LPL activity. Our findings in Chapter 2 
suggest that post-transcriptional modifications may be mediated by ANGPTL4.  To test 
this hypothesis that ANGPTL4 inhibits LPL activity during declining energy balance in a 
tissue/isoform specific manner, in vitro assays would need to be conducted to determine 
the ability of ANGPTL4 to inhibit the activity of LPL from adipose tissue, muscle and 
mammary gland.  
 Additionally, changes in transcript abundances of ANGPTL4 were altered with 
declining energy balance suggesting ANGPTL4 may serve as a biomarker for energy 
balance. Unlike circulating and transcript abundances of leptin, ANGPTL4 transcript 
abundances were altered by modest changes in energy balance.  For example, energy 
balance during late pregnancy was 2.56 Mcal/day and 4.91 Mcal/day during mid 
lactation. Although this difference in energy balance was slight and positive, ANGPTL4 
transcript abundance increased in adipose tissue during late pregnancy. Physiological 
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state has been shown to alter transcript abundance of ANGPTL4 in mice (Joesphs et 
al., 2007). However, these changes were observed during declining energy balance 
following growth hormone administration.  This consistency between models suggests 
that ANGPTL4 may be a biomarker for energy balance. To determine if ANGPTL4 could 
be a useful on-the-farm biomarker for energy balance, characterization of circulating 
ANGPTL4 concentrations and energy balance are required.  Additionally, the correlation 
between circulating ANGPTL4 and already easily measured traits such as body 
condition score would need to be evaluated to determine if this potential biomarker 
would provide additional information about the energy status of a cow.  
 
 5.2.2 Differential regulation of hormone sensitive lipase (HSL) and adipose 
triglyceride lipase (ATGL) 
Hormone sensitive lipase (HSL), adipose triglyceride lipase (ATGL), and perilipin 
are critical regulators of lipid catabolism. Phosphorylation of both HSL and perilipin were 
increased during early lactation, and negatively correlated with energy balance at 21 
days in milk. This indicates the involvement of PKA dependent mechanisms in lipid 
mobilization during the transition period. However, ATGL protein abundance decreased 
during early lactation, but increased with leptin induced lipolysis when PKA 
phosphorylation was not significantly altered. The ability of signal transducer and 
activator of transcription (STAT) 3 inhibitor, STATTIC, to attenuate lipolysis and ATGL 
protein abundance in bovine adipocytes indicates leptin induced lipolysis may be 
regulated by a STAT3 mediated increase in ATGL protein abundance.  Additionally, 
ATGL translocated to the lipid droplet with leptin administration in stromal vascular cell 
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(SVC)-derived adipocytes. These results suggest that HSL and ATGL are differentially 
regulated during leptin induced lipolysis.  
 Differential regulation of HSL and ATGL was observed during altered energy 
balance in mid lactation but both HSL and ATGL translocate to the lipid droplet during 
isoproterenol treatment. Two additional studies were conducted using the energy 
altering models from Chapter 2. In these studies, protein abundance of ATGL 
decreased with declining energy balance, while phosphorylation of HSL at serine 563 
was not altered with negative energy balance during feed restriction or declining energy 
balance following growth hormone administration (personal communication, P.Faylon). 
This would suggest that declining energy balance may decrease ATGL activity.   
However, both HSL and ATGL translocated to the lipid droplet following isoproterenol 
stimulation in SVC-derived adipocytes indicating that both HSL and ATGL are involved 
in PKA-dependent lipolysis in bovine adipocytes. The increased activity of ATGL with 
isoproterenol stimulated lipolysis suggests ATGL may be activated during the transition 
period.  The ability of leptin to regulate ATGL protein abundance indicates that 
decreases in ATGL during the transition period may be due to decreased leptin 
concentrations, and are not reflective of ATGL activity. To test this hypothesis, 
additional studies are needed to 1) better characterize leptin induced STAT3 binding of 
the promoter region of ATGL and 2) determine if ATGL activity is increased during the 
transition period when protein abundances are decreased.   
With this additional knowledge, our understanding of lipid metabolism can be 
utilized to regulate lipolysis.  It might be expected that slowing lipolysis during early 
lactation might attenuate the adverse effects associated with rapid or prolonged 
147 
 
 
mobilization of lipids.  However, at this time it is unknown if inhibiting lipolysis during 
early lactation would reduce milk production and alleviate negative energy balance or 
result in the mobilization of energy from muscle to overcome the energy deficit brought 
on by lactation.  
5.3 GENERAL CONCLUSIONS 
 
In conclusion, this dissertation identified ANGPTL4 as a potentially important 
adipokine in regulating lipid uptake in adipose tissue and a potential biomarker for 
energy balance. This initial characterization of ANGPTL4 during altered energy balance 
has important implications for regulating lipid uptake by dairy cattle, particularly during 
the dry period when excessive accumulation of adipose tissue can increase the risk for 
metabolic diseases during early lactation. However, additional research is needed to 
understand the regulation of LPL by ANGPTL4 and the association of circulating 
concentrations of ANGPTL4 with energy status. Differential regulation of HSL and ATGL 
was observed in lipolysis of bovine adipocytes.  One potential mechanism by which this 
differential regulation may occur is through a leptin induced STAT3 mediated increase 
in ATGL protein abundance.  However, additional research is needed to understand the 
activation of ATGL by STAT3 during the transition period prior to the development of 
strategies to optimize lipid metabolism.  Overall, results from this dissertation provide 
information about lipid metabolism in dairy cattle which may be used to develop 
strategies to reduce adverse effects of prolonged or severe negative energy balance.  
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APPENDIX A. TRANSLOCATION OF ADIPOSE TRIGLYCERIDE LIPASE 
TO THE LIPID DROPLET INCREASED WITH LEPTIN TREATMENT IN 
BOVINE ADIPOCYTES 
Supplemental data for Chapter 4. 
Dawn A. Koltes and Diane M. Spurlock 
 
A.1 ABSTRACT 
 
Leptin stimulates an increase in adipose triglyceride lipase (ATGL) protein 
abundance, but not phosphorylation of hormone sensitive lipase (HSL), via signal 
transducer and activator of transcription (STAT) 3 in bovine adipocytes. However, the 
mechanisms that regulate the leptin induced increase in ATGL protein abundance and 
its subsequent activity are unclear. Therefore, the objectives of this study were to 
determine1) if ATGL translocates to the lipid droplet with leptin administration and 2) if 
STAT3 translocates to the nucleus. Stromal vascular cell (SVC) derived bovine 
adipocytes were treated with 100 nM of isoproterenol or 100 ng/mL of bovine leptin for  
two hours or were treated for 0, 5, 10, 20 or 120 minutes with 100ng/mL of leptin.  
Immunofluorescence was used to detected the translocation of ATGL, HSL, 
comparative gene identity- 58 (CGI-58), G1/G0 switch protein 2 (G0S2), and 
phosphorylated STAT3. Lipid droplets and nuclei were detected with Bodipy and DAPI, 
respectively.  As expected, HSL and ATGL translocated to the lipid droplet after two 
hours of exposure to isoproterenol, suggesting PKA-dependent lipolysis involves both 
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ATGL and HSL. However, only ATGL translocated to the lipid droplet with leptin 
exposure. These results were confirmed when ATGL translocated to the lipid droplet at 
120 minutes of exposure to leptin in a second experiment. Additionally, STAT3 
translocated to the nucleus within 10 minutes of leptin exposure suggesting that STAT3 
increases transcription of ATGL. In conclusion, ATGL and HSL work in tandem following 
lipolytic stimulation by isoproterenol, but are differentially regulated by leptin.  This 
differential regulation may occur through increased transcription of ATGL by STAT3. 
A.2 INTRODUCTION 
 
Adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL) are the 
key lipases involved in PKA-dependent lipolysis. Under catecholamine stimulation, 
protein kinase A (PKA) phosphorylates HSL and perilipin. Phosphorylated HSL 
translocates to the lipid droplet where it interacts with phosphorylated perilipin to 
hydrolyze tri- and diacylglycerides. Phosphorylation of perilipin by PKA allows for the 
translocation of ATGL from the cytosol to the lipid droplet through the release of CGI-58 
from the lipid droplet. Comparative gene identity-58 activates ATGL through the release 
of G0/G1 Switch protein 2 (G0S2) which inhibits ATGL activity (5, 6, 8, 11, 18).  
Mechanisms that regulate PKA-dependent lipolysis are well established, but the 
contribution of these mechanisms during leptin induced lipolysis is not well 
characterized. Leptin signaling results in the phosphorylation of signal transducer and 
activator of transcription (STAT) 3 via janus kinase 2 (JAK) (2). The increased STAT3 
signaling contributes to increased protein abundance of ATGL during leptin induced 
lipolysis suggesting STAT3 translocates to the nucleus to increase transcription of 
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ATGL. Therefore, the objectives of this study were to determine 1) if ATGL translocates 
to the lipid droplet with exposure to leptin and 2) if phosphorylated STAT3 translocates 
to the nucleus to potentially increase transcription. 
A.3 MATERIALS AND METHODS 
 
A.3.1 Culture of Stromal Vascular Cell Derived Adipocytes 
 
 Stromal vascular cells (SVC) were harvested using a previously described 
method with slight modifications (Ajuwon et al., 2004).  Cells were isolated from 2 
multiparous mid lactation Jersey cows (Chapter 4). Following collagenase digestion of 
adipose tissue, SVCs were pelleted and rinsed two times in warmed cocktail media [20 
mM Sodium bicarbonate, 20 mM HEPES, 10 mM D-glucose, and 3% bovine serum 
albumin (w/v), pH 7.4]. Cells were counted using trypan blue staining, plated at 10,000 
cells per cm2 in 6-well plates or 60 cm petri dishes, and grown on a glass cover slip in 
low glucose DMEM (D5523, Sigma Aldrich, St. Louis, MO) media containing 5% fetal 
bovine serum (FBS, s11150, Atlanta Biologicals, Norcross, GA). Media was changed 
every 4 days until reached 90% conflunency.  Subsequently, SVC-cells were cultured in 
differentiation media [10% FBS, 0.5 mM of 3-isobutyl-1-methylxanthine (IBMX, I5879, 
Sigma-Aldrich, St. Louis, MO) 1μM of dexamethasone (D4902, Sigma Aldrich, St. Louis, 
MO), and 10ug/ml of insulin (I6634, Sigma Aldrich, St. Louis, MO)] as previously 
described (19). The first day of differentiation was denoted as day 0. After 48 hours, 
differentiation media was change to lipogeneic media [10% FBS, 10 μM of troglitizone 
(71750, Caymen Chemical, Ann Arbor, MI), 10ug/ml of insulin, 2% v/v of fatty acid 
supplement (F7175-5 mL, Sigma Aldrich, MO), 1mM of Sodium Acetate (S209-500g, 
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Fisher Scientific, Waltham, MA)] on day 2 day of differentiation, and changed every 2 
days until 14 days post differentiation.  
A.3.2 Experimental treatment and immunofluorescent labeling 
 
 On day 14, SVC-derived adipocytes were conditioned with low glucose DMEM 
for one hour prior to the addition of fresh low glucose DMEM media and treatments.  For 
the first experiment, SVC-derived adipocytes were exposed to media (control), 100 
ng/mL of bovine leptin (CYT-502, ProSpec, Ness-Ziona, Isreal) or 100nM of 
isoproterenol (151358; MP Biomedicals; Solon, OH) for two hours. For the second 
experiment, SVC-derived adipocytes were treated with 100 ng/mL of bovine leptin for 0, 
5, 10, 20, 120 or 240 minutes. Following treatments, SVC-derived adipocytes were 
rinsed twice with phosphate buffered saline (PBS) then fixed for five minutes using 4 % 
paraformaldehyde. Cells were rinsed three times using PBS and then permeated for five 
minutes 0.6% Trition-X 100 in PBS.  The SVC-derived adipocytes were blocked for one 
hour in PBS containing 5 % bovine serum albumin after rinsing in PBS. Coverslips with 
cells were then removed and exposed to primary antibodies overnight.  Primary 
antibodies and their corresponding secondary antibody are listed in Table 1. Cover slips 
were rinsed in PBS containing 0.5% Tween-20 and then exposed to fluorescently 
labeled secondary antibodies and either 4',6-Diamidino-2-Phenylindole, Dihydrochloride 
(DAPI,IW-1404, IHC World, Woodstock, MD) to stain nuclei or Bodipy (D-2184, 
Molecular Probes, Eugene, Oregon) to the lipid droplet, respectively. After one hour of 
incubation, cover slips were rinsed with PBS containing 0.5% Tween-20 in PBS and 
placed in Fluorogel with DABCO mounting media on microscope slides (17985-01, 
Electron Microscopy Sciences, Hatifield, PA) and sealed with nail polish.   
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A.3.3 Analysis of Immunofluorescence  
 
Fluorescence was captured from a dual labeled coverslip using a Qimaging QIcam 
(Surrey BC, Canada) accompanied by a Leica DMI3000B microscope (Wetzlar, 
Germany). Each fluorescent wavelength was captured, saved individually, and then 
compiled by Qimaging software. Five views containing well-formed and well dispersed 
lipid droplets or nuclei were captured per coverslip.  Views were captured from two 
coverslips per time point from a single cell line for analysis of time dependent 
translocation of ATGL. All other treatments had one coverslip per treatment for each of 
the two cows.  
 Fluorescence was measured using ImageJ software (17). Currently, software is 
not available to automatically measure the translocation of HSL and ATGL to the lipid 
droplet.  To measure the translocation of HSL and ATGL, the difference in fluorescence 
at the lipid droplet and cytosol were measured.  To determine this difference, a line was 
extended from the edge of the lipid droplet into the cytosol (Figure 1A). This line was 
arbitrarily drawn around the lipid droplet, but areas where the line would overlap with 
another lipid droplet were avoided. The average fluorescence measured between 0 and 
0.02 inches was considered to be fluorescence at the lipid droplet. The average 
fluorescence between 0.06 and 0.0733 inches was considered to be cytosolic 
fluorescence. These averages were used to determine the increased fluorescence at 
the lipid droplet by subtracting the average fluorescence at the lipid droplet from the 
average fluorescence in the cytosol. To prevent bias from the location of the line, 
fluorescence was measured along five different lines for each lipid droplet and two to 
three lipid droplets were measured per view. The difference in fluorescence was 
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averaged by lipid droplet, and was used for statistical analysis.  For simplicity, we will 
refer to the difference in fluorescence at the lipid droplet and the fluorescence in the 
cytosol as translocation of the protein of interest. To account for changes that occurred 
within an image, fluorescence was measured at random points within the image.  The 
difference in background fluorescence was quantified to assess overall variability in 
fluorescence, and was measured as the difference in the average fluorescence between 
0 and 0.02 from the average fluorescence between 0.6 and 0.0733.  
  Translocation of phosphorylated STAT3 to the nucleus was determined by 
calculating the  colocalization of FITC and DAPI using the Mander’s Coefficient plugin 
from the ImageJ software (17).  Four correlation coefficients were determined for each 
slide.  See table 2 for a list of these correlation coefficients and definitions. Five views 
were measured per slide with one slide per cow. The correlation coefficients were 
averaged by slide and used for statistical analysis. Views were dropped from the 
analysis when the colocalization of FITC and DAPI greatly deviated from nucleus (see 
Figure 1B). Translocation of phosphorylated STAT3 to the nucleus caused a notable 
increase in the fluorescence in the nucleus compared to the cytosol.  This increase in 
fluorescence was quantified by counting noticeable areas with increase fluorescence in 
the phosphorylated STAT3 image that corresponded to a DNA nucleus in the 
corresponding image. Counting these “visible nuclei” allowed for the confirmation of 
results observed with the Mander’s plugin.  These counts will be identified as visual 
nuclei counts. 
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A.3.4 Statistical Analysis 
 
 Differences in lipid droplet diameter, translocation, and colocalization were 
estimated using PROC MIXED of SAS(16). Differences in lipid droplet diameter were 
estimated using treatment (time or stimulant) as a fixed effect, and view was grouped 
within slide or cow as a random effect. Differences in translocation of HSL, ATGL, CGI-
58, and G0S2 were estimated using treatment (time or stimulant) as a fixed effect, lipid 
droplet diameter and background fluorescence as covariates, and view was grouped 
within slide or cow as a random effect. Differences in the colocalization of FITC and 
DAPI for total colocalization (Rtotal), Manders’ adjusted colocalization (Rcoloc), 
overlapping of FITC with DAPI or overlapping of DAPI with FITC (tM1 and tM2, 
respectively), and visual nuclei counts were estimated using as a fixed effect of time 
and cow as a random effect. Residuals were tested for normality and were found to be 
normally distributed (16). When overall significance was P < 0.05, pairwise comparisons 
were conducted using the LSmeans statement in SAS (16). 
A.4 RESULTS AND DISCUSSION 
 
A.4.1Translocation of ATGL and HSL to the lipid droplet under β-agonist and 
leptin stimulation 
 
Lipid droplet size has been associated with differential translocation of ATGL due 
to differences in perilipin abundance (7).  Therefore, the diameter of lipid droplets was 
measured and included as a covariate.  Lipid droplet diameter did not differ across time 
for cells immunostained for ATGL (P < 0.21, Figure 2) or among different lipolytic stimuli 
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treatments for cells immunostained for HSL (P < 0.40).  Lipid droplet diameter tended to 
be different between different lipolytic stimulation for SVC-derived adipocytes 
immunostained for ATGL (P < 0.08; Figure 2).   
Translocation of ATGL and HSL was altered by the addition of lipolytic stimuli (P 
< 0.03, Figure 3; P < 0.01, respectively; Figure 4).  Isoproterenol and leptin increased 
ATGL translocation to the lipid droplet compared to control SVC-derived adipocytes (P = 
0.01 and P = 0.04, respectively). No difference in ATGL translocation to the lipid droplet 
was observed between isoproterenol and leptin treated SVC-derived adipocytes (P = 
0.81). Treatment with isoproterenol increased the translocation of HSL to the lipid 
droplet compared to control and leptin treatment (P < 0.01, and P < 0.01, respectively). 
However, translocation of HSL to the lipid droplet was not different between control and 
leptin treated SVC-derived adipocytes (P = 0.70). 
The results indicate that translocation of ATGL to the lipid droplet may be 
regulated by two different mechanisms.  As expected, isoproterenol stimulated the 
translocation of HSL to the lipid droplet through PKA mediated phosphorylation. 
Additionally, isoproterenol likely stimulated the translocation of ATGL either through 
direct phosphorylation (14) or indirectly through the phosphorylation of perilipin (7). 
Leptin administration increased translocation of ATGL, but not HSL, suggesting that 
ATGL translocates to the lipid droplet via a PKA-independent mechanism during leptin 
induced lipolysis. One possible explanation is that leptin increases protein abundance of 
ATGL quicker than its inhibitor, G0S2. Therefore, the observed increase in ATGL 
translocation to the lipid droplet due to stimulated lipolysis may be a function of overall 
increases in ATGL protein abundance.  
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These two mechanisms regulating ATGL translocation may explain the 
discrepancy between ATGL protein abundance during early lactation and expected 
activity.  During early lactation, circulating leptin concentrations decrease to increase 
appetite (1, 3, 15), and coincide with decreased ATGL protein abundance (Chapter 3).  
Additionally, ATGL protein abundance is decreased during feed restriction (P. Faylon, 
personal communication) when circulating leptin concentrations decrease (4, 9). 
Therefore, the decrease in ATGL protein abundance may be due to decreased leptin 
signaling in adipose tissue. However, during times of stimulated lipolysis both HSL and 
ATGL may work in tandem to maximize lipolysis.       
A.4.2 Translocation of phosphorylated STAT3 to the nucleus with leptin 
stimulation 
 
Pearson’s correlation coefficients between phosphorylated STAT3, as measured 
by FITC, and nuclear DNA, as measured by DAPI, for all positive pixel (Rtotal) within a 
field of SVC-derived adipocytes treated with leptin differed across time points (P = 0.01, 
Figure 5 A). Colocalization between phosphorylated STAT3 and nuclear DNA increased 
after 5, 10, 120 and 240 minutes of exposure to leptin compared to 0 minutes of 
exposure (P < 0.03).  Peak colocalization between phosphorylated STAT3 and nuclear 
DNA occurred at 10 minutes of leptin exposure (P < 0.02). This measurement 
determines the overlap of all pixels for each wavelength.  Since background staining of 
one or both channels can greatly influence this correlation, methods have been 
developed to reduce the influence of background staining (12). When correlations were 
adjusted to only include those that passed the Manders’ threshold for the whole image 
(Rcoloc), phosphorylated STAT3 tended to colocalize with nuclear DNA (P = 0.06, 
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Figure 5C). Peak colocalization occurred after 10 minutes of exposure to bovine leptin. 
Additionally, the overlap of phosphorylated STAT3 with nuclear DNA tended to be 
altered by leptin exposure (tM1, P = 0.06), but the overlap between nuclear DNA and 
phosphorylated STAT3 was not altered by leptin exposure (tM2, P = 0.13).  As with 
colocalization of the whole image, phosphorylated STAT3 pixels overlapped with 
nuclear DNA pixels at 10 of leptin exposure compared to all other time points (P < 0.01). 
These results were confirmed by the observation that visual colocations was 
significantly altered with leptin treatment (P = P 0.05; Figure 5D), and peak visual 
colocalization was observed after 10 minutes of treatment compared to all other time 
points (P < 0.01). Phosphorylated STAT3 was expected to rapidly translocate to the 
nucleus following leptin exposure.  However, the lack of colocalization between 
phosphorylated STAT3 and nuclear DNA  after 10 minutes of leptin exposure was not 
expected based on previous work in islets (13).  
A.4.3 Leptin induced translocation of ATGL to the lipid droplet after 2 hours  
 
Translocation of ATGL to the lipid droplet was altered with leptin administration 
across time points (P = 0.004). Translocation of ATGL increased with 120 minutes of 
exposure to bovine leptin compared to all other time points (P < 0.03). Adipose 
triglyceride lipase did not translocate to the lipid droplet at 5, 10, or 20 minutes of leptin 
exposure compared to control samples (Figure 6). However, its cofactors, CGI-58 and 
G0S2, did not translocate to the lipid droplet following leptin administration (P = 0.084, 
Figure 6; P = 0.169, Figure 7; respectively). 
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After two hours of leptin exposure, ATGL translocation to the lipid droplet , but 
CGI-58 did not significantly translocated from the lipid droplet. This supports our 
previous conclusion that leptin induces ATGL translocation to the lipid droplet through a 
PKA-independent mechanism.   The inhibition of the leptin induced increase in ATGL 
protein abundance by STATTIC suggested that STAT3 may regulate ATGL activity. 
Porcine SVC-derived adipocytes exposed to leptin also exhibited a JAK  and mitogen 
activated protein kinase (MAPK) dependent increase in ATGL transcript abundances 
(10).  However, Li et al. (10) did not determine the interaction of the JAK/STAT3 or 
MAPK pathways with the translocation of ATGL.  
In conclusion, ATGL may participate in lipolysis through two different 
mechanisms. One mechanism by which ATGL participates in lipolysis is through the 
PKA pathway. Following activation of PKA, HSL and perilipin are phosphorylated. 
Phosphorylated HSL translocates to the lipid droplet where it is expected to hydrolyze 
tri- and diacylglycerides, and phosphorylated perilipin releases CGI-58 from the lipid 
droplet, allowing for the translocation of ATGL to the lipid droplet. A second mechanism 
by which ATGL may participate in lipolysis is through a leptin induced increased in total 
protein abundance. The increase in ATGL protein abundance may increase its 
translocation to the lipid droplet due to decreased availability of its inhibitor, G0S2. 
However, it remains unknown if leptin stimulates STAT3 to directly increase ATGL 
transcription through binding the promoter region.  
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A.5 TABLES 
 
Table 1. Primary and secondary antibodies used for immunofluorscence 
Antibody Company Catalog 
number 
Secondary 
Antibody 
Fluoroform Catalog 
number a 
PSTAT3 b Cell Signaling 9145 Rabbit IgG FITC 111-095-003 
HSL Cell Signaling 8719 Rabbit IgG Dylight 405 711-475-152 
ATGL Cell Signaling 2138 Rabbit IgG Dylight 405 711-475-152 
CGI-58 Santa Cruz 
Biotechnology 
Sc-102285 Goat IgG Dylight 649 705-495-003 
G0S2 Novus 
Biologicals 
4137 Mouse IgG Dylight 594 115-515-146 
aAll secondary antibodies were purchased from Jackson Immunoresearch in West 
Grove, PA 
b Abbreviations: PSTAT, phosphorylated signal transduction and activator of 
transcription 3 at tyrosine 705; HSL, hormone sensitive lipase; ATGL, adipose 
triglyceride lipase; CGI-58, comparative gene identity-58; G0S2, G0/G1 switch protein 
2; FITC, fluorescein isothiocyanate 
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Table 2. A list of Correlation Coefficients calculated by the Manders’ Coefficient plug-in 
from ImageJ.  
Correlation 
Coefficient 
Definition 
Rtotala Pearson’ correlation coefficient for the whole image using only positive 
pixels 
 
Rcoloc Returns correlation coefficients where both channel 1b and 2 are above 
their threshold 
 
tM1 Returns the percentage of above-background pixels in channel 1 that 
overlap with above-background pixels in channel 2 
 
tM2 Returns the percentage of above-background pixels in channel 1 that 
overlap with above-background pixels in channel 2 
a Abbreviation given by the plugin. 
b Channel 1 represents the 490 nm wavelength (FITC) and channel 2 represents the 
358 nm wavelength (DAPI). 
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A.6 FIGURES 
 
Figure 1. Demonstrates how images where assessed. A) Illustrates how the 
diameters of assessed lipid droplets were measured. The white line represents where 
the fluorescence was measured. The upper box represents the relative fluorescent 
abundance. B). Illustrates how translocation was measured for each lipid droplet. The 
white lines represent how the fluorescence was measured. The upper box represents 
the relative fluorescent abundance.  The values along the line were exported and 
utilized for statistical analysis. C). Represents expected colocalization of phosphorylated 
STAT3 (FITC) and nuclear DNA (DAPI) fluorescence. The top left images is the 
phosphorylated STAT3 image, and the lower left image is the nuclear DNA image.  The 
larger image is the merged images.  Green represent phosphorylated STAT3, blue 
represents nuclear DNA, and white represents areas of colocalization.  D). Represents 
abnormal colocalization of phosphorylated STAT3 and nuclear DNA fluorescent. The 
top left images is the phosphorylated STAT3 image, and the lower left image is the 
nuclear DNA image.  The larger image is the merged images.  Green represent 
phosphorylated STAT3, blue represents nuclear DNA, and white represents areas of 
colocalization. 
 
Figure 2. Average diameter for lipid droplets used to determine fluorescence for 
hormone sensitive lipase and adipose triglyceride lipase. A) Average diameter of 
lipid droplets treated with media, 100nM isoproterenol, or 100ng/mL of leptin for 2 hours 
for SVC-derived adipocytes used to detect HSL and ATGL translocation. B) Average 
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diameter of lipid droplets treated with 100 ng/mL of leptin through the 2 hour time 
course for SVC-derived adipocytes stained with ATGL and CGI-58 or G0S2.  
Abbreviations: HSL, hormone sensitive lipase; ATGL, adipose triglyceride lipase; CGI-
58, comparative gene identity-58; G0S2, G0/G1 switch protein 2 
 
Figure 3. Translocation of adipose triglyceride lipase (ATGL) to the lipid droplet 
after treatment with isoproterenol or leptin.  A) Representative images of SVC-
derived adipocytes treated with media (Control), 100nM of isoproterenol, or 100 ng/mL 
of leptin. DyLight 405 was used to detect ATGL antibody, and bodipy was used to 
detect neutral lipids in the lipid droplet. In the merged image, ATGL is blue and bodipy is 
green. B) Translocation of ATGL to the lipid droplet. The white line in the lower right 
hand image is 0.2 inches relative to the view. Differences in subscripts were given when 
the overall P < 0.05, and indicated pairwise differences of P < 0.05.  
 
Figure 4. Translocation of hormone sensitive lipase (HSL) to the lipid droplet after 
treatment with isoproterenol or leptin.   A) Representative images of SVC-derived 
adipocytes treated with media (Control), 100nM of isoproterenol, or 100 ng/mL of leptin. 
DyLight 405 was used to detect HSL antibody, and bodipy was used to detect neutral 
lipids in the lipid droplet. In the merged image, HSL is blue and bodipy is green. B) 
Translocation of HSL to the lipid droplet.  The white line in the lower right hand image is 
0.2 inches relative to the view. Differences in subscripts were given when the overall P 
< 0.05, and indicated pairwise differences of P < 0.05.  
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Figure 5. Colocalization of phosphorylated signal transducer and activator of 
transcription (STAT) 3 with the nucleus. A) Representative images of SVC-derived 
adipocytes treated with 100 ng/mL over the course of 4 hours.  Time of exposure is 
listed on the left hand side.  DAPI was used to stain for nuclear DNA and FITC was 
used to detect the antibody for phosphorylated STAT3.  In the merged image, blue 
represents nuclear DNA and green represents phosphorylated STAT3. B) Average 
Pearson’s correlation coefficients for the colocalization nuclear DNA and 
phosphorylated STAT3 for all positive pixels within the image. C) Average Pearson’s 
correlation coefficients for the colocalization of nuclear DNA and phosphorylated STAT3 
for pixels above Manders’ threshold. D) Average number of visual colocalization.  
Arrows in 10 minutes images represent the increased fluorescence in phosphorylated 
STAT3 that would count as a visual colocalization. Arrows in 120 minute images 
represent an area that would not be counted as visual colocalization. The white line in 
the lower right hand image is 0.2 inches relative to the view.  Differences in subscripts 
were given when the overall P < 0.05, and indicated pairwise differences of P < 0.05.  
 
Figure 6. Translocation of adipose triglyceride lipase (ATGL) and comparative 
gene identity -58 (CGI-58) to the lipid droplet after leptin exposure over the course 
of 2 hours. A) Representative images of SVC-derived adipocytes treated with 100 
ng/mL of leptin over the course of 2 hours. Time of exposure is listed on the left hand 
side. DyLight 405 was used to detect the ATGL antibody, bodipy was used to stain 
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neutral lipids, and DyLight 649 was used to detect the CGI-58 antibody. In the merged 
image, blue represents ATGL, green represents bodipy, and red represents CGI-58. B)  
Translocation of ATGL to the lipid droplet for both images that contained CGI-58 and 
G0S2.  C) Translocation of CGI-58 to the lipid droplet. The white line in the lower right 
hand image is 0.2 inches relative to the view. Differences in subscripts were given when 
the overall P < 0.05, and indicated pairwise differences of P < 0.05.  
 
Figure 7. Translocation of adipose triglyceride lipase (ATGL) and G0/G1 switch 
protein 2 (G0S2) to the lipid droplet after leptin exposure over the course of 2 
hours. A) Representative images of SVC-derived adipocytes treated with 100 ng/mL of 
leptin over the course of 2 hours. Time of exposure is listed on the left hand side. 
DyLight 405 was used to detect the ATGL antibody, bodipy was used to stain neutral 
lipids, and DyLight 594 was used to detect the G0S2 antibody. In the merged image, 
blue represents ATGL, green represents bodipy, and red represents G0S2. B)  
Translocation of ATGL to the lipid droplet for both images that contained CGI-58 and 
G0S2.  C) Translocation of G0S2 to the lipid droplet. The white line in the lower right 
hand image is 0.2 inches relative to the view. Differences in subscripts were given when 
the overall P < 0.05, and indicated pairwise differences of P < 0.05. 
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APPENDIX B. IDENTIFICATION OF A POTENTIAL SIGNAL 
TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 BINDING 
SITE IN THE PROMOTER REGION OF ADIPOSE TRIGLYCERIDE 
LIPASE 
 
Preliminary Data 
 
Dawn A. Koltes and Diane M. Spurlock 
 
B.1 ABSTRACT 
 
 Previous work indicated that leptin induced lipolysis occurs through a signal 
transducer and activator of transcription (STAT) 3 mediated increase in adipose 
triglyceride lipase (ATGL) protein abundance.  To determine if STAT3 regulates the 
transcription of ATGL, a DNA pull down assay was used to determine if STAT3 binds 
any of the computationally predicted transcription factor binding sites in the promoter 
region of ATGL.  Following leptin administration, STAT3 binding increased for 1 of 5 
STAT3 promoter regions which contained 2 putative transcription factor binding sites for 
STAT3. These results indicate that leptin may modulate ATGL transcription by 
increasing STAT3 binding in the ATGL promoter region.  
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B.2 INTRODUCTION 
   
 Previous research identified STAT3 as a potential mediator of leptin induced 
lipolysis in bovine adipocytes (Chapter 4). Adipose triglyceride lipase (ATGL) protein 
abundance increased with leptin exposure, and this effect was attenuated with the 
addition of a STAT3 inhibitor. Based on these results, we hypothesized that leptin 
increases lipolysis by STAT3 mediated regulation of ATGL transcript expression.  
Therefore, the objective of this study was to determine if STAT3 binds to the promoter 
region of ATGL in adipocytes.   
B.3 MATERIALS AND METHODS 
B.3.1 Prediction of STAT3 Binding Sites 
Adipose triglyceride lipase is located on the reverse strand of bovine 
chromosome 29.  Potential transcription factor binding sites for STAT3 were predicted in 
the promoter region of ATGL using two approaches.  Eight predicted transcription factor 
binding sites were identified within 2 kilobase (kbps) of the ATGL start site in the 
UMD3.1 bovine genome build using TRANSFAC (Matys et al., 2006). The TRANSFAC 
database includes more than 37,000 computationally and experientially validated 
transcription factor binding sites from multiple species. The TRANSFAC algorithm uses 
a positional weighing matrix to predict transcription factor binding sites based on core 
matches and matrix matches to sites in the database.  Core and matrix matches with 
correlation coefficients greater than 0.89 and 0.80, respectively were considered for 
validation. The eight potential transcription factor binding sites from TRANSFAC are 
listed in table 1, and predicted sequences are highlighted in red and purple font in figure 
1. Additionally, TRANSFAC allows for tissue specific searches based on experimentally 
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validated data in human and mouse. These sites are identified in table 1. Consensus 
transcription factor binding sites were also identified using JASPER software (Bryne et 
al., 2008). The consensus site for Mus musculus STAT3 was utilized to search for 
potential transcription factor binding sites within 2 kb of the start site of ATGL. The 
corresponding bovine transcription factor binding sites predicted by JASPER are in blue 
in figure 1.   
B.3.2 Pull-down assay 
 Adipocytes were harvested from 3 mid lactation (278-288 DIM) primiparous cows 
utilizing methods previously described in chapter 4. Following a thirty minute acclimation 
period, adipocytes were exposed to media only or media containing 100 ng/mL of leptin 
for 20 minutes.   Protein-DNA complexes were crosslinked using 4% paraformaldehyde 
for 10 minutes, followed by quenching for 5 minutes with 1M glycine. Adipocytes were 
centrifuged and stored until the pull-down assays were performed. DNA pull-down was 
performed using the Chromatin- ImmunoPrecipitation (ChIP) agarose kit (26156, Pierce, 
Thermo-Scientific, Rockford, IL; Figure 2). Briefly, adipocytes were lysed and DNA was 
sheared by micrococcal nuclease digestion.  Approximately 10% of the preparations 
were stored as input controls (IC).  The remainder of the preparation was split and 
exposed to STAT3 (8719, Cell Signaling, Boston, MA) or IgG (included in the kit) 
antibodies for 72 hours at 4°C.  The protein-DNA complexes were pulled down using 
protein A/G agarose beads.  Protein was subsequently digested from STAT3 enriched 
(SE), IgG enriched (IE) and IC samples using Proteinase K. The DNA fraction was 
purified prior to real-time polymerase chain reactions (qPCR) using columns provided in 
the kit. 
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B.3.3 Primer design 
 Primers were designed to target all nine predicted STAT3 binding sites. Primers 
were also designed for a known STAT3 binding site upstream of hepatocyte growth 
factor (HGF) (Tomida and Saito, 2004) and within an exonic region of ATGL to act as 
positive and negative controls, respectively.  Due to the affinity of micrococcal nuclease 
to cleave 5’ of adenosine (A) or thymine (T), primers were designed to avoid AT-rich 
regions.  Primers for qPCR are listed in table 2 and the sequences amplified are shown 
in figure 2. For simplicity, we named the sequences to be amplified as promoter regions 
1-5.   
B.3.4 Real-time polymerase chain reaction 
 The standard protocol for qPCR was 95° C for 2 min followed by 40 repeated 
cycles of 95° C for 30 s, 50° C for 30 s, and 72° C for 45 s. The PCR products were 
then held at 95° C for 1 min, followed by 56° C for 1 min. Due to low abundance of input 
DNA, qPCR was increased to 50 cycles for the first cow (8156). Since, multiple melt 
curves were observed using 50 cycle with the first cow (8156) and threshold values (Ct) 
were between 25 and 35, the number of cycles was reduced to 40 cycles for the 
remaining cows (8144 and 8200). Quantitative PCR was run in a 96-well format on a 
MyiQ thermocycler (Bio Rad, Hercules, CA) using SYBR Green chemistry (Bio-Rad, 
Hercules, CA) according to manufacturer’s protocol, scaled to a total volume of 12.5 μl 
with 2.5 μl of the reaction being DNA.  A serially diluted standard curve from input DNA 
was included with each assay as a positive control and for evaluation of PCR efficiency. 
Reactions devoid of template were included as negative controls for each set of 
primers. All samples and controls were run in duplicate, and the average of duplicate 
180 
 
 
threshold cycle (Ct) values was used in statistical analyses. Replicated qPCR reactions 
with a major peak that deviated from the average more than + 1.5°C from the average 
melt curve were removed from the analysis.  Samples removed included three HGF 
replicates and one ATGL promoter region 4 replicate.   
B.3.3 Statistical analysis 
 Threshold cycle values were normalized by subtracting the input Ct value and 
adjusted for PCR efficiency (ΔCt values) as previously described (Vandesompele et al., 
2002). The average ΔCt values were analyzed using PROC MIXED of SAS (SAS/STAT 
User’s Guide, 1990).  Treatment, antibody, and the interaction of treatment and 
antibody were fit as fixed effects and cow was fit as a random effect (SAS/STAT User’s 
Guide, 1990).  A promoter region was considered enriched when the interaction 
between treatment and antibody was significant (P < 0.05). When a promoter region 
was significantly enriched by leptin treatment, correlations between the  ΔΔCt  for leptin 
treated adipocytes and normalized ATGL and phosphorylated STAT3 protein 
abundance were analyzed using PROC CORR of SAS (SAS/STAT User’s Guide, 
1990). Protein abundances were normalized by subtracting protein abundances from 
adipocytes treated with 100ng/mL of leptin from control adipocytes (Chapter 4). Results 
are presented as LSmeans of the ΔCt (Table 3) and as fold change differences in 
amplification of the target sequence following pull-down assay using STAT3 relative to 
IgG antibodies (2-(SE DNA – IC DNA)- (IE DNA-IC DNA)) in figure 1. 
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B.4 RESULTS AND DISCUSSION 
 The promoter region of HGF tended to be enriched with leptin treatment, while 
amplification of exon 4 and 5 of ATGL was similar for leptin and control treated 
adipocytes.  Promoter region 1 of ATGL was enriched with leptin treatment. 
Amplification of promoter region 1 of ATGL increased with leptin treated STAT3 
enriched samples compared to all other treatments (P < 0.05).  All other promoter 
regions examined were not enriched by treatment.  See table 3 for LSmeans and P-
values and figure 3 for ΔΔCt fold changes. 
 Enrichment of the promoter region of HGF serves as an important positive 
control of STAT3 signaling. The low number of biological samples and high variation of 
enrichment between cows may have prevented this enrichment from reaching 
significance.  Leptin treatment did not enrich STAT3 binding of exon 4 and 5 of ATGL 
demonstrating the specificity of this assay.  Enrichment of ATGL promoter region 1 
indicates that leptin increased ATGL protein abundance via STAT3 increased 
transcription of ATGL. Two putative transcription factor binding sites reside within the 
ATGL promoter region 1, and this assay was not sensitive enough to determine which 
of the two transcription factor binding site is enriched by leptin treatment. Regardless, 
this is the first study to demonstrate potential binding of STAT3 to the promoter region 
of ATGL under leptin treatment.  
Correlations between the enriched promoter region 1 and protein abundance for 
ATGL and phosphorylated STAT3 were not significant (Figure 4).  This is not surprising 
since only 3 biological replicates were used in this analysis. Interestingly, both ATGL 
and phosphorylated STAT3 abundance may be positively associated with enrichment of 
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ATGL promoter region 1 in the 2 samples (8200 and 8156) with similar enrichment, but 
the lowly enriched sample (8144) had higher protein abundance for both ATGL and 
phosphorylated STAT3.  The inclusion of additional biological samples would allow for a 
better understanding of STAT3 enrichment of ATGL promoter region 1.  
 These preliminary data provide evidence that STAT3 binds a DNA element less 
than 150 bps upstream of the ATGL start site.  The enriched amplicon contains two 
predicted STAT3 transcription factor binding sites, and the increased binding is 
dependent on leptin treatment. These results indicate that leptin may stimulate STAT3 
binding to the promoter region of ATGL, potentially increasing transcription and 
subsequent translation of ATGL. These results in combination with Chapter 4 provide 
multiple lines of evidence indicating STAT3 mediates leptin induced lipolysis.  
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B.5 TABLES 
Table 1. Predicted signal transducer and activator of transcription 3 binding sites from 
TRANSFAC with their corresponding core and matrix matches. 
 Position 
(strand) 
Core Match Matrix Match AT specific 
searcha 
Seq.1 (+) 0.928 0.892 X 
Seq.2 (+) 0.905 0.869 X 
Seq.3 (+) 0.941 0.853  
Seq.4 (+) 0.932 0.846  
Seq.5 (+) 0.898 0.864  
Seq.6 (-) 0.909 0.829 X 
Seq.7 (+) 1 0.893  
Seq.8 (+) 0.984 0.859  
aTRANSFAC allows for tissue specific prediction.  Those marked with X were identified 
as adipose tissue specific. 
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Table 2. Primer sequences used for quantitative real-time polymerase chain reaction of predicted transcription factor 
binding site (TFBS). 
Primer Name Primer Sequence Accession Number TFBSa   Amplicon Size 
(nucleotides) 
ATGL PR 1 
Forward 
5’-CCT CTT TCA CTT GTG TGC GG-3’ NM_001046005.2 1,2 119  
ATGL PR 1 
Reverse 
5’-GGC TGG CTG GCA GGC CCT GA-3’    
ATGL PR 2 
Forward 
5’-TCA GGG CCT GCC AGC CAG CC-3’ NM_001046005.2 3,4 138  
ATGL PR 2 
Reverse 
5’-GCA AGG ATC TTG GTC CCC AA-3’    
ATGL PR 3 
Forward 
5’- TTG GGA CCA AGA TCC TTG C-3’ NM_001046005.2 5 91 
ATGL PR 3 
Reverse 
5’-TCC AAC CGG GAA ATC ATC CC-3’    
ATGL PR 4 
Forward 
5’-CCT GCC CGA ATA TAG GAT GG-3’ NM_001046005.2 6,7 171  
ATGL PR 4 
Reverse 
5’-CCC GTC CGC TCA GAA ACC CC-3’    
ATGL PR 5 
Forward 
5’-CCA CCC AGT TCT AGT TCA GC-3’ NM_001046005.2 8* 155 
ATGL PR 5 
Reverse 
5’-AGA AAA TGC CAG CTT CTT CC- 3’    
ATGL exon 4 
Forward 
5’-AGC TCA AGA ACA CCA TCA CG-3’ NM_001046005.2 NBC
b 189  
ATGL exon 5 
Reverse 
5’-GTT TGC ACA TCT CTC GAA GC-3’    
HGF 
Forward 
5’-GAG AGA GTA AAG GGC TGT TGT T-3’ NM_001031751.1 PBCc 98 
HGF 
Reverse 
5’-GCG ATG AGC TAA GTT TGT TGT G-3’    
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a Abbreviations: ATGL, adipose triglyceride lipase; ATGL PR, ATGL promoter; HGF, 
hepatocyte growth factor 
b NBC refers to the negative binding control. 
c PBC refers to the positive binding controls.  
*Includes one consensus transcription factor binding site identified by JASPER.
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Table 3. Least squared (ls) means and P-values for analyses of DNA enrichment from pull down assays. 
Amplicon Controla Leptin  P-value 
 IgGb STAT3 IgG STAT3  SEM Treatment Antibody Interactionc 
ATGL PR 1 -0.702f -2.302 f -0.007f 3.655 g 1.943 0.190 0.362 0.045 
ATGL PR 2 -7.443 -4.918 -4.363 -0.802 2.540 0.206 0.276 0.845 
ATGL PR 3 -2.222 -2.255 0.155 2.582 1.983 0.010 0.265 0.253 
ATGL PR 4 -3.940 -2.803 -2.197 -0.058 3.801 0.506 0.623 0.879 
ATGL PR 5 0.585 1.640 -0.458 1.415 2.069 0.779 0.530 0.856 
HGF 1.045 -0.142 0.298 2.773 1.598 0.302 0.527 0.098 
ATGL  -1.550 -2.893 -1.470 -10.895 3.729 0.366 0.245 0.358 
Abbreviations: ATGL PR 1, Adipose triglyceride lipase (ATGL) promoter region 1; ATGL PR 2, ATGL promoter region 2; 
ATGL PR 3, ATGL promoter region 3; ATGL PR 4, ATGL promoter region 4; ATGL PR 5, ATGL promoter region 5; HGF, 
hepatocyte growth factor 
a Control and Leptin represent either the untreated or leptin treatments adipocytes, respectively.  
b IgG and STAT3 represent antibodies applied to DNA pull-down samples.  
c Interaction refers to the interaction between treatment and antibody.  
d LSmeans were calculated from the ΔCt.    
Differences in subscripts indicated differences in pairwise comparisons. 
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B.6 FIGURES 
 
Figure 1.  The region upstream of the ATGL start site including predicted 
transcription factor binding sites from TRANSFAC and JASPER.  TRANSFAC 
predicted are numbered according to their identification by TRANSFAC and are listed in 
table 1. Sequences identified in the 5’ to 3’ orientation are in red font and those in the 3’ 
to 5’ orientation are in purple font. Lowercase letters indicate nucleotides included in the 
core matches, and all other nucleotides in a different color were included in the matrix 
matches. Sequences predicted by JASPER are all in the 5’ to 3 prime orientation and 
are in blue font.  Amplified products using primers listed in table 2 are in different 
colored boxes.  The promoter regions (PR) were labeled 1-5 according to their location 
from the start site.  PR 1 is outlined in a blue box, PR 2 is outlined in a green box, PR3 
is outlined in a black box, PR 4 is outlined in a red box, and PR 5 is outlined in a purple 
box.  
 
Figure 2. Experimental design for the DNA pull-down. A) Overview of laboratory 
techniques. 1) Harvested adipocytes were treated with leptin or media for 20 minutes.  
2)  Protein bound to DNA is crosslinked. 3)  DNA is sheared using micrococcal 
nuclease. 4)  A portion of the sheared DNA is saved as Input control (IC) and the 
remainder of the samples is exposed to either STAT3 (SE) or IgG (IE) antibody for 72 
hours then DNA was pulled down using protein A/G beads. 5)  All DNA is purified after 
proteinase K digestion. 6) Semi-quantitative PCR was performed using the purified DNA 
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from step 5. B) Formulas used to calculate ΔCt values used for statistical analyses and 
fold change calculated by ΔΔCt.  
 
Figure 3.  Fold change between DNA exposed to IgG and STAT3 antibodies for 
control and leptin treated adipocytes.  A) and B) Fold change of the amplification of 
DNA exposed to the IgG and STAT3 antibodies.  The dark gray box represents the fold 
change for the control adipocytes and the light gray box represents the fold change for 
the adipocytes treated with 100 ng/mL of leptin for 20 minutes. ATGL exon refers to 
primers designed to amplify exons in ATGL and serves as the negative binding control. 
HGF refers to the primers designed to amplify the known STAT3 transcription factor 
binding site in hepatocyte growth factor and serves as the positive binding control. 
ATGL PR1-5 refer to the promoter regions (PR) that were tested for enrichment as 
defined in figure 1 and table 2.  These regions were designed to encompass eight 
predicted transcription factor binding regions.  † represents tendencies in enrichment as 
defined by a P value < 0.1 for the interaction of antibody (IgG and STAT3) and 
treatment (control and Leptin), and * represents significance enrichment as defined by a 
P -value < 0.05 for the interaction of antibody (IgG and STAT3) and treatment (control 
and Leptin). 
Figure 4.  Scatterplots of the fold change of leptin treated adipocytes for adipose 
triglyceride lipase (ATGL) promoter region1 with A) ATGL protein abundance and 
B) phosphorylated STAT 3 protein abundance of leptin treated adipocytes 
compared to control adipocytes.  
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